syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187	100.0
RECURRENT ACUTE PANCREATITIS	2.376392149	89.15308487612562
HEREDITARY ANGIOEDEMA TYPE 1	1.9032674999999997	71.4032694649638
AFRICAN IRON OVERLOAD	1.8018226700000002	67.59744998224924
CHILDHOOD ABSENCE EPILEPSY	1.52074085	57.05234219516074
HEPATOCELLULAR CARCINOMA	1.4720719	55.226470555243154
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	1.4639773090000001	54.92279266320661
LYMPHEDEMA, HEREDITARY, III	1.3763795539999997	51.63646212648967
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	1.345413664	50.47474114512872
AUTOIMMUNE HEPATITIS	1.3350949799999998	50.087623845970384
SECKEL SYNDROME 10; SCKL10	1.25934579	47.245805853847514
MYOCLONIC-ASTASTIC EPILEPSY	1.220712254	45.79642431321154
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	1.20271637	45.121288025478876
%210500 BILIARY ATRESIA, EXTRAHEPATIC; EHBA	1.19721556	44.914918811111704
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.78280343709462
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1521162600000001	43.22296669687593
LYMPHATIC MALFORMATION 1	1.1421568	42.84932609926916
HEPATOCELLULAR CARCINOMA	1.1145833	41.814874530799585
PULMONARY ARTERIOVENOUS MALFORMATION	1.083874719	40.66280679253911
CRANIOECTODERMAL DYSPLASIA 1	1.07100188	40.179867430680574
MOSAIC TRISOMY 1	1.0588235	39.72298149699719
WILSON DISEASE	1.04164923	39.078669003522656
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	1.040758319	39.045245452601776
MONOSOMY 22Q13.3	1.0368301329999998	38.89787503647976
TEMPI SYNDROME	1.027027	38.53009922609059
COMPLEX REGIONAL PAIN SYNDROME	1.0263158	38.50341774004436
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	1.0204082	38.28178733092363
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	1.017013454	38.154429529982295
MEVALONIC ACIDURIA; MEVA	1.0163665039999998	38.130158456588575
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	1.01497094	38.077802267903806
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.00934579	37.86676829541658
PREECLAMPSIA	1.00720026	37.786276269605615
DISTAL 16P11.2 MICRODELETION SYNDROME	1.0010869729999998	37.556929276091736
LOWRY-MACLEAN SYNDROME	1.000541419	37.53646219026713
HEPARIN-INDUCED THROMBOCYTOPENIA	1.0	37.51615023372374
268040 RETINOHEPATOENDOCRINOLOGIC SYNDROME;;RHE SYNDROME	1.0	37.51615023372374
ENTEROKINASE DEFICIENCY	1.0	37.51615023372374
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.51615023372374
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	1.0	37.51615023372374
CONGENITAL MACROGLOSSIA	1.0	37.51615023372374
CARDIAC-UROGENITAL SYNDROME; CUGS	1.0	37.51615023372374
AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK	1.0	37.51615023372374
PRIMARY SCLEROSING CHOLANGITIS	0.9982306599999999	37.4497714084692
HYPERCHOLESTEROLEMIA DUE TO CHOLESTEROL 7ALPHA-HYDROXYLASE DEFICIENCY	0.9759634	36.61438953701582
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.05661993667499
ISOLATED BILIARY ATRESIA	0.884160819	33.17031011637623
JUVENILE POLYPOSIS SYNDROME	0.875	32.826631454508274
MARTINEZ-FRIAS SYNDROME	0.833333	31.26344602271971
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.8047616	30.19155708793189
LAFORA DISEASE	0.7730060599999999	29.00021147853887
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.910586896276513
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.750483724	28.155260137548467
EARLY MYOCLONIC ENCEPHALOPATHY	0.708728914	26.588780412607875
SOMATOSTATINOMA	0.7064654800000001	26.50386508261976
AGEL AMYLOIDOSIS	0.7014771	26.31672026911685
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.7	26.261305163606618
LYSINURIC PROTEIN INTOLERANCE	0.68440929	25.6764017449962
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.681916754	25.582891389957236
ANGIOEDEMA, HEREDITARY, TYPE III	0.6635850999999999	24.89515830446059
MEIGE DISEASE	0.6604669	24.778175444801796
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.6582567500000001	24.695259125362735
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.622449579	23.351911918682095
DUPLICATION/INVERSION 15Q11	0.611652419	22.94684404202454
RING CHROMOSOME 13 SYNDROME	0.611111	22.92653208548115
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59421851	22.292790892819475
GRAFT VERSUS HOST DISEASE	0.59266153	22.23437899722857
ALAGILLE SYNDROME 1; ALGS1	0.59108942	22.17539948228463
ROLANDIC EPILEPSY	0.5906213	22.157837422037222
SICKLE CELL ANEMIA	0.5870826	22.025079021205144
GALLBLADDER NEUROENDOCRINE TUMOR	0.5839289000000001	21.90676433821305
METACHROMATIC LEUKODYSTROPHY	0.582375619	21.84849121486186
MECKEL SYNDROME, TYPE 6; MKS6	0.5692983	21.357880550603532
MECKEL SYNDROME	0.5666667	21.25915304964846
LATHOSTEROLOSIS	0.566511189	21.253318875609466
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.56629196	21.245094247509876
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.565363104	21.210247146268383
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.563041419	21.123146463012997
DIAPHANOSPONDYLODYSOSTOSIS	0.559369054	20.98537346595993
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.55918473	20.97845833908425
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.842307352786534
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.5552631600000001	20.831336129812186
PETERS-PLUS SYNDROME; PTRPLS	0.553718573	20.77338917187113
PULMONARY FIBROSIS-HEPATIC HYPERPLASIA-BONE MARROW HYPOPLASIA SYNDROME	0.5425042600000001	20.352671320595128
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.5357143	20.09793816115415
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5348101000000001	20.06401605811282
HEREDITARY ANGIOEDEMA	0.5302521	19.893017445347503
ACQUIRED ANGIOEDEMA	0.5302521	19.893017445347503
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.772024109228724
SPLENOPORTAL VASCULAR ANOMALIES	0.52536235	19.709572849742155
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.525177614	19.702642266212575
ALAGILLE SYNDROME	0.52392578	19.655678273800895
PAROXYSMAL HEMICRANIA	0.5227273	19.61071591806878
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.520228924	19.51698646871245
MOSAIC TRISOMY 9	0.515470954	19.3384857513849
NUCHAL BLEB, FAMILIAL	0.5149254	19.31801866556029
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.51301586	19.24638007604299
CREST SYNDROME	0.50862069	19.08149021802023
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.022273225845314
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.502018519	18.833802178915498
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.501086973	18.798854159229876
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.501086973	18.798854159229876
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.500545554	18.77854220268648
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.75807511686187
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.75807511686187
PSEUDOXANTHOMA ELASTICUM; PXE	0.5	18.75807511686187
NPHP3-RELATED MECKEL-LIKE SYNDROME	0.5	18.75807511686187
MATTHEW-WOOD SYNDROME	0.5	18.75807511686187
INHALATIONAL ANTHRAX	0.5	18.75807511686187
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.5	18.75807511686187
PORTAL VEIN, CAVERNOUS TRANSFORMATION OF	0.5	18.75807511686187
PRIMARY BILIARY CHOLANGITIS	0.4944281099999999	18.549039254536083
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.42766089	16.044190198328003
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.422928519	15.866649856930287
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42074085000000006	15.784576938064628
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.415131304	15.57412836758564
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.414724933	15.558882892099014
SARCOIDOSIS	0.41207636999999997	15.45951900468753
KLATSKIN TUMOR	0.41172834	15.44646225892169
PMM2-CDG	0.411168203	15.425448075078222
SPINOCEREBELLAR ATAXIA TYPE 10	0.40889129999999996	15.340027440062604
IMMUNE DEFICIENCY DISEASE	0.4047616	15.185096994442397
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.39458529	14.803321019657451
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.39458396	14.803271123177641
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.39154326	14.689195765161955
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.389601104	14.616333548888626
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.38836981000000004	14.570140138202747
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.37616221299999997	14.112158095157989
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.375541419	14.088868294189796
COG4-CDG	0.36679626400000004	13.760783745392596
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.676884352752804
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.363568459	13.639688928087432
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.360577999	13.527498381459488
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.36035523399999997	13.519141096252675
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769365
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769365
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.35683145299999997	13.38694239886593
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.307012252437023
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.35022597	13.139130106271624
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.34964553	13.117354232029962
CHYLOMICRON RETENTION DISEASE	0.34660036	13.003111176822731
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.344263504	12.915441336052154
OVARIAN HYPERSTIMULATION SYNDROME	0.3418371	12.824411999060448
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841279
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.339499569	12.736716834888458
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.33859616	12.702824407121959
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.33831527	12.692286495682811
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.33503688	12.569293923918073
DUODENAL NEUROENDOCRINE TUMOR	0.33397086	12.529300957445919
CODAS SYNDROME	0.333878554	12.525837991682446
MITCHELL-RILEY SYNDROME; MTCHRS	0.3333333	12.505382160702908
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.505370905857834
SPINOCEREBELLAR ATAXIA TYPE 42	0.333333	12.505370905857834
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.333333	12.505370905857834
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857834
ACITRETIN/ETRETINATE EMBRYOPATHY	0.333333	12.505370905857834
PLACENTAL INSUFFICIENCY	0.333333	12.505370905857834
APOLIPOPROTEIN A-I; APOA1	0.333333	12.505370905857834
CHOLANGIOCARCINOMA	0.333333	12.505370905857834
16P12.1P12.3 TRIPLICATION SYNDROME	0.333333	12.505370905857834
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857834
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 3	0.33018661000000005	12.387330465923952
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.32847085000000004	12.322961755998938
TRISOMY 8P	0.327464519	12.285208091018083
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.32296933999999994	12.1165662803266
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.321413119	12.058182859493728
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.32001585	12.005762705772801
ARGININOSUCCINIC ACIDURIA	0.316388853	11.869691741423537
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.31622816000000004	11.863663158694031
ALSTROM SYNDROME; ALMS	0.307183194	11.524330855379105
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.3055556	11.463269794355597
WILSON DISEASE	0.30493573999999996	11.44001503347172
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	11.302918790252718
LEPTOSPIROSIS	0.30106183	11.294680843919796
SCLEROSING CHOLANGITIS, NEONATAL	0.29839536	11.19464515480608
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.2982093	11.187664899893594
HEMOCHROMATOSIS, NEONATAL	0.29807505	11.182628356724717
CHOLANGIOCARCINOMA	0.29693016	11.139676491483629
PEUTZ-JEGHERS SYNDROME	0.291667	10.942222990219504
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.28888256	10.837761520862713
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.281158884	10.547998931690108
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.281158884	10.547998931690108
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.28062515	10.52797528676126
POTOCKI-LUPSKI SYNDROME	0.27936987300000005	10.480882126244325
EISENMENGER SYNDROME	0.27801968	10.4302280828118
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.2763158	10.366305064751563
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.27619053299999996	10.361605529160233
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.27432977	10.29179686490288
VIPOMA	0.27313218	10.246867898544476
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.272763619	10.233040908698184
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 1	0.27221556	10.21247984491724
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 2	0.27221556	10.21247984491724
BARE LYMPHOCYTE SYNDROME, TYPE II	0.2714286	10.18295613532931
GCGR-RELATED HYPERGLUCAGONEMIA	0.2712766	10.177253680493783
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.2712766	10.177253680493783
POEMS SYNDROME	0.2704082	10.144674655630816
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.26882296	10.085202553634307
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.26683558	10.01064370698281
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.26566239	9.966630134690108
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.26490139	9.938080344362245
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.261508394	9.81078819668382
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.25966720400000004	9.741713836034991
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.259237069	9.725576826754208
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.259237069	9.725576826754208
118900 CIRRHOSIS, FAMILIAL	0.25869565	9.705264870210815
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.257508159	9.660714779453622
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.256172413	9.610602731843525
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.256166569	9.61038348746156
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.256166569	9.61038348746156
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.256101154	9.60792936849402
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25562995400000005	9.590251758503891
GLYCOGEN STORAGE DISEASE VI	0.25562514999999997	9.590071530918165
CHILDHOOD APRAXIA OF SPEECH	0.2555556	9.58746228266941
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.2555556	9.58746228266941
LAMBERT SYNDROME	0.25526316	9.57649105969506
LAMBERT SYNDROME	0.25526316	9.57649105969506
PEHO SYNDROME; PEHO	0.25505497299999996	9.568680684926353
KETOADIPICACIDURIA	0.25505497299999996	9.568680684926353
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.25498227	9.565953148255911
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.254042054	9.53067986354776
ACRAL SELF-HEALING COLLODION BABY	0.25396799999999997	9.527901642558351
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.25396799999999997	9.527901642558351
KASABACH-MERRITT SYNDROME	0.25327869	9.502041385040743
NON-INVOLUTING CONGENITAL HEMANGIOMA	0.25327869	9.502041385040743
RAPIDLY INVOLUTING CONGENITAL HEMANGIOMA	0.25327869	9.502041385040743
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.252564073	9.47523170630917
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.252450614	9.470975161419803
8P INVERTED DUPLICATION/DELETION SYNDROME	0.252446179	9.470808777293517
DISTAL TRISOMY 5Q	0.25190476	9.450496820750123
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.25170358	9.442949321646102
GLYCOGEN STORAGE DISEASE IXB	0.25170358	9.442949321646102
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2506428	9.403152939801174
PALLISTER-HALL SYNDROME	0.250545554	9.399504644255545
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.25	9.379037558430936
KETAMINE-INDUCED BILIARY DILATATION	0.25	9.379037558430936
MEDULLARY THYROID CARCINOMA	0.25	9.379037558430936
HYPEREKPLEXIA 1; HKPX1	0.25	9.379037558430936
NEUROFIBROMA	0.25	9.379037558430936
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.379037558430936
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.25	9.379037558430936
MENTAL RETARDATION, BUENOS AIRES TYPE	0.25	9.379037558430936
PEHO SYNDROME	0.248513754	9.323279330210665
NAVAJO NEUROHEPATOPATHY	0.24767835400000002	9.291938338305412
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.24425798	9.16361907346589
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.24304515400000004	9.118118511042525
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.24223708000000002	9.08780268545856
GAUCHER DISEASE TYPE 1	0.23999372000000002	9.003640454670231
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.2399687	9.002701800591382
FIBROSCLEROSIS, MULTIFOCAL	0.237037	8.892715702951175
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.234614804	8.80184423391965
LENNOX-GASTAUT SYNDROME	0.23257131	8.725180206013937
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.23069506	8.654790529137914
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.23065328899999998	8.6532234420265
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.22801686000000002	8.554314775581954
PPOMA	0.22774208	8.544006087820733
GRFOMA	0.22774208	8.544006087820733
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.226476114	8.496511917173946
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.475991933577507
HALOTHANE HEPATITIS	0.22567136	8.466320645208754
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME	0.22472750000000005	8.430910651649153
BETA-THALASSEMIA INTERMEDIA	0.22309419	8.369635148310909
PYKNOACHONDROGENESIS	0.22272730000000002	8.355870847951659
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.22022892400000002	8.262141398595329
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.21837028	8.19241223106032
TETRASOMY 9P	0.21658819299999998	8.125555187438753
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.21554631300000004	8.086467860833242
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.21201585000000003	7.954018480530639
%211890 CAMPOMELIA, CUMMING TYPE;;CERVICAL LYMPHOCELE WITH BOWED LONG BONES;;CUMMING SYNDROME	0.21111110000000002	7.920075743606677
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.20696674	7.764595311224041
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.20666700000000002	7.753350220352985
GLUCAGONOMA	0.20646548000000003	7.745789965757886
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.205148293	7.696374180379978
CARCINOID SYNDROME	0.20392157000000002	7.650352256016814
CRYOGLOBULINEMIC VASCULITIS	0.20170358000000002	7.567141809959916
ISOLATED POLYCYSTIC LIVER DISEASE	0.20170358000000002	7.567141809959916
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.201086973	7.544009089112751
TUBEROUS SCLEROSIS COMPLEX	0.2010849	7.543931318133317
BRANCHIOSKELETOGENITAL SYNDROME	0.200541419	7.523542003288142
LYMPHATIC MALFORMATION 7; LMPHM7	0.2001867	7.5102343119933845
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.50323004674475
MODY	0.2	7.50323004674475
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.50323004674475
CARNEY COMPLEX	0.2	7.50323004674475
SCARF SYNDROME	0.2	7.50323004674475
SOLITARY BONE CYST	0.2	7.50323004674475
MYOTONIA FLUCTUANS	0.2	7.50323004674475
BLEPHAROCHALASIS, SUPERIOR	0.2	7.50323004674475
BLEPHAROCHALASIS AND DOUBLE LIP	0.2	7.50323004674475
HEPATIC ADENOMAS, FAMILIAL	0.2	7.50323004674475
EOSINOPHILIC FASCIITIS	0.2	7.50323004674475
AXIAL OSTEOMALACIA	0.2	7.50323004674475
DYSFERLIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R2	0.2	7.50323004674475
CLEFT VELUM	0.2	7.50323004674475
CARCINOMA OF GALLBLADDER AND EXTRAHEPATIC BILIARY TRACT	0.19320676	7.248373834331007
PERIPARTUM CARDIOMYOPATHY	0.1929828	7.2399717173246625
NON-HISTAMINIC ANGIOEDEMA	0.19190030000000002	7.199360484696657
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.18939175000000003	7.105249346027849
NEPHRONOPHTHISIS 18; NPHP18	0.1888892	7.08639560472789
LIVER FAILURE, INFANTILE, TRANSIENT	0.18781141	7.045961073167486
SMITH-LEMLI-OPITZ SYNDROME	0.18491047300000002	6.9371290848569185
GRACILE SYNDROME	0.18312063999999997	6.86998144113564
JUVENILE MYOCLONIC EPILEPSY	0.18297529999999998	6.864528843860672
HELLP SYNDROME	0.18237036	6.841833823938283
MICROSPORIDIOSIS	0.18166391899999998	6.815330877251021
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	6.801145833266899
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	6.801145833266899
CAROLI DISEASE, ISOLATED	0.17972128	6.7424505406771305
H SYNDROME	0.17871520000000002	6.704706292249986
YELLOW NAIL SYNDROME	0.17777810000000002	6.669549907865964
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.177738004	6.668045660306192
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.17771637	6.667234035912036
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.17705954300000004	6.642592415502471
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.17699127000000003	6.640031075377563
TURNER SYNDROME	0.17672501000000002	6.630042025216332
MONOSOMY X	0.17672501000000002	6.630042025216332
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.17672501000000002	6.630042025216332
MOSAIC MONOSOMY X	0.17672501000000002	6.630042025216332
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.176255884	6.612442223721785
AICARDI SYNDROME; AIC	0.17511530000000003	6.569651903023605
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.17498253000000002	6.564670883757073
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.17448915999999998	6.546161540716258
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.174231054	6.536478397244035
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.17218615400000004	6.459761621631094
AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE	0.1719299	6.4501479580691
UNILATERAL POLYMICROGYRIA	0.16990646	6.374236279040174
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.169658733	6.364942515691224
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.169457553	6.357395016587204
LEIGH SYNDROME; LS	0.169231073	6.34889835888227
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.16911731400000002	6.344630559147832
DISTAL MONOSOMY 12Q	0.169117014	6.344619304302762
13Q12.3 MICRODELETION SYNDROME	0.16857176000000001	6.324163473323223
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.167571403	6.286633929823866
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.167571403	6.286633929823866
LIGNEOUS CONJUNCTIVITIS	0.167212254	6.273160041983574
CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1	0.166667	6.252704211004036
HYPERPLASTIC POLYPOSIS SYNDROME	0.166667	6.252704211004036
RIN2 SYNDROME	0.166667	6.252704211004036
NEOVASCULAR GLAUCOMA	0.166667	6.252704211004036
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2; ADMIO2	0.166667	6.252704211004036
ASCHER SYNDROME	0.166667	6.252704211004036
MÉNÉTRIER DISEASE	0.166667	6.252704211004036
AMOEBIC KERATITIS	0.166667	6.252704211004036
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.166667	6.252704211004036
FAMILIAL IDIOPATHIC STEROID-RESISTANT NEPHROTIC SYNDROME	0.166667	6.252704211004036
HERPES SIMPLEX VIRUS STROMAL KERATITIS	0.166667	6.252704211004036
NEPHROTIC SYNDROME, TYPE 15; NPHS15	0.166667	6.252704211004036
NEUROTROPHIC KERATOPATHY	0.166667	6.252704211004036
SCALP-EAR-NIPPLE SYNDROME; SENS	0.1655843	6.212085475145982
SCALP-EAR-NIPPLE SYNDROME	0.1655843	6.212085475145982
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.16488410000000003	6.18581666675233
RARE HEREDITARY HEMOCHROMATOSIS	0.16475635	6.1810239785599705
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.16178346400000002	6.069492740756237
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.16025640000000002	6.012203178315727
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.98403980433527
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.98403980433527
FAMILIAL PANCREATIC CARCINOMA	0.15932823000000002	5.977381813153291
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.15882676999999998	5.958568964457086
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.15854980000000002	5.9481781163268534
CONGENITAL ENTEROVIRUS INFECTION	0.15816579	5.9337715394756
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.15663521900000002	5.87635040789622
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.155878654	5.847967001694643
WOLF-HIRSCHHORN SYNDROME	0.154591073	5.799661919460554
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.72728354897679
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	5.6871294881555325
ENHANCED S-CONE SYNDROME	0.15147769	5.682859775097433
BECKWITH-WIEDEMANN SYNDROME	0.15005528	5.629496427843482
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.14970512000000002	5.616359772677642
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.14786326000000002	5.5472602762081555
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.147740053	5.542638023886308
JOHANSON-BLIZZARD SYNDROME; JBS	0.1472222	5.523210172939323
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.146899054	5.5110869790558965
XANTHINURIA, TYPE I	0.14664487999999998	5.501551349086389
ACERULOPLASMINEMIA	0.14623886	5.4863190417684935
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.14549495399999998	5.458410552512725
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.1454082	5.455155876415349
NEUROFIBROMATOSIS TYPE 1	0.14487551899999998	5.435171735992697
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.14476176	5.43090393625826
COMBINED SAPOSIN DEFICIENCY	0.14456058	5.42335643715424
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14438761	5.416867268648313
SCHINZEL-GIEDION SYNDROME	0.14285720000000002	5.35945217716912
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.14285699999999998	5.3594446739390715
RETINITIS PIGMENTOSA 27; RP27	0.14285699999999998	5.3594446739390715
POSTERIOR URETHRAL VALVE	0.14285699999999998	5.3594446739390715
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.14285699999999998	5.3594446739390715
HAND-FOOT-GENITAL SYNDROME; HFG	0.14285699999999998	5.3594446739390715
WOLFRAM-LIKE SYNDROME	0.14285699999999998	5.3594446739390715
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.14285699999999998	5.3594446739390715
STEINERT MYOTONIC DYSTROPHY	0.14285699999999998	5.3594446739390715
IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION	0.14285699999999998	5.3594446739390715
IDIOPATHIC ANTERIOR UVEITIS	0.14285699999999998	5.3594446739390715
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.14285699999999998	5.3594446739390715
IRVAN SYNDROME	0.14285699999999998	5.3594446739390715
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3594446739390715
DISTAL TRISOMY 14Q	0.14285699999999998	5.3594446739390715
RETINITIS PIGMENTOSA 11	0.14285699999999998	5.3594446739390715
LYMPHEDEMA, HEREDITARY, II	0.14215680000000003	5.333175865545421
SECONDARY INTESTINAL LYMPHANGIECTASIA	0.14116840000000003	5.296094902654408
AL AMYLOIDOSIS	0.14026438	5.262179552520116
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.13869371400000002	5.203254210897114
TRICHOHEPATOENTERIC SYNDROME 1	0.13866399000000001	5.202139080847568
HENNEKAM SYNDROME	0.137688919	5.165558170723019
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.136382004	5.116527751240312
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.1359649	5.100879614913225
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.13438346	5.041550074287605
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.134261954	5.036991636937306
CASTLEMAN DISEASE	0.13354185	5.0099761070894
WILLIAMS SYNDROME	0.1327317	4.97958239797755
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.1302521	4.886557351858008
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.130193104	4.88434404905882
INTESTINAL LYMPHANGIECTASIA	0.13005730000000001	4.87924920579248
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.12957786000000002	4.861262462724423
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.12835239999999998	4.815287921259002
FUCOSIDOSIS	0.127790553	4.794209584798637
TRIPLOIDY	0.12670358	4.753430542430635
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.126086973	4.730297821583469
TRANSALDOLASE DEFICIENCY	0.12572612	4.716760006223179
VACTERL/VATER ASSOCIATION	0.125	4.689518779215468
GENITOPALATOCARDIAC SYNDROME	0.125	4.689518779215468
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.125	4.689518779215468
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.125	4.689518779215468
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.125	4.689518779215468
PANCREATIC INSUFFICIENCY, COMBINED EXOCRINE	0.125	4.689518779215468
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.12467241399999998	4.677229013625003
SOLAR URTICARIA	0.12406020000000001	4.654261101225814
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.12388457300000003	4.647672252308717
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.12293674999999998	4.612113582245737
LYMPHANGIOLEIOMYOMATOSIS	0.12276351899999999	4.605614622024599
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.12219530399999999	4.5842973827195435
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.121460199	4.556719073101982
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.120915814	4.536295843656997
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.12061402900000001	4.524974032258712
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.12005800999999999	4.504114339921907
WILD TYPE ATTR AMYLOIDOSIS	0.11985618	4.4965424553202356
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11869880399999999	4.453122163427328
SYSTEMIC CAPILLARY LEAK SYNDROME	0.11815260000000001	4.432630692105068
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.11747741	4.40730016262876
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.11626946899999999	4.361982866599285
LYSOSOMAL ACID LIPASE DEFICIENCY	0.11536828400000002	4.328173874750908
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.1150926	4.317831272389873
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.11489887999999998	4.310563643766596
NIEMANN-PICK DISEASE TYPE B	0.11474503	4.304791784053138
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.11428187000000001	4.2874158039108865
DEHYDRATED HEREDITARY STOMATOCYTOSIS	0.11323059	4.247975825493178
IMMUNODEFICIENCY 23; IMD23	0.11313365399999999	4.24433915995412
JOUBERT SYNDROME 2	0.11313365399999999	4.24433915995412
PGM3-CDG	0.11312951899999998	4.244184030672904
REFSUM DISEASE	0.11258809999999998	4.2238720741295115
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.11221571000000001	4.209901434943976
COFFIN-SIRIS SYNDROME 1; CSS1	0.11219797299999999	4.20923601098728
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.11219797299999999	4.20923601098728
DOWN SYNDROME	0.11190470000000001	4.198233537059786
MICROVILLUS INCLUSION DISEASE	0.11165655399999999	4.188924054443888
NON-DISTAL MONOSOMY 20Q	0.11165241899999999	4.188768925162671
FRYNS SYNDROME; FRNS	0.11165241899999999	4.188768925162671
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.11165241899999999	4.188768925162671
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.11165241899999999	4.188768925162671
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.11111120000000001	4.168464471849326
COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D	0.11111099999999999	4.168456968619278
SEVERE CONGENITAL NEMALINE MYOPATHY	0.11111099999999999	4.168456968619278
WELL-DIFFERENTIATED LIPOSARCOMA	0.11111099999999999	4.168456968619278
RADIO-RENAL SYNDROME	0.11111099999999999	4.168456968619278
LIPODYSTROPHY, PARTIAL, ACQUIRED, WITH LOW COMPLEMENT COMPONENT C3, WITH OR WITHOUT GLOMERULONEPHRITIS; APLDC3	0.11111099999999999	4.168456968619278
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.11111099999999999	4.168456968619278
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.11111099999999999	4.168456968619278
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.11111099999999999	4.168456968619278
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.11090585400000001	4.160760680463431
MILROY DISEASE	0.10964910000000001	4.113612108592599
CITRULLINEMIA TYPE II	0.109429113	4.1053590432511315
BETA-THALASSEMIA MAJOR	0.10752726	4.0340088403806735
HEMOCHROMATOSIS TYPE 4	0.10743544	4.030564107466213
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000001	4.005181580605681
BILATERAL POLYMICROGYRIA	0.106565524	3.997928208119493
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.106166569	3.982960952402998
HARDIKAR SYNDROME	0.10557271000000001	3.960681648941349
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.105527824	3.9589976990219586
BUDD-CHIARI SYNDROME	0.10533976	3.9519422617444033
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4	0.10450580000000001	3.9206552930954874
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.10438218	3.9160175466035936
NOCARDIOSIS	0.10428291900000002	3.912293656015245
MELIOIDOSIS	0.10374150000000001	3.891981699471852
AICARDI SYNDROME	0.1036867	3.8899258144390436
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.10266750000000001	3.8516893541208326
WALDENSTRÖM MACROGLOBULINEMIA	0.10253628000000001	3.846766484887163
ADAMS-OLIVER SYNDROME	0.102438259	3.8430891143251036
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.10230656300000002	3.838148387403924
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.102249134	3.8359938724121503
ACROCEPHALOSYNDACTYLY	0.10195418	3.8249283338361124
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.1017026	3.8154900207603126
CONGENITAL ISOLATED ACTH DEFICIENCY	0.10096379999999999	3.7877730889676373
INSULIN-RESISTANCE SYNDROME TYPE B	0.10050099	3.7704102394779677
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.10032689400000001	3.7638788277868778
BARDET-BIEDL SYNDROME 1; BBS1	0.10025271399999999	3.76109587976254
SYNDROMIC DIARRHEA	0.09904008400000001	3.7156026705046195
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	3.7123395157572903
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.09880425400000001	3.706755236795
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.0984556	3.693675080951411
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.098393854	3.69135860873908
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.098393854	3.69135860873908
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.098393854	3.69135860873908
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.681154065810906
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.681154065810906
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.09744489	3.655757132748685
KAWASAKI DISEASE	0.09679205	3.6312650892301006
KAPOSI SARCOMA	0.0957671	3.592812911048045
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.09575837000000001	3.5924853950565048
SIALURIA	0.09559252300000001	3.586263454088693
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.09555889900000002	3.585002011053234
KAGAMI-OGATA SYNDROME	0.095242873	3.5731459321594707
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.09480348000000001	3.556661598359825
ENTERIC ANENDOCRINOSIS	0.0946844	3.5521941751899924
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.09444440000000001	3.543190299133899
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.09444440000000001	3.543190299133899
BLAU SYNDROME	0.09415590000000001	3.5323668897914695
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.09354038	3.509274948999608
NEPHRONOPHTHISIS 19; NPHP19	0.09322408	3.4974085906806813
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.093138154	3.494184977955698
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.093025213	3.4899478664321504
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.09282763999999999	3.4825356880820233
MECKEL SYNDROME, TYPE 5	0.09263160000000001	3.475181021990205
COACH SYNDROME	0.092521673	3.471056984143462
NEONATAL HEMOCHROMATOSIS	0.09166669999999999	3.438981688629684
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.090911713	3.4106574829131757
DDOST-CDG	0.09073187900000002	3.4039108035520447
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.09017040400000001	3.382846423099565
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.089585314	3.360896098759315
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.08896295400000001	3.337547547499855
CIRRHOSIS, FAMILIAL	0.08859646000000002	3.323798103536097
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.088481873	3.319499240429265
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0881577	3.307337517459548
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.08661199000000001	3.2493484288817793
THANATOPHORIC DYSPLASIA TYPE 2	0.086391919	3.2410922121836925
THANATOPHORIC DYSPLASIA TYPE 1	0.086391919	3.2410922121836925
THANATOPHORIC DYSPLASIA	0.086391919	3.2410922121836925
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.085794449	3.21867743790355
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.08535181900000001	3.202071664325597
CONGENITAL ANALBUMINEMIA	0.0851393	3.194098769594076
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE I; CDG1	0.08503688000000001	3.190256365487138
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE II; CDG2	0.08503688000000001	3.190256365487138
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.08503688000000001	3.190256365487138
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.08503688000000001	3.190256365487138
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-NEGATIVE	0.08503688000000001	3.190256365487138
CHRONIC GRANULOMATOUS DISEASE	0.08503688000000001	3.190256365487138
VON HIPPEL-LINDAU DISEASE	0.08481040000000001	3.1817597077822044
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.084802034	3.1814458476693486
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.084692319	3.1773297632464557
BURKITT LYMPHOMA	0.08465600000000001	3.1759672141861177
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.08465600000000001	3.1759672141861177
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.08456676900000001	3.1726196105846123
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.08442027300000002	3.1671236446399726
ILEAL NEUROENDOCRINE TUMOR	0.08397086000000001	3.150263399014984
JEJUNAL NEUROENDOCRINE TUMOR	0.08397086000000001	3.150263399014984
%300712 CRANIOFACIOSKELETAL SYNDROME	0.08387885400000002	3.1468116880965806
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.08347680000000002	3.1317281698305113
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.08333330000000001	3.1263446022719714
OVERHYDRATED HEREDITARY STOMATOCYTOSIS	0.08333330000000001	3.1263446022719714
MYCETOMA	0.08333330000000001	3.1263446022719714
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.08333330000000001	3.1263446022719714
184705 STEINFELD SYNDROME	0.08333330000000001	3.1263446022719714
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.08333330000000001	3.1263446022719714
PENTALOGY OF CANTRELL	0.08333330000000001	3.1263446022719714
PAPILLON-LEFÈVRE SYNDROME	0.08333330000000001	3.1263446022719714
APLASIA CUTIS CONGENITA WITH INTESTINAL LYMPHANGIECTASIA	0.08333330000000001	3.1263446022719714
BULLOUS IMPETIGO	0.08333330000000001	3.1263446022719714
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.08333330000000001	3.1263446022719714
FAMILIAL MELANOMA	0.08333330000000001	3.1263446022719714
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.08333330000000001	3.1263446022719714
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.08333330000000001	3.1263446022719714
CONGENITAL ALVEOLAR CAPILLARY DYSPLASIA	0.08333330000000001	3.1263446022719714
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.08333330000000001	3.1263446022719714
RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS	0.08333330000000001	3.1263446022719714
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.08312401900000001	3.118493184834907
DILATED CARDIOMYOPATHY WITH ATAXIA	0.082863189	3.1087078473694447
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.08254825	3.096892548530986
ALPORT SYNDROME	0.08222609	3.08480634557169
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.081677879	3.064239579335909
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.0815921	3.061021481485011
CHROMOSOME 1P36 DELETION SYNDROME	0.081507633	3.057852604823219
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.08096515400000001	3.0375008811605793
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08051991	3.020797040365915
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.08020179000000001	3.008862402653563
CRIGLER-NAJJAR SYNDROME TYPE 1	0.080077779	3.004209987346928
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.08004929000000001	3.0031411897429203
ETHYLMALONIC ENCEPHALOPATHY	0.078941619	2.9615856380973806
GRISCELLI SYNDROME TYPE 2	0.07893675900000001	2.961403309607245
DISORDER OF BILE ACID SYNTHESIS	0.07877537	2.9553486156371744
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.07839534000000001	2.9410913530638525
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2	0.07824334	2.935388898228326
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.07777780000000001	2.9179236296485187
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.07777780000000001	2.9179236296485187
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.07777780000000001	2.9179236296485187
MPI-CDG	0.0777778	2.9179236296485183
RETINITIS PIGMENTOSA 59; RP59	0.077595169	2.9110720176151834
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.07749784300000001	2.9074207207775364
NEUTRAL LIPID STORAGE MYOPATHY	0.07747094	2.9064114237877985
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.9063256618683644
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07746451900000001	2.9061705325871476
FETAL PARVOVIRUS SYNDROME	0.07702759	2.889778638581677
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	2.885858576043755
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.885858576043755
ZOLLINGER-ELLISON SYNDROME	0.07669176000000001	2.877179589848686
LYSINURIC PROTEIN INTOLERANCE; LPI	0.07641087	2.8666416784095348
GAUCHER DISEASE, PERINATAL LETHAL	0.07639538900000001	2.8660608908877663
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.07614049900000001	2.856498399354693
NEURAMINIDASE DEFICIENCY	0.075993899	2.8509985317304287
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 3	0.0759638	2.8498693331245435
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 4	0.0759638	2.8498693331245435
NEPHROPATHY, PROGRESSIVE TUBULOINTERSTITIAL, WITH CHOLESTATIC LIVERDISEASE	0.07535017000000001	2.826848297856624
CRYPTOCOCCOSIS	0.075099769	2.817454216321949
AMYLOIDOSIS	0.0748664	2.8086991098580554
YUNIS-VARON SYNDROME	0.07429445400000001	2.7872418977964784
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07427589999999999	2.786545823145041
SIMPSON-GOLABI-BEHMEL SYNDROME	0.07421915300000001	2.7844168941677285
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.07421915300000001	2.7844168941677285
TRISOMY 1Q	0.0737489	2.766774811971869
HISTIOCYTOID CARDIOMYOPATHY	0.073673599	2.7639498083431193
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.07321722	2.7468282252156024
BECKWITH-WIEDEMANN SYNDROME	0.07313218	2.7436378517997273
MASTOCYTOSIS	0.07313218	2.7436378517997273
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.07313218	2.7436378517997273
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.07313218	2.7436378517997273
TURCOT SYNDROME WITH POLYPOSIS	0.0729057	2.735141194094793
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07289361	2.734687623838467
SMITH-MAGENIS SYNDROME; SMS	0.072403533	2.716301821480375
DK1-CDG	0.07229184999999999	2.7121119052738214
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.072194524	2.7084606084361744
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.700193174409169
NETHERTON SYNDROME; NETH	0.07197415400000001	2.700193174409169
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.700193174409169
IMMUNOGLOBULIN A VASCULITIS	0.07197001900000001	2.7000380451279526
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.07197001900000001	2.7000380451279526
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.07197001900000001	2.7000380451279526
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.07197001900000001	2.7000380451279526
GRISCELLI SYNDROME, TYPE 2; GS2	0.07197001900000001	2.7000380451279526
MULTIPLE ENDOCRINE NEOPLASIA TYPE 4	0.07142860000000001	2.67972608858456
CRYPTOSPORIDIOSIS	0.07142860000000001	2.67972608858456
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.07142860000000001	2.67972608858456
MULTIPLE ENDOCRINE NEOPLASIA TYPE 1	0.07142860000000001	2.67972608858456
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.07142860000000001	2.67972608858456
RETINITIS PIGMENTOSA 77; RP77	0.07142860000000001	2.67972608858456
FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1	0.07142860000000001	2.67972608858456
IDIOPATHIC PANUVEITIS	0.07142860000000001	2.67972608858456
CARBOXYPEPTIDASE N DEFICIENCY	0.07142860000000001	2.67972608858456
PULMONARY EDEMA OF MOUNTAINEERS	0.07142860000000001	2.67972608858456
ALAGILLE SYNDROME 2	0.07142860000000001	2.67972608858456
INTERMEDIATE UVEITIS	0.07142860000000001	2.67972608858456
RETINITIS PUNCTATA ALBESCENS	0.07142860000000001	2.67972608858456
RETINITIS PIGMENTOSA 83; RP83	0.07142860000000001	2.67972608858456
PSORIASIS 14, PUSTULAR	0.07142860000000001	2.67972608858456
GARDNER SYNDROME	0.07142860000000001	2.67972608858456
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07142860000000001	2.67972608858456
RETINITIS PIGMENTOSA 76; RP76	0.07142860000000001	2.67972608858456
BIRDSHOT CHORIORETINOPATHY	0.07142860000000001	2.67972608858456
ACQUIRED ANGIOEDEMA	0.07142860000000001	2.67972608858456
MICROPHTHALMIA, ISOLATED 5	0.07142860000000001	2.67972608858456
RETINITIS PIGMENTOSA 13; RP13	0.07142860000000001	2.67972608858456
RETINITIS PIGMENTOSA 78; RP78	0.07142860000000001	2.67972608858456
JOUBERT SYNDROME 6	0.07132095399999999	2.6756876250765003
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.070875373	2.6589711413392076
HEMOCHROMATOSIS TYPE 2	0.07058827	2.6482001420586547
ALPHA-THALASSEMIA	0.07003656	2.627502106813207
RHABDOID TUMOR	0.06994539	2.624081759396398
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.0699346	2.6236769601353767
OROFACIODIGITAL SYNDROME I; OFD1	0.069839719	2.6201173902850505
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.06895295300000001	2.5868493438068927
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5771231693103487
SENIOR-LOKEN SYNDROME	0.068689354	2.5769601241214324
LAURENCE-MOON SYNDROME	0.06814379999999999	2.5564930382968236
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.06792670399999999	2.548348432145683
GLYCOGEN STORAGE DISEASE IV	0.06754573999999999	2.534056129488043
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.5213898893299826
EPENDYMOMA	0.067208119	2.5213898893299826
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.067208119	2.5213898893299826
SUBEPENDYMOMA	0.067208119	2.5213898893299826
GLYCOGEN STORAGE DISEASE IXC	0.0669524	2.5117962969083654
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.066829299	2.5071780212984436
GAUCHER DISEASE	0.06679012999999999	2.505708551209939
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.066703819	2.5024704947671164
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.5010779327865906
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.0666667	2.5010779327865906
MUIR-TORRE SYNDROME	0.0666667	2.5010779327865906
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.5010779327865906
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.5010779327865906
NEPHROBLASTOMA	0.0666667	2.5010779327865906
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL	0.0666667	2.5010779327865906
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.5010779327865906
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.5010779327865906
ADENOCARCINOMA OF THE ANAL CANAL	0.0666667	2.5010779327865906
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.5010779327865906
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.5010779327865906
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.5010779327865906
TRANSALDOLASE DEFICIENCY	0.06652049400000001	2.4955928465255193
REYNOLDS SYNDROME	0.06644391000000001	2.4927197096760194
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0662919	2.487016879678991
SLC35A2-CDG	0.066137024	2.4812065283953926
HEMOCHROMATOSIS, TYPE 1	0.065979	2.4752780762708584
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.06589500899999999	2.472127057296578
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.06548385000000001	2.456701954482631
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.065330119	2.45093455919105
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.4316017741687577
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.063041419	2.3650713461511264
COCAINE EMBRYOFETOPATHY	0.0627273	2.3532868105558595
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.3484303449081043
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.06210219	2.3298350898832565
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.06200055	2.3260219483735005
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.061614053	2.3115220688566174
1P36 DELETION SYNDROME	0.061548263000000006	2.3090538813327406
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.06153544	2.3085728117382933
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.061512413	2.3077089273468614
HEREDITARY ELLIPTOCYTOSIS	0.061202	2.2960634266043605
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.06088831	2.2842949854375436
NOONAN SYNDROME	0.060433680000000004	2.267239018056786
19P13.13 MICRODELETION SYNDROME	0.059910473	2.24761030564145
BLAU SYNDROME	0.0597643	2.242126457413336
DUBIN-JOHNSON SYNDROME	0.05959834000000001	2.2359002771205474
GRISCELLI SYNDROME	0.059533502999999995	2.233467842487843
FOUNTAIN SYNDROME	0.059364919	2.2271432198168415
FOUNTAIN SYNDROME	0.059364919	2.2271432198168415
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.059364919	2.2271432198168415
CORNELIA DE LANGE SYNDROME	0.059364919	2.2271432198168415
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA	0.0588235	2.2068312632734486
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.0588235	2.2068312632734486
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.0588235	2.2068312632734486
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.0588235	2.2068312632734486
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.0588235	2.2068312632734486
HYDROPS FETALIS, NONIMMUNE, WITH GRACILE BONES AND DYSMORPHIC FEATURES	0.0588235	2.2068312632734486
HYDROPS FETALIS, NONIMMUNE	0.0588235	2.2068312632734486
MELKERSSON-ROSENTHAL SYNDROME	0.0588235	2.2068312632734486
CITRULLINEMIA, CLASSIC	0.058417803	2.1916110736720773
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.058147619	2.181474810137329
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.058119673000000004	2.1804263838028977
PORPHYRIA CUTANEA TARDA	0.05791213	2.1726401694349398
DUBIN-JOHNSON SYNDROME	0.05789476	2.1719885139053803
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.0578571	2.170575655687578
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.1676047517505697
CYSTIC FIBROSIS	0.05725918000000001	2.14814399913983
8Q24.3 MICRODELETION SYNDROME	0.056642573	2.1250112782926642
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.056628979999999995	2.124501321262537
RENAL CYSTS AND DIABETES SYNDROME; RCAD	0.05655317	2.1216572219133187
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.05651325	2.1201595771959885
219400 CYANOSIS AND HEPATIC DISEASE	0.056122500000000006	2.1055001414921612
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.056101154	2.1046993217492718
FLOATING-HARBOR SYNDROME	0.056101154	2.1046993217492718
WHITE-SUTTON SYNDROME; WHSUS	0.056101154	2.1046993217492718
17P11.2 MICRODUPLICATION SYNDROME	0.056101154	2.1046993217492718
LATHOSTEROLOSIS	0.056069243	2.1035021438791635
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.05591029	2.097538839251062
NEPHROTIC SYNDROME, TYPE 7; NPHS7	0.05591029	2.097538839251062
THROMBOCYTOPENIA WITH ELEVATED SERUM IGA AND RENAL DISEASE	0.05591029	2.097538839251062
IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6	0.05591029	2.097538839251062
CYSTIC FIBROSIS	0.055555600000000004	2.084232235924663
DYSPHASIA, FAMILIAL DEVELOPMENTAL	0.055555600000000004	2.084232235924663
GITELMAN SYNDROME	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.084232235924663
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.055555600000000004	2.084232235924663
BILIARY CIRRHOSIS, PRIMARY	0.055555600000000004	2.084232235924663
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.084232235924663
FAMILIAL DEVELOPMENTAL DYSPHASIA	0.055555600000000004	2.084232235924663
FLOATING-HARBOR SYNDROME	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.084232235924663
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.055555600000000004	2.084232235924663
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.055435519	2.0797272590884472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.054777714	2.055048947883952
SILVER-RUSSELL SYNDROME; SRS	0.054522853999999996	2.0454875818353853
POLYCYSTIC LIVER DISEASE 2	0.054335180000000004	2.0384467758564218
AMERICAN TRYPANOSOMIASIS	0.054335180000000004	2.0384467758564218
COG2-CDG	0.05426045399999999	2.035643344014056
KIKUCHI-FUJIMOTO DISEASE	0.05351644	2.0077308030140624
GRANULOMATOSIS WITH POLYANGIITIS	0.053173019	1.9948469691846473
LEUKOCYTE ADHESION DEFICIENCY	0.053173019	1.9948469691846473
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.053173019	1.9948469691846473
CONGENITAL MEMBRANOUS NEPHROPATHY DUE TO FETOMATERNAL ANTI-NEUTRAL ENDOPEPTIDASE ALLOIMMUNIZATION	0.0526316	1.9745350126412546
LACRIMAL DUCT DEFECT	0.0526316	1.9745350126412546
%174770 ACTINIC PRURIGOPOLYMORPHIC LIGHT ERUPTION, HEREDITARY; HPLE;;JUVENILE SPRING ERUPTION OF EARS, INCLUDED	0.0526316	1.9745350126412546
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0526316	1.9745350126412546
POLYCYSTIC KIDNEYS	0.0526316	1.9745350126412546
POLYCYSTIC KIDNEY DISEASE 3	0.0526316	1.9745350126412546
NAIL-PATELLA SYNDROME	0.0526316	1.9745350126412546
SENIOR-LOKEN SYNDROME 8; SLSN8	0.0526316	1.9745350126412546
PEUTZ-JEGHERS SYNDROME	0.0526316	1.9745350126412546
POLYCYSTIC KIDNEY DISEASE 2	0.0526316	1.9745350126412546
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.0526316	1.9745350126412546
ROBERTS SYNDROME; RBS	0.0526316	1.9745350126412546
NEPHRONOPHTHISIS 13	0.0526316	1.9745350126412546
MECKEL SYNDROME, TYPE 1; MKS1	0.0526316	1.9745350126412546
ACUTE MONOBLASTIC LEUKEMIA	0.0526316	1.9745350126412546
POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS; PCLD3	0.0526316	1.9745350126412546
POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6	0.0526316	1.9745350126412546
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0526316	1.9745350126412546
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.0526316	1.9745350126412546
MELKERSSON-ROSENTHAL SYNDROME	0.0526316	1.9745350126412546
GOODPASTURE SYNDROME	0.0526316	1.9745350126412546
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.0526316	1.9745350126412546
%247800 LYMPHOPENIC HYPERGAMMAGLOBULINEMIA, ANTIBODY DEFICIENCY, AUTOIMMUNEHEMOLYTIC ANEMIA, AND GLOMERULONEPHRITIS	0.0526316	1.9745350126412546
DERMATOMYOSITIS	0.0526316	1.9745350126412546
POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS; PCLD4	0.0526316	1.9745350126412546
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.0526316	1.9745350126412546
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.0526316	1.9745350126412546
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.0526316	1.9745350126412546
MECKEL SYNDROME, TYPE 4; MKS4	0.0526316	1.9745350126412546
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.0526316	1.9745350126412546
VISCERAL STEATOSIS, CONGENITAL	0.052187369	1.9578691757067772
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0514889	1.9316653077691783
CEPHALIN LIPIDOSIS	0.05140688	1.9285882331270086
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.050642523999999994	1.89991253859896
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.05043650399999999	1.8921834613278083
RETINAL VENOUS BEADING	0.050287389999999994	1.8865892781018567
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.05026319	1.8856813872662008
12Q14 MICRODELETION SYNDROME	0.050069314000000004	1.8784079061234877
IRIDA SYNDROME	0.05	1.8758075116861874
MEDNIK SYNDROME	0.05	1.8758075116861874
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.049322580000000005	1.850393321194858
IMMUNODEFICIENCY 47	0.049208009	1.8460950583464297
MCLEOD SYNDROME; MCLDS	0.0490852	1.8414877374523768
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076853999999996	1.8411746276625256
ADULT-ONSET STILL DISEASE	0.048760649999999996	1.8293118708940217
HOLOPROSENCEPHALY	0.048705973	1.8272606003476923
LISSENCEPHALY 2; LIS2	0.048693653999999996	1.826798438892963
DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	0.04865153999999999	1.8252184837420198
LYSOSOMAL ACID LIPASE DEFICIENCY	0.048459920000000004	1.818029639034234
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.048272854	1.8110116428746121
CONGENITAL HYPOTHYROIDISM	0.048272854	1.8110116428746121
DEXTROCARDIA	0.048164554	1.8069486438042996
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.048130104	1.805656212428748
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.047762500000000006	1.7918651255382305
MEACHAM SYNDROME	0.047619	1.786481557979691
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.047619	1.786481557979691
TUFTSIN DEFICIENCY	0.047619	1.786481557979691
LARYNGOTRACHEOESOPHAGEAL CLEFT TYPE 4	0.047619	1.786481557979691
PAGOD SYNDROME	0.047619	1.786481557979691
FEINGOLD SYNDROME	0.047619	1.786481557979691
CEROID STORAGE DISEASE	0.047619	1.786481557979691
MAPLE SYRUP URINE DISEASE; MSUD	0.047473019000000005	1.7810049128524221
SIALIDOSIS TYPE 2	0.04741361299999999	1.7787762284316369
THYROCEREBRORETINAL SYNDROME	0.046963909	1.7619050656069304
LASSA FEVER	0.046955608999999995	1.7615936815599906
300270 ADRENOMYODYSTROPHY	0.046928344	1.7605708037238683
BETA-THALASSEMIA	0.04666707	1.750768809087702
RHEUMATOID ARTHRITIS	0.0466532	1.7502484600839605
MUCOPOLYSACCHARIDOSIS TYPE 7	0.04644469999999999	1.742426342760229
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.046203244	1.7333678431893949
GLIOBLASTOMA	0.045995919	1.7255898073421885
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.045995919	1.7255898073421885
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.045995919	1.7255898073421885
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0458128	1.7187198874275393
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.045775053999999996	1.7173038028208167
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.04565769	1.7129007573647863
MYH9-RELATED DISEASE	0.04558826999999999	1.710296386215561
TYROSINEMIA, TYPE I; TYRSN1	0.045570799999999995	1.709640979070978
THYROCEREBRORENAL SYNDROME	0.045486808999999996	1.7064899600966972
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.045486808999999996	1.7064899600966972
SOMATOMAMMOTROPINOMA	0.0454546	1.7052816024138193
ACROMEGALY	0.0454546	1.7052816024138193
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.045454579999999994	1.7052808520908143
ALPORT SYNDROME, X-LINKED; ATS	0.044945389999999995	1.6861780035533045
FECHTNER SYNDROME	0.044945389999999995	1.6861780035533045
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6854321824866583
SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS	0.044839079999999996	1.6821896616219574
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.04466131	1.6755204155949086
ERDHEIM-CHESTER DISEASE	0.044612599999999995	1.6736930039170237
CONGENITAL TRACHEAL STENOSIS	0.0442684	1.660779945006576
ALSTRÖM SYNDROME	0.04408779299999999	1.6540042656613136
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	0.04386722	1.645729215855811
ALKAPTONURIA	0.04378788	1.6427526844962674
HYPERBILIVERDINEMIA; HBLVD	0.043498800000000004	1.6319075157867025
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	0.04337028	1.6270859401586641
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.04324875399999999	1.6225267524853604
KOOLEN-DE VRIES SYNDROME; KDVS	0.042991733	1.6128843140361386
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.04279685	1.60557305413014
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.042069579999999995	1.5782886835496595
AICARDI-GOUTIÈRES SYNDROME	0.042056743	1.5778070887291094
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.04202195399999999	1.576501939378628
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.042019270000000004	1.5764012460314014
PELIZAEUS-MERZBACHER DISEASE	0.042018519000000004	1.5763730714025754
MENTAL RETARDATION, X-LINKED 98; MRX98	0.041739532999999995	1.5659065907134697
COMPLEMENT COMPONENT C1R DEFICIENCY	0.041666699999999994	1.5631741769434968
%161900 RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1;;NEPHROPATHY, FAMILIAL;;NEPHRITIS, FAMILIAL, WITHOUT DEAFNESS OR OCULAR DEFECT;;RENAL FAILURE, ADULT-ONSET; AORF	0.041666699999999994	1.5631741769434968
%613944 IGA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.041666699999999994	1.5631741769434968
DYSCHONDROSTEOSIS AND NEPHRITIS	0.041666699999999994	1.5631741769434968
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.041666699999999994	1.5631741769434968
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.041666699999999994	1.5631741769434968
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1; HNFJ1	0.041666699999999994	1.5631741769434968
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.041661114	1.5629646117282914
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.0414771	1.5560611148591832
NEONATAL ADRENOLEUKODYSTROPHY	0.041366299	1.5519042878971363
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.041205109999999996	1.5458570971571124
FANCONI ANEMIA	0.040861244	1.5329565686408428
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.04082488	1.5315923313537438
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.04059248	1.5228735780394262
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.04059248	1.5228735780394262
TRISOMY 12P	0.040545554	1.5211130951735585
KAPUR-TORIELLO SYNDROME	0.040541419	1.5209579658923424
CHRISTIANSON SYNDROME	0.0405335	1.5206608754986413
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.04031569	1.512489482816234
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.04031569	1.512489482816234
DK PHOCOMELIA SYNDROME	0.04031569	1.512489482816234
PRIMARY MYELOFIBROSIS	0.04028627	1.5113857576763579
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.04	1.5006460093489498
BLACKFAN-DIAMOND ANEMIA	0.04	1.5006460093489498
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.04	1.5006460093489498
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.04	1.5006460093489498
3Q13 MICRODELETION SYNDROME	0.04	1.5006460093489498
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.04	1.5006460093489498
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.04	1.5006460093489498
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.04	1.5006460093489498
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.04	1.5006460093489498
NON-DISTAL TRISOMY 10Q	0.04	1.5006460093489498
PORPHYRIA CUTANEA TARDA	0.03994565	1.498607006583747
BUDD-CHIARI SYNDROMEMEMBRANOUS OBSTRUCTION OF INFERIOR VENA CAVA, INCLUDED	0.03994565	1.498607006583747
HEMOLYTIC ANEMIA DUE TO RED CELL PYRUVATE KINASE DEFICIENCY	0.0399254	1.497847304541514
ADAMS-OLIVER SYNDROME 6; AOS6	0.0399225	1.497738507705836
AMISH INFANTILE EPILEPSY SYNDROME	0.03989015	1.496524860245775
MUCOLIPIDOSIS IV; ML4	0.039756354	1.4915053494091037
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.039708304	1.4897026983903734
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.039502180000000005	1.4819697194395975
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.039502180000000005	1.4819697194395975
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.039502180000000005	1.4819697194395975
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.039502180000000005	1.4819697194395975
16P13.11 MICRODELETION SYNDROME	0.039487313999999996	1.4814120043502226
HYPERLYSINEMIA, TYPE I	0.039483179	1.4812568750690063
SENIOR-LOKEN SYNDROME 9	0.039434454	1.4794289006488681
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938224
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.039162749999999996	1.4692356125657644
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.039093649999999994	1.466643246584614
LEPRECHAUNISM	0.038888900000000004	1.4589618148242594
AUTOSOMAL ERYTHROPOIETIC PROTOPORPHYRIA	0.03859294	1.4478585350010864
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4451708779983423
MYOCLONUS AND ATAXIA	0.0385141	1.4449007617166598
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4212340735032172
LISSENCEPHALY 5; LIS5	0.037629319	1.4117071847967153
TRICHOTHIODYSTROPHY	0.037582554	1.4099527420310352
SLC39A8-CDG	0.037578419	1.4097976127498186
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.037221679	1.3964141013154403
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.0370879	1.3913952282533228
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.037037179999999996	1.3894924091134682
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.037037	1.3894856562064262
RHYNS SYNDROME	0.037037	1.3894856562064262
SITOSTEROLEMIA	0.037037	1.3894856562064262
NATHALIE SYNDROME	0.037037	1.3894856562064262
LABIA MINORA, INCOMPLETE ADHESION OF	0.037037	1.3894856562064262
PEYRONIE DISEASE	0.037037	1.3894856562064262
SCIMITAR SYNDROME	0.037037	1.3894856562064262
ATRANSFERRINEMIA	0.037037	1.3894856562064262
BENIGN SCHWANNOMA	0.037037	1.3894856562064262
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.3894856562064262
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.037037	1.3894856562064262
BUTYRYLCHOLINESTERASE DEFICIENCY	0.037037	1.3894856562064262
GASTROINTESTINAL STROMAL TUMOR	0.037037	1.3894856562064262
APOLIPOPROTEIN A-I DEFICIENCY	0.037037	1.3894856562064262
URINARY BLADDER, ATONY OF	0.037037	1.3894856562064262
POLAND SYNDROME	0.037037	1.3894856562064262
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3894856562064262
RCAD (RENAL CYSTS AND DIABETES)	0.037037	1.3894856562064262
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.3894856562064262
TESTICULAR TORSION	0.037037	1.3894856562064262
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.037037	1.3894856562064262
CANAVAN DISEASE	0.037037	1.3894856562064262
OVARIAN HYPERSTIMULATION SYNDROME	0.037037	1.3894856562064262
JEUNE SYNDROME	0.037037	1.3894856562064262
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.037037	1.3894856562064262
207620 APHALANGY WITH HEMIVERTEBRAE	0.037037	1.3894856562064262
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.037037	1.3894856562064262
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	0.037037	1.3894856562064262
ADENOMYOSIS	0.037037	1.3894856562064262
GALACTORRHEA	0.037037	1.3894856562064262
GENITOURINARY TRACT ANOMALIES	0.037037	1.3894856562064262
FAMILIAL SUPERNUMERARY NIPPLES	0.037037	1.3894856562064262
CONGENITAL RESPIRATORY-BILIARY FISTULA	0.037037	1.3894856562064262
HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	0.037037	1.3894856562064262
FRYNS MICROPHTHALMIA SYNDROME	0.037037	1.3894856562064262
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.037037	1.3894856562064262
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.037037	1.3894856562064262
SYSTEMIC MASTOCYTOSIS	0.03693372	1.3856109882102874
GLYCOGEN STORAGE DISEASE IB	0.03687515	1.3834136672910982
GLYCOGEN STORAGE DISEASE IA	0.03687515	1.3834136672910982
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.036856813999999995	1.3827257711604124
ALPERS-HUTTENLOCHER SYNDROME	0.036842704000000004	1.3821964182806148
PHELAN-MCDERMID SYNDROME	0.036830132999999994	1.3817248027560263
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.036587399	1.372618357545194
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.036300153999999994	1.3618420309713077
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.03629715	1.3617293324560058
3P25.3 MICRODELETION SYNDROME	0.03620051	1.3581037716974185
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.03617885399999999	1.3572913219479568
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.03604598	1.3523064010018013
GALACTOSEMIA	0.035846613	1.3448269186781545
KAPOSIFORM LYMPHANGIOMATOSIS	0.03573509	1.340643005055639
SCLERODERMA, FAMILIAL PROGRESSIVE	0.035714300000000004	1.33986304429228
METHANE PRODUCTION	0.035714300000000004	1.33986304429228
AMYLOIDOSIS, FINNISH TYPE	0.035714300000000004	1.33986304429228
PARANA HARD-SKIN SYNDROME	0.035714300000000004	1.33986304429228
BLUE DIAPER SYNDROME	0.035714300000000004	1.33986304429228
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.035714300000000004	1.33986304429228
POLYPOSIS SYNDROME, HEREDITARY MIXED, 1	0.035714300000000004	1.33986304429228
PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS	0.035714300000000004	1.33986304429228
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.035714300000000004	1.33986304429228
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.035714300000000004	1.33986304429228
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.035714300000000004	1.33986304429228
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.035714300000000004	1.33986304429228
GASTRIC SNEEZING	0.035714300000000004	1.33986304429228
GALLBLADDER, AGENESIS OF	0.035714300000000004	1.33986304429228
MESOMELIA-SYNOSTOSES SYNDROME	0.035714300000000004	1.33986304429228
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.035714300000000004	1.33986304429228
%243600 JEJUNAL ATRESIA;;APPLE PEEL SYNDROME;;APPLE PEEL SMALL BOWEL SYNDROME; APSB	0.035714300000000004	1.33986304429228
TERATOMA, PINEAL	0.035714300000000004	1.33986304429228
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3380603932735493
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3380603932735493
JUVENILE ABSENCE EPILEPSY	0.03566625	1.3380603932735493
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.03533359999999999	1.325580645898301
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.035220513999999994	1.3213380945329702
%152800 LYMPHANGIECTASIA, INTESTINAL	0.03493649	1.3106826074789872
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457726
MONOSOMY 22	0.0347755	1.30464288245286
DOORS SYNDROME	0.03461480399999999	1.2986141871749013
RING CHROMOSOME 22 SYNDROME	0.034511032999999997	1.2947210987489977
FUMARASE DEFICIENCY; FMRD	0.03426205399999999	1.2853803651799551
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.034162859999999996	1.2816589881736713
ALG13-CDG	0.034162859999999996	1.2816589881736713
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.2781471013502925
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2781471013502925
EPILEPSY, PYRIDOXINE-DEPENDENT	0.03403400399999999	1.2768248071191546
PIGMENTED VILLONODULAR SYNOVITIS	0.0338384	1.2694864980688374
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.033606343999999996	1.2607806503102004
CONGENITAL DISORDER OF GLYCOSYLATION	0.033579942999999994	1.2597901864278798
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.033496859999999996	1.2566732321180114
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.033328053999999996	1.2503402808616573
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.033199679999999995	1.2455241825915533
MYELOPEROXIDASE DEFICIENCY	0.033199679999999995	1.2455241825915533
BLOOD GROUP, DUFFY SYSTEM; FY	0.033199679999999995	1.2455241825915533
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.03314408	1.2434382846385583
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.033038423	1.2394744407533138
TYROSINEMIA TYPE 1	0.03295358	1.236291458019034
CHROMOSOME 17Q12 DELETION SYNDROME	0.03285333	1.2325304639581032
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978763
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978763
AMYLOIDOSIS, FAMILIAL VISCERAL	0.03254647	1.2210182580973827
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.032456399999999996	1.2176391784458311
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.032456399999999996	1.2176391784458311
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.0322823	1.21110761669014
WEST SYNDROME	0.0322581	1.2101997258544839
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.03204225	1.2021018648265347
LYNCH SYNDROME	0.031791419	1.1926916513472596
FAMILIAL COLORECTAL CANCER TYPE X	0.031791419	1.1926916513472596
ACUTE INTERMITTENT PORPHYRIA	0.031791419	1.1926916513472596
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.03161573299999999	1.186100588977297
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0315921	1.1852139697988238
FAMILIAL ATRIAL MYXOMA	0.03157896	1.1847210075847527
22Q11.2 MICRODUPLICATION SYNDROME	0.031563133	1.1841272394750035
FOLLICULAR LYMPHOMA	0.0315193	1.1824827940618088
SHORT SYNDROME	0.03131656	1.1748767697634237
RUIJS-AALFS SYNDROME; RJALS	0.03125	1.172379694803867
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1715134468949702
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.031135473	1.1680830826660493
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.031135473	1.1680830826660493
MOWAT-WILSON SYNDROME; MOWS	0.031064919	1.1654361682024592
PROPIONIC ACIDEMIA	0.030820534	1.1562677838275905
TRICHOHEPATOENTERIC SYNDROME 2	0.030807429999999997	1.1557761721949278
GAUCHER DISEASE TYPE 3	0.03064403	1.1496460332467373
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.0305235	1.1451242116590665
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.0305235	1.1451242116590665
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.030498773	1.1441965498122373
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.03035805	1.1389171646028973
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.030315104	1.1373059960149594
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.030280143	1.1359943938866384
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.03026316	1.135357257107219
NEONATAL ICHTHYOSIS-SCLEROSING CHOLANGITIS SYNDROME	0.03022254	1.1338333510847252
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.030057663000000002	1.1276478007826396
WHIPPLE DISEASE	0.030037899	1.1269063315894203
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.030018733	1.1261872970540405
PROTOPORPHYRIA, ERYTHROPOIETIC	0.02989729	1.1216312232212065
ARIMA SYNDROME	0.029738723999999998	1.1156824373432457
HEREDITARY SPHEROCYTOSIS	0.029720439999999997	1.1149964920523723
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.02968256	1.1135753802815191
GALLOWAY-MOWAT SYNDROME	0.029658373000000002	1.112667977155816
SOTOS SYNDROME	0.029658373000000002	1.112667977155816
ALG1-CDG	0.029658373000000002	1.112667977155816
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.02959449	1.110271332930435
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.029583473000000002	1.1098580175033101
7P22.1 MICRODUPLICATION SYNDROME	0.029477313999999998	1.105875340510648
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.029473179	1.1057202112294318
9Q33.3Q34.11 MICRODELETION SYNDROME	0.029473179	1.1057202112294318
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0294118	1.1034175074442358
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	1.1034175074442358
ECHO VIRUS 11 SENSITIVITY	0.0294118	1.1034175074442358
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0294118	1.1034175074442358
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0294118	1.1034175074442358
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0294118	1.1034175074442358
MYASTHENIA GRAVIS; MG	0.0294118	1.1034175074442358
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	1.1034175074442358
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	1.1034175074442358
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0294118	1.1034175074442358
MONOMELIC AMYOTROPHY	0.0294118	1.1034175074442358
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	1.1034175074442358
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	1.1034175074442358
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.0294118	1.1034175074442358
IMMUNE SUPPRESSION	0.0294118	1.1034175074442358
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	1.1034175074442358
RAGWEED SENSITIVITY	0.0294118	1.1034175074442358
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	1.1034175074442358
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.029271999	1.098172712125411
NIEMANN-PICK DISEASE, TYPE C2	0.029267653	1.0980096669364954
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.029267653	1.0980096669364954
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.029260454	1.0977395881709628
MENINGIOMA	0.0292549	1.0975312234725647
TETRASOMY X	0.029116954	1.0923560206124234
FETAL ALCOHOL SYNDROME	0.029116954	1.0923560206124234
PENTASOMY X	0.029116954	1.0923560206124234
CHARGE SYNDROME	0.029116954	1.0923560206124234
C SYNDROME	0.029112819	1.0922008913312071
NORRIE DISEASE	0.029112819	1.0922008913312071
COFS SYNDROME	0.029112819	1.0922008913312071
DISTAL MONOSOMY 7Q36	0.029112819	1.0922008913312071
CRI-DU-CHAT SYNDROME	0.028931759999999997	1.085408254686039
PRADER-WILLI SYNDROME	0.028923969	1.0851159663595682
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901084
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901084
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0285714	1.0718889347878144
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.0285714	1.0718889347878144
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0285714	1.0718889347878144
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0285714	1.0718889347878144
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.0285714	1.0718889347878144
ALG12-CDG	0.0285714	1.0718889347878144
SCHWARTZ-JAMPEL SYNDROME	0.0285714	1.0718889347878144
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.0285714	1.0718889347878144
CHEILITIS GLANDULARIS	0.0285714	1.0718889347878144
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.0285714	1.0718889347878144
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.0285714	1.0718889347878144
CONGENITAL LOBAR EMPHYSEMA	0.0285714	1.0718889347878144
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.0285714	1.0718889347878144
COG7-CDG	0.0285714	1.0718889347878144
ACRODYSOSTOSIS	0.0285714	1.0718889347878144
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.028392909	1.065192639616447
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.028323354000000002	1.0625832037869403
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028323354000000002	1.0625832037869403
SICKLE CELL ANEMIA	0.02824334	1.059581386542139
CHROMOSOME 16P13.3 DELETION SYNDROME	0.028113973	1.0547280347348529
BOHRING-OPITZ SYNDROME	0.028113973	1.0547280347348529
RECOMBINANT 8 SYNDROME	0.028113973	1.0547280347348529
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.02801938	1.0511792695357944
PULMONARY ARTERIAL HYPERTENSION	0.02801938	1.0511792695357944
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.027991733	1.0501420605302827
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.027847913000000002	1.0447464878036685
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0421161179623315
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0421161179623315
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623315
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0421161179623315
GANGLIOCYTOMA	0.027777800000000002	1.0421161179623315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.027777800000000002	1.0421161179623315
CAMPOMELIA, CUMMING TYPE	0.02774008	1.0407010087755153
HEMORRHAGIC FEVER-RENAL SYNDROME	0.027608459999999998	1.0357631330817525
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0344160781914604
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.027572554	1.0344160781914604
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	1.0342609489102441
LINEAR VERRUCOUS NEVUS SYNDROME	0.027568419	1.0342609489102441
ALPHA-1-ANTITRYPSIN DEFICIENCY	0.027374939999999997	1.0270023616791735
NIEMANN-PICK DISEASE, TYPE A	0.027249134	1.0222826048828697
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.02720447	1.0206069835488307
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.027193483999999997	1.0201948311223628
LEGIONELLOSIS	0.027148459999999996	1.0185057039742396
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.02706593	1.0154094960954505
BARDET-BIEDL SYNDROME 11; BBS11	0.027027	1.0139489923668517
BARDET-BIEDL SYNDROME 12; BBS12	0.027027	1.0139489923668517
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668517
LIPOSARCOMA	0.027027	1.0139489923668517
POLYARTERITIS NODOSA	0.027027	1.0139489923668517
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.027027	1.0139489923668517
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668517
INFANTILE MYOFIBROMATOSIS	0.027027	1.0139489923668517
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668517
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668517
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.027027	1.0139489923668517
NIPPLES, SUPERNUMERARY	0.027027	1.0139489923668517
WAARDENBURG SYNDROME TYPE 2	0.027027	1.0139489923668517
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.02690476	1.0093630181622812
FAMILIAL MEDITERRANEAN FEVER	0.026857219	1.0075794628640198
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.026769354	1.0042831063237336
14Q12 MICRODELETION SYNDROME	0.026765219	1.004127977042517
NEONATAL LUPUS ERYTHEMATOSUS	0.02676094	1.003967445435667
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.02665715	1.0000736442029088
OCULOCEREBRORENAL SYNDROME OF LOWE	0.026547409	0.9959565843601099
HEMOGLOBIN--BETA LOCUS	0.02653976	0.9956696233269721
GLYCOGEN STORAGE DISEASE VII	0.02653976	0.9956696233269721
SPHEROCYTOSIS, TYPE 1; SPH1	0.02653976	0.9956696233269721
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	0.02653976	0.9956696233269721
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.02650107	0.9942181234744293
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.02647668	0.9933031045702287
HUGHES-STOVIN SYNDROME	0.0263158	0.9872675063206273
MALIGNANT PERITONEAL MESOTHELIOMA	0.0263158	0.9872675063206273
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.0263158	0.9872675063206273
LIPEDEMA	0.0263158	0.9872675063206273
FIBRONECTIN GLOMERULOPATHY	0.0263158	0.9872675063206273
DISTICHIASIS WITH CONGENITAL ANOMALIES OF THE HEART AND PERIPHERAL	0.0263158	0.9872675063206273
OSTEOSCLEROSIS-ICHTHYOSIS-PREMATURE OVARIAN FAILURE SYNDROME	0.0263158	0.9872675063206273
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.026285143	0.9861173737029121
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.02627305	0.9856636908981355
OCCIPITAL HORN SYNDROME	0.026216913999999997	0.9835576842886152
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.026212779	0.9834025550073988
PLIN1-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.02601249	0.9758884827932366
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.02586209	0.9702460537980845
20Q11.2 MICRODUPLICATION SYNDROME	0.025719033	0.9648791058940986
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.025719033	0.9648791058940986
22Q11.2 DELETION SYNDROME	0.025642263	0.9619989910406557
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.025545554	0.9583708416677026
PEROXISOME BIOGENESIS DISORDER 10B	0.025545554	0.9583708416677026
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.025541419000000003	0.9582157123864862
ACUTE BILIRUBIN ENCEPHALOPATHY	0.025541419000000003	0.9582157123864862
MENKES DISEASE	0.025541419000000003	0.9582157123864862
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.025541419000000003	0.9582157123864862
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.025509689999999998	0.9570253624557202
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.025314519	0.9497032978984542
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.025173479	0.9444120200694897
CRIGLER-NAJJAR SYNDROME TYPE 2	0.025	0.9379037558430937
GALACTOKINASE DEFICIENCY	0.025	0.9379037558430937
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.025	0.9379037558430937
FARBER DISEASE	0.024976434	0.9370196502466855
MIXED CONNECTIVE TISSUE DISEASE	0.024972299	0.9368645209654691
PORTAL HYPERTENSION, NONCIRRHOTIC	0.02495938	0.9363798498205997
POLYCYTHEMIA VERA	0.02495938	0.9363798498205997
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.02489935	0.9341277553220694
MILLER-DIEKER SYNDROME	0.024745819	0.9283678632605353
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.0247329	0.927883192115666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730213999999997	0.9277824237361381
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.02455529	0.9212199486726543
CRANIOFACIOFRONTODIGITAL SYNDROME	0.02443088	0.9165525644220766
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.02443088	0.9165525644220766
JUVENILE IDIOPATHIC ARTHRITIS	0.02443088	0.9165525644220766
PACHYDERMOPERIOSTOSIS	0.02443088	0.9165525644220766
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.02443088	0.9165525644220766
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.024417963999999997	0.9160680058256577
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.024417963999999997	0.9160680058256577
CHRONIC GRAFT VERSUS HOST DISEASE	0.024329769999999997	0.9127593064719448
DIGEORGE SYNDROME; DGS	0.024268333	0.9104544267500356
RHOMBENCEPHALOSYNAPSIS	0.024204399999999997	0.9080559067171429
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.02419608	0.9077437723471983
PEHO-LIKE SYNDROME; PEHOL	0.024157044	0.9062792919066747
SALT-AND-PEPPER SYNDROME	0.024055704	0.9024774052419893
AA AMYLOIDOSIS	0.02392578	0.8976031569390228
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.023814273	0.893419843574911
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.023814273	0.893419843574911
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.023814273	0.893419843574911
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.023814273	0.893419843574911
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.023814273	0.893419843574911
X-LINKED AGAMMAGLOBULINEMIA	0.02368689	0.8886409238096885
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.023666589999999998	0.887879345959944
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.023666589999999998	0.887879345959944
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.023666589999999998	0.887879345959944
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.023666589999999998	0.887879345959944
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.02354609	0.8833586498567803
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.02354609	0.8833586498567803
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.023459443000000003	0.8801079879874789
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.023444749999999997	0.8795567631920946
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.023295119	0.8739431841164723
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.023272854	0.8731078870315184
OPTIC ATROPHY 11; OPA11	0.023272854	0.8731078870315184
FETAL HYDANTOIN SYNDROME	0.023272854	0.8731078870315184
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.023272854	0.8731078870315184
COWDEN SYNDROME 5; CWS5	0.023268719	0.8729527577503022
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.023268719	0.8729527577503022
HYPOADRENOCORTICISM, FAMILIAL	0.023268719	0.8729527577503022
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.023268719	0.8729527577503022
COWDEN SYNDROME 6; CWS6	0.023268719	0.8729527577503022
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.023268719	0.8729527577503022
WILLIAMS-BEUREN SYNDROME; WBS	0.0232558	0.8724680866054326
NODULAR REGENERATIVE HYPERPLASIA OF THE LIVER	0.0232558	0.8724680866054326
CYSTINOSIS	0.0232558	0.8724680866054326
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.02309757	0.8665319061539506
AICARDI-GOUTIERES SYNDROME 5	0.023055044	0.8649364943491111
ISOLATED COMPLEX I DEFICIENCY	0.022957033999999998	0.8612595364647039
CEREBROTENDINOUS XANTHOMATOSIS	0.022763619000000002	0.8540033502672483
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	0.8526408012069097
ARTERIES, ANOMALIES OF	0.0227273	0.8526408012069097
POPLITEAL CYST	0.0227273	0.8526408012069097
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0227273	0.8526408012069097
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0227273	0.8526408012069097
WATSON SYNDROME	0.0227273	0.8526408012069097
RHEUMATOID FACTOR-NEGATIVE JUVENILE IDIOPATHIC ARTHRITIS	0.0227273	0.8526408012069097
RHEUMATOID FACTOR-POSITIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS	0.0227273	0.8526408012069097
AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS	0.0227273	0.8526408012069097
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	0.8526408012069097
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.0227273	0.8526408012069097
FACIOSCAPULOHUMERAL DYSTROPHY	0.0227273	0.8526408012069097
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	0.8526408012069097
OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS	0.0227273	0.8526408012069097
BLEPHAROPTOSIS-MYOPIA-ECTOPIA LENTIS SYNDROME	0.0227273	0.8526408012069097
SILVER-RUSSELL SYNDROME	0.0227273	0.8526408012069097
ATROPHODERMA VERMICULATA; AVA	0.0227273	0.8526408012069097
BETHLEM MYOPATHY 1	0.0227273	0.8526408012069097
LARSEN SYNDROME	0.0227273	0.8526408012069097
127820 DYSPLASIA EPIPHYSEALIS HEMIMELICA WITH CHONDROMAS AND OSTEOCHONDROMAS;;OSTEOCHONDROMATOSIS, DOMINANT CARPOTARSAL	0.0227273	0.8526408012069097
THYMIC TUMOR	0.0227273	0.8526408012069097
GAPO SYNDROME	0.0227273	0.8526408012069097
THYMIC CARCINOMA	0.0227273	0.8526408012069097
OSTEOSARCOMA	0.0227273	0.8526408012069097
LYME DISEASE	0.0227273	0.8526408012069097
MACS SYNDROME	0.0227273	0.8526408012069097
OSTEOCHONDRITIS DISSECANS	0.0227273	0.8526408012069097
FATCO SYNDROME	0.0227273	0.8526408012069097
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	0.8526408012069097
REACTIVE ARTHRITIS	0.0227273	0.8526408012069097
ACRORENAL-MANDIBULAR SYNDROME	0.0227273	0.8526408012069097
FAMILIAL AFIBRINOGENEMIA	0.0227273	0.8526408012069097
HEMOPHILIA A	0.0227273	0.8526408012069097
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	0.8526408012069097
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.0227273	0.8526408012069097
PREPAPILLARY VASCULAR LOOPS	0.0227273	0.8526408012069097
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0227273	0.8526408012069097
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0227273	0.8526408012069097
PANNER DISEASE	0.0227273	0.8526408012069097
CONGENITAL ATRANSFERRINEMIA	0.0227273	0.8526408012069097
SINDING-LARSEN-JOHANSSON DISEASE	0.0227273	0.8526408012069097
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	0.8526408012069097
CRANIO-OSTEOARTHROPATHY	0.0227273	0.8526408012069097
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	0.8526408012069097
MUSCULAR HYPERTONIA, LETHAL	0.0227273	0.8526408012069097
JUVENILE DERMATOMYOSITIS	0.0227273	0.8526408012069097
SEVERE HEMOPHILIA A	0.0227273	0.8526408012069097
SIRENOMELIA	0.0227273	0.8526408012069097
ALKAPTONURIA	0.0227273	0.8526408012069097
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	0.8526408012069097
ENTHESITIS-RELATED JUVENILE IDIOPATHIC ARTHRITIS	0.0227273	0.8526408012069097
THUMB DEFORMITY	0.0227273	0.8526408012069097
NAIL-PATELLA SYNDROME	0.0227273	0.8526408012069097
ATAXIA-PANCYTOPENIA SYNDROME	0.02261289	0.8483485784586693
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.022578604	0.8470622997317557
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8446087435064703
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8446087435064703
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.022440573000000002	0.8418839079988447
BEHÇET DISEASE	0.022426718999999998	0.8413641592535066
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.022325933	0.8375830565360506
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.022324224	0.8375189414353011
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.022312959999999996	0.8370963595190684
SECONDARY SHORT BOWEL SYNDROME	0.0222222	0.8336913937238557
PLEURAL MESOTHELIOMA	0.022111779999999998	0.8295488604150478
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.021899154	0.8215719514554523
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.021895019	0.8214168221742358
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.02180921	0.8181975988388301
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.021794873	0.8176597297929293
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.021794873	0.8176597297929293
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.021794873	0.8176597297929293
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.021794873	0.8176597297929293
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.021681113999999998	0.8133919300584911
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.02164498	0.8120363214859458
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.02151033	0.8069847718569748
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.021493459000000003	0.8063518368863818
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.021299113999999997	0.7990607606692086
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.798583930399738
PANCREATIC COLIPASE DEFICIENCY	0.0212766	0.7982161220628465
MYOTONIC DYSTROPHY 1	0.0212766	0.7982161220628465
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.021249319	0.7971926439683203
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.021135559999999998	0.7929248442338822
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	0.7889376277870421
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	0.7889376277870421
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	0.7889376277870421
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	0.7889376277870421
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	0.7889376277870421
SEVERE COMBINED IMMUNODEFICIENCY DUE TO COMPLETE RAG1/2 DEFICIENCY	0.02095204	0.7860398803429893
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.020949619	0.7859490537432734
MYASTHENIA GRAVIS	0.020949619	0.7859490537432734
MALIGNANT ATROPHIC PAPULOSIS	0.020949619	0.7859490537432734
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.020949619	0.7859490537432734
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.020848833	0.7821679510258173
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751291
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751291
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.020707899999999998	0.7768806874249279
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.020707899999999998	0.7768806874249279
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.020647653000000002	0.7746204519217968
LETTERER-SIWE DISEASE	0.020590050000000002	0.7724594091198836
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.020450363	0.7672188906421853
FETAL GAUCHER DISEASE	0.020449088999999997	0.7671710950667875
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.020441309999999997	0.7668792569341194
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.020421173	0.766123794216863
MULTIPLE MYELOMA	0.020408199999999998	0.7656370971998808
HEPATITIS B VACCINE, RESPONSE TO	0.020408199999999998	0.7656370971998808
OVARIAN FIBROTHECOMA	0.020408199999999998	0.7656370971998808
PANCREATITIS, HEREDITARY	0.020408199999999998	0.7656370971998808
NOONAN SYNDROME 8; NS8	0.020408199999999998	0.7656370971998808
ADENOCARCINOMA OF OVARY	0.020408199999999998	0.7656370971998808
RELAPSING POLYCHONDRITIS	0.020408199999999998	0.7656370971998808
OVARIAN FIBROMA	0.020408199999999998	0.7656370971998808
AUTOSOMAL AGAMMAGLOBULINEMIA	0.020408199999999998	0.7656370971998808
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.020408199999999998	0.7656370971998808
PRIMARY EFFUSION LYMPHOMA	0.020408199999999998	0.7656370971998808
LICHEN PLANOPILARIS	0.020408199999999998	0.7656370971998808
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.020408199999999998	0.7656370971998808
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.020317773	0.762244624282696
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.020317773	0.762244624282696
GABRIELE-DE VRIES SYNDROME; GADEVS	0.020307414	0.7618559944824248
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.020307414	0.7618559944824248
HEMOGLOBIN--ALPHA LOCUS 1; HBA1	0.020188559999999998	0.7573970499625458
COG5-CDG	0.020119529000000004	0.7548072725957619
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.01994539	0.7482742477102112
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.01990767	0.746859138523395
PEROXISOME BIOGENESIS DISORDER 6B	0.019879754	0.7458118376734705
RIDDLE SYNDROME	0.019879754	0.7458118376734705
OCULODENTODIGITAL DYSPLASIA; ODDD	0.019875619	0.7456567083922541
MEGALENCEPHALY WITH DYSMYELINATION	0.019875619	0.7456567083922541
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.019875433	0.7456497303883106
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.019835818999999998	0.7441635656129517
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.019776354	0.7419326677393034
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.019772219	0.741777538458087
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.019772219	0.741777538458087
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.019772219	0.741777538458087
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.019772219	0.741777538458087
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.019772219	0.741777538458087
49,XYYYY SYNDROME	0.01976186	0.7413889086578158
49,XXXYY SYNDROME	0.01976186	0.7413889086578158
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.01974502	0.7407571366878799
ACQUIRED GENERALIZED LIPODYSTROPHY	0.01974502	0.7407571366878799
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.019392523999999998	0.7275328437950932
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0193342	0.7253447518488615
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.0193342	0.7253447518488615
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.019334014	0.7253377738449182
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.019248460000000002	0.7221281171278222
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.0192308	0.7214655819146945
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.0192308	0.7214655819146945
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.0192308	0.7214655819146945
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.0192308	0.7214655819146945
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.0192308	0.7214655819146945
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.0192308	0.7214655819146945
FREE SIALIC ACID STORAGE DISEASE	0.019193052999999998	0.7200494597918221
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.019076074	0.7156608580536313
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.018989544	0.7124145855739074
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.01894498	0.7107427158548917
LISSENCEPHALY 1; LIS1	0.018944073000000002	0.7107086887066297
HAREL-YOON SYNDROME; HAYOS	0.018852814	0.7072850023524502
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.018823390000000002	0.7061811271479732
JOUBERT SYNDROME 1	0.018689354	0.7011526124352457
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.018402654	0.6903967321632373
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.018402654	0.6903967321632373
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.018402654	0.6903967321632373
ADRENOLEUKODYSTROPHY	0.018398519000000002	0.6902416028820209
CHROMOSOME 18Q DELETION SYNDROME	0.018398519000000002	0.6902416028820209
JUVENILE HUNTINGTON DISEASE	0.018398519000000002	0.6902416028820209
MERCURY POISONING	0.018398519000000002	0.6902416028820209
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.01837028	0.6891821843155707
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.01837028	0.6891821843155707
PERMANENT NEONATAL DIABETES MELLITUS	0.018324164	0.6874520895313923
PRIMARY LIPODYSTROPHY	0.01804144	0.6768453734727129
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.018032034	0.6764924965636144
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.01800509	0.6754816614117171
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.0178571	0.6699296463386283
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0178571	0.6699296463386283
NEPHROPATHIC INFANTILE CYSTINOSIS	0.0178571	0.6699296463386283
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.0178571	0.6699296463386283
PROGRESSIVE NON-FLUENT APHASIA	0.0178571	0.6699296463386283
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.0178571	0.6699296463386283
SPASTIC PARAPLEGIA TYPE 7	0.0178571	0.6699296463386283
19P13.3 MICRODUPLICATION SYNDROME	0.017740653999999998	0.665561040708512
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.017740653999999998	0.665561040708512
INFANTILE SIALIC ACID STORAGE DISEASE	0.017715953	0.6646343542815889
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.017621879	0.6611050599645015
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.017535013	0.6578461820582988
PYRIDOXINE-DEPENDENT EPILEPSY	0.017531314	0.6577074098185842
HYPERLIPOPROTEINEMIA, TYPE I	0.01731136	0.649455582510076
RETICULOENDOTHELIOSIS, X-LINKED	0.01731136	0.649455582510076
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397246
THUMBS, CONGENITAL CLASPED	0.0172414	0.6468309526397246
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397246
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397246
PALMOMENTAL REFLEX	0.0172414	0.6468309526397246
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397246
MOTION SICKNESS	0.0172414	0.6468309526397246
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397246
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6468309526397246
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397246
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397246
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397246
DIASTEMATOMYELIA	0.0172414	0.6468309526397246
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397246
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397246
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397246
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397246
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6468309526397246
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397246
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397246
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397246
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397246
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397246
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6468309526397246
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6468309526397246
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397246
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397246
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397246
CERVICAL RIB	0.0172414	0.6468309526397246
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397246
TRANSSEXUALITY	0.0172414	0.6468309526397246
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397246
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397246
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397246
ERYTHERMALGIA, PRIMARY	0.0172414	0.6468309526397246
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397246
MOSAIC TRISOMY 15	0.0172414	0.6468309526397246
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397246
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397246
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397246
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397246
NEPHRONOPHTHISIS 11; NPHP11	0.017212254	0.6457375069250124
FADD-RELATED IMMUNODEFICIENCY	0.017208119	0.645582377643796
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.017195099999999998	0.6450939548839031
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.017030470000000002	0.6389176710709252
TRANSIENT NEONATAL DIABETES MELLITUS	0.016847064	0.6320369840211588
PORPHYRIA CUTANEA TARDA, TYPE I	0.0166667	0.6252704211004035
BARDET-BIEDL SYNDROME	0.0166667	0.6252704211004035
HB BART'S HYDROPS FETALIS	0.016628979999999998	0.6238553119135873
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.016628979999999998	0.6238553119135873
KLIPPEL-TRÉNAUNAY SYNDROME	0.016628979999999998	0.6238553119135873
MYOCLONIC-ATONIC EPILEPSY	0.016402499999999997	0.6153586542086537
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.016402499999999997	0.6153586542086537
PREECLAMPSIA/ECLAMPSIA 1	0.016362369	0.6138530935836242
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965498
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6115698981965498
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965498
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
CHÉDIAK-HIGASHI SYNDROME	0.016167033	0.6065248388615695
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.016148913999999997	0.6058450837354845
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.016148913999999997	0.6058450837354845
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.016148913999999997	0.6058450837354845
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.016148913999999997	0.6058450837354845
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.016148913999999997	0.6058450837354845
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.01609337	0.6037612866869027
INFANTILE LIVER FAILURE SYNDROME 1	0.016057912999999997	0.6024310765480654
HYPERPROLINEMIA, TYPE I	0.015963132999999997	0.5988752958289131
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.015836080000000002	0.594108756393268
CHOLESTERYL ESTER STORAGE DISEASE	0.015662389999999998	0.5875925762591724
REYNOLDS SYNDROME	0.015662389999999998	0.5875925762591724
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.015632843	0.5864840865682166
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.015603359999999998	0.5853779979108756
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.015603359999999998	0.5853779979108756
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.015536353999999999	0.5828641907483147
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.015536353999999999	0.5828641907483147
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.015536353999999999	0.5828641907483147
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.015536353999999999	0.5828641907483147
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.015536353999999999	0.5828641907483147
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.015512359	0.5819639907234566
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.015512358999999998	0.5819639907234565
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5804106345230292
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5804106345230292
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.5804106345230292
TRISOMY 13	0.015466818999999998	0.5802555052418127
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.015421714	0.5785633392855207
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.015421714	0.5785633392855207
TANGIER DISEASE	0.015326890000000003	0.5750059078557582
CONGENITAL TOXOPLASMOSIS	0.015253973	0.5722703427291657
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.015175699999999999	0.5693338411019213
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.015175699999999999	0.5693338411019213
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.014990799999999999	0.5623971049237059
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.014990799999999999	0.5623971049237059
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.014990799999999999	0.5623971049237059
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.014990799999999999	0.5623971049237059
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.014990799999999999	0.5623971049237059
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.014970939999999999	0.561652034180064
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.014970939999999999	0.561652034180064
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.014970939999999999	0.561652034180064
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5599435486984203
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.014925399999999998	0.5599435486984203
ACHONDROGENESIS TYPE 1B	0.014925399999999998	0.5599435486984203
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.014925399999999998	0.5599435486984203
ACHONDROGENESIS	0.014925399999999998	0.5599435486984203
PHOCOMELIA, SCHINZEL TYPE	0.014925399999999998	0.5599435486984203
YUNIS-VARON SYNDROME	0.014925399999999998	0.5599435486984203
INDOMETHACIN EMBRYOFETOPATHY	0.014925399999999998	0.5599435486984203
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.014925399999999998	0.5599435486984203
ULNAR AGENESIS AND ENDOCARDIAL FIBROELASTOSIS	0.014925399999999998	0.5599435486984203
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.014925399999999998	0.5599435486984203
UMBILICAL CORD ULCERATION-INTESTINAL ATRESIA SYNDROME	0.014925399999999998	0.5599435486984203
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC 27; CMH27	0.014925399999999998	0.5599435486984203
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.014925399999999998	0.5599435486984203
FIBROCHONDROGENESIS 1; FBCG1	0.014925399999999998	0.5599435486984203
ACHONDROGENESIS TYPE 1A	0.014925399999999998	0.5599435486984203
BOOMERANG DYSPLASIA	0.014925399999999998	0.5599435486984203
ACHONDROGENESIS TYPE 2	0.014925399999999998	0.5599435486984203
FRASER SYNDROME 3; FRASRS3	0.014925399999999998	0.5599435486984203
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5599435486984203
PEDIATRIC-ONSET GRAVES DISEASE	0.014712554	0.5519583861857732
RETINITIS PIGMENTOSA 71; RP71	0.014447020000000001	0.5419965727496117
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.014354332999999999	0.5385193133328984
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.014320799999999998	0.5372612842671108
HEMOCHROMATOSIS, TYPE 2B	0.014320799999999998	0.5372612842671108
HURLER SYNDROME	0.014297334000000002	0.5363809302857265
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.014244153999999998	0.534385821416297
AYMÉ-GRIPP SYNDROME	0.014244153999999998	0.534385821416297
DYSKERATOSIS CONGENITA	0.014223474	0.5336099874294635
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.013996993999999999	0.5251133297245297
WRINKLY SKIN SYNDROME	0.013944614	0.5231482337752873
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.013901653	0.5215365024450963
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.013812913999999999	0.518207356789506
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.013808779	0.5180522275082896
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.013751780000000002	0.5159138444611175
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.013751780000000002	0.5159138444611175
PERLMAN SYNDROME	0.013743433999999999	0.5156007346712668
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.513918735591688
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.513918735591688
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.513918735591688
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.513918735591688
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.513918735591688
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.513918735591688
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.513918735591688
SEA-BLUE HISTIOCYTOSIS	0.01360296	0.5103306909833347
MONOSOMY 18P	0.013561414	0.5087720450057245
SANDHOFF DISEASE	0.013525300000000002	0.5074171867561839
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.013525300000000002	0.5074171867561839
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.013516954	0.507104076966333
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.013516954	0.507104076966333
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.013516954	0.507104076966333
CRONKHITE-CANADA SYNDROME	0.013356099	0.5010694166204874
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.013301314000000002	0.499014094329933
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.013301314000000002	0.499014094329933
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.013301314000000002	0.499014094329933
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.013267359999999999	0.49774027096489704
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.013267359999999999	0.49774027096489704
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.013204163000000001	0.4953693628185764
CEREBROFACIOARTICULAR SYNDROME	0.013133754000000001	0.4927278881967702
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.013083679	0.4908492669738165
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.013027313000000002	0.48873463164974246
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.0129714	0.4866369911417241
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.01281468	0.48075746007709497
HEMOCHROMATOSIS, TYPE 3; HFE3	0.012617219999999998	0.47334952105194383
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.012581272999999999	0.4720009279994922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.01254226	0.47053731043042396
CHANARIN-DORFMAN SYNDROME	0.01252647	0.46994493041823343
MARBURG HEMORRHAGIC FEVER	0.01246342	0.46757953714599715
RELAPSING FEVER	0.01246342	0.46757953714599715
BETA-KETOTHIOLASE DEFICIENCY	0.012342789	0.4630539264271529
19P13.12 MICRODELETION SYNDROME	0.012337523	0.46285636638002203
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.012198073	0.4576247392299293
OCULOECTODERMAL SYNDROME; OES	0.012198073	0.4576247392299293
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.012198073	0.4576247392299293
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.012136342999999999	0.45530886727600145
HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	0.012048200000000002	0.4520020812459505
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.012048200000000002	0.4520020812459505
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.012048200000000002	0.4520020812459505
NEUTROPHILIA, HEREDITARY	0.012048200000000002	0.4520020812459505
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.012048200000000002	0.4520020812459505
ROIFMAN SYNDROME	0.012048200000000002	0.4520020812459505
INTERMEDIATE OSTEOPETROSIS	0.012048200000000002	0.4520020812459505
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.012048200000000002	0.4520020812459505
BENT BONE DYSPLASIA SYNDROME; BBDS	0.012048200000000002	0.4520020812459505
FGFR2-RELATED BENT BONE DYSPLASIA	0.012048200000000002	0.4520020812459505
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.012048200000000002	0.4520020812459505
ANEMIA, SIDEROBLASTIC, PYRIDOXINE-RESPONSIVE, AUTOSOMAL RECESSIVE	0.012048200000000002	0.4520020812459505
COG1-CDG	0.012048200000000002	0.4520020812459505
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.012048200000000002	0.4520020812459505
ACROCEPHALOPOLYDACTYLY	0.012048200000000002	0.4520020812459505
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.45168897145609965
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.45168897145609965
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.012039854	0.45168897145609965
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.45168897145609965
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.45168897145609965
RING CHROMOSOME 14 SYNDROME	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.45168897145609965
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012039854	0.45168897145609965
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.012039854	0.45168897145609965
BETA-UREIDOPROPIONASE DEFICIENCY	0.012039854	0.45168897145609965
SEA-BLUE HISTIOCYTE DISEASE	0.01197434	0.4492311383896876
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.011823333	0.4435659370913437
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.011709574	0.4392981373569055
GERMAN SYNDROME	0.011656654	0.4373127826865368
CARDIOFACIOCUTANEOUS SYNDROME	0.011656654	0.4373127826865368
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.011656654	0.4373127826865368
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.011656654	0.4373127826865368
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.011652519	0.43715765340532037
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.011652519	0.43715765340532037
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.011652519	0.43715765340532037
FABRY DISEASE	0.011652519	0.43715765340532037
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.011652519	0.43715765340532037
PROTEUS SYNDROME	0.011652519	0.43715765340532037
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.011612423	0.435653405845549
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4312218856314908
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.4312218856314908
DESMOSTEROLOSIS	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.011494299999999999	0.4312218856314908
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.011429729	0.4287994302947491
WOLCOTT-RALLISON SYNDROME	0.011429729	0.4287994302947491
BIOTINIDASE DEFICIENCY	0.011281914	0.42325398054795116
KRABBE DISEASE	0.011281914	0.42325398054795116
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.011281914	0.42325398054795116
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.011277779	0.42309885126673474
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.011277779	0.42309885126673474
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.011184763	0.4196092490365947
XQ12-Q13.3 DUPLICATION SYNDROME	0.01116402	0.41883105153229655
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.0111111	0.41684569686192785
BUSCHKE-OLLENDORFF SYNDROME	0.0111111	0.41684569686192785
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.0111111	0.41684569686192785
DAHLBERG-BORER-NEWCOMER SYNDROME	0.0111111	0.41684569686192785
INFANTILE SYSTEMIC HYALINOSIS	0.0111111	0.41684569686192785
MELORHEOSTOSIS	0.0111111	0.41684569686192785
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0111111	0.41684569686192785
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.0111111	0.41684569686192785
LYMPHEDEMA, HEREDITARY, IB	0.0111111	0.41684569686192785
CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH	0.0111111	0.41684569686192785
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.0111111	0.41684569686192785
LYMPHEDEMA-CEREBRAL ARTERIOVENOUS ANOMALY SYNDROME	0.0111111	0.41684569686192785
GREENBERG DYSPLASIA	0.0111111	0.41684569686192785
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	0.0111111	0.41684569686192785
GERMAN SYNDROME	0.0111111	0.41684569686192785
SCHNECKENBECKEN DYSPLASIA	0.0111111	0.41684569686192785
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.0111111	0.41684569686192785
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.0111111	0.41684569686192785
IDIOPATHIC STEROID-SENSITIVE NEPHROTIC SYNDROME	0.0111111	0.41684569686192785
CHYLOUS ASCITES	0.0111111	0.41684569686192785
CLAPO SYNDROME	0.0111111	0.41684569686192785
TERMINAL TRANSVERSE LIMB DEFECT	0.0111111	0.41684569686192785
DOHLE BODIES AND LEUKEMIA	0.0111111	0.41684569686192785
PROXIMAL SPINAL MUSCULAR ATROPHY	0.0111111	0.41684569686192785
ALG8-CDG	0.0111111	0.41684569686192785
LYMPHEDEMA, HEREDITARY, ID; LMPH1D	0.0111111	0.41684569686192785
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.011084304	0.41584041410026495
NOONAN SYNDROME 6; NS6	0.011071004	0.4153414493021565
AKT2-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.01104937	0.4145298249080001
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.01104937	0.4145298249080001
CIDEC-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.01104937	0.4145298249080001
LIPE-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.01104937	0.4145298249080001
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.01104937	0.4145298249080001
FAMILIAL PARTIAL LIPODYSTROPHY, KÖBBERLING TYPE	0.01104937	0.4145298249080001
DYSBETALIPOPROTEINEMIA	0.01104937	0.4145298249080001
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.01104937	0.4145298249080001
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.01104937	0.4145298249080001
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.010969664	0.411539562637471
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.01096284	0.411283552428276
GAUCHER DISEASE TYPE 2	0.01096284	0.411283552428276
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.01088831	0.4084874737513565
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.01088831	0.4084874737513565
HEPATIC VENO-OCCLUSIVE DISEASE	0.01088831	0.4084874737513565
CINCA SYNDROME	0.010869824	0.4077939501981359
PELGER-HUET ANOMALY; PHA	0.010866494	0.40766902141785766
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01083013	0.40630478413075855
CONGENITAL RUBELLA SYNDROME	0.010786849000000001	0.4046810476324928
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.01073636	0.4027868947233422
MERRF	0.01073636	0.4027868947233422
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.010643343999999999	0.39929729249320217
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01053875	0.395373328275656
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.01053875	0.395373328275656
OLIVER SYNDROME	0.01053875	0.395373328275656
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.010432763	0.39139710406083433
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.010432763	0.39139710406083433
GALACTOSEMIA	0.010399229999999999	0.3901390749950469
HEMOCHROMATOSIS, TYPE 2A	0.010399229999999999	0.3901390749950469
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.010399229999999999	0.3901390749950469
CLASSIC MYCOSIS FUNGOIDES	0.01032427	0.38732686437352704
NODULAR NON-SUPPURATIVE PANNICULITIS	0.01032427	0.38732686437352704
SÉZARY SYNDROME	0.01032427	0.38732686437352704
PLAGUE	0.01032427	0.38732686437352704
MAJEED SYNDROME	0.01032427	0.38732686437352704
OMENN SYNDROME	0.01032427	0.38732686437352704
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.010271703	0.3853547529041909
BABESIOSIS	0.01024543	0.3843690910891002
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.009982143	0.37449157644251385
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.009891344	0.3710851475174419
MONOSOMY 13Q34	0.009891344	0.3710851475174419
ACQUIRED PARTIAL LIPODYSTROPHY	0.009887209	0.37093001823622546
ADRENOMYODYSTROPHY	0.009887209	0.37093001823622546
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.009804814	0.36783887503771784
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.36783887503771784
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.36783887503771784
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.009804814	0.36783887503771784
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.36783887503771784
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.36783887503771784
INFANTILE LIVER FAILURE SYNDROME 2	0.009726149	0.364887667079582
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.009707663	0.36419414352636137
AICARDI-GOUTIERES SYNDROME 7	0.009565743000000002	0.35886985148519135
NIEMANN-PICK DISEASE TYPE C	0.009530812999999999	0.35755941235752725
1Q44 MICRODELETION SYNDROME	0.009492564	0.3561244571272376
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.009492564	0.3561244571272376
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.009449394	0.3545048849216477
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.009445259000000001	0.3543497556404313
PSEUDO-TORCH SYNDROME 2	0.009445259000000001	0.3543497556404313
GALACTOSE EPIMERASE DEFICIENCY	0.009417054	0.35329161262308906
AROMATASE DEFICIENCY	0.00934579	0.35061806169283305
ATYPICAL WERNER SYNDROME	0.00934579	0.35061806169283305
MICROCEPHALIC PRIMORDIAL DWARFISM-INSULIN RESISTANCE SYNDROME	0.00934579	0.35061806169283305
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.00934579	0.35061806169283305
%613387 FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2; NAFLD2	0.00934579	0.35061806169283305
%613282 FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1; NAFLD1LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1, INCLUDED	0.00934579	0.35061806169283305
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.00934579	0.35061806169283305
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00934579	0.35061806169283305
PATENT DUCTUS VENOSUS	0.00934579	0.35061806169283305
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL	0.00934579	0.35061806169283305
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00934579	0.35061806169283305
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.009302899	0.3490089564931584
CARNOSINASE DEFICIENCY	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
PAINE SYNDROME	0.00925926	0.3473717892131089
MICROHYDRANENCEPHALY; MHAC	0.00925926	0.3473717892131089
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.3473717892131089
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3473717892131089
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.3473717892131089
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00925926	0.3473717892131089
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
HYDROXYLYSINURIA	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.3473717892131089
CARNOSINEMIA	0.00925926	0.3473717892131089
GLYCINE ENCEPHALOPATHY	0.00925926	0.3473717892131089
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3473717892131089
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3473717892131089
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3473717892131089
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.009241204	0.3466943976044888
SCLERODERMA	0.009237068999999999	0.3465392683232723
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.009166244	0.34388218698296885
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.009166244	0.34388218698296885
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.009166244	0.34388218698296885
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.009162109	0.34372705770175244
SYSTEMIC SCLEROSIS	0.009162109	0.34372705770175244
FAMILIAL MULTIPLE NEVI FLAMMEI	0.009162109	0.34372705770175244
PAPILLORENAL SYNDROME	0.009162109	0.34372705770175244
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.009162109	0.34372705770175244
SARCOSINEMIA	0.009064904	0.3400803003182833
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.009064904	0.3400803003182833
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00894701	0.3356573713026287
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00894701	0.3356573713026287
LEISHMANIASIS	0.00890384	0.3340377990970388
AMISH LETHAL MICROCEPHALY	0.00874583	0.3281098721986081
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00874583	0.3281098721986081
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.00869565	0.32622731177987985
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1	0.00869565	0.32622731177987985
CRANIOECTODERMAL DYSPLASIA 3	0.00869565	0.32622731177987985
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2; PFBMFT2	0.00869565	0.32622731177987985
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00869565	0.32622731177987985
MASTOCYTOSIS, CUTANEOUS; MASTC	0.00862069	0.3234151011583599
KERATOENDOTHELIITIS FUGAX HEREDITARIA; KEFH	0.00862069	0.3234151011583599
LIPEDEMA	0.00862069	0.3234151011583599
GENERALIZED JUVENILE POLYPOSIS/JUVENILE POLYPOSIS COLI	0.00862069	0.3234151011583599
KAPOSI SARCOMA, SUSCEPTIBILITY TO	0.00862069	0.3234151011583599
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00862069	0.3234151011583599
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00862069	0.3234151011583599
EOSINOPHILIC ESOPHAGITIS	0.00862069	0.3234151011583599
JOHANSON-BLIZZARD SYNDROME	0.00862069	0.3234151011583599
LETHAL CONGENITAL CONTRACTURE SYNDROME 2	0.00862069	0.3234151011583599
LETHAL RECESSIVE CHONDRODYSPLASIA	0.00862069	0.3234151011583599
THORACIC OUTLET SYNDROME	0.00862069	0.3234151011583599
CLUSTER HEADACHE, FAMILIAL	0.00862069	0.3234151011583599
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00862069	0.3234151011583599
OPSISMODYSPLASIA; OPSMD	0.00862069	0.3234151011583599
DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS	0.00862069	0.3234151011583599
LETHAL KNIEST-LIKE DYSPLASIA	0.00862069	0.3234151011583599
CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3; FECD3	0.00862069	0.3234151011583599
ANTISYNTHETASE SYNDROME	0.00862069	0.3234151011583599
BAZEX SYNDROME	0.00862069	0.3234151011583599
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.00862069	0.3234151011583599
RARE CUTANEOUS LUPUS ERYTHEMATOSUS	0.00862069	0.3234151011583599
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.00862069	0.3234151011583599
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.00862069	0.3234151011583599
SUPERFICIAL EPIDERMOLYTIC ICHTHYOSIS	0.00862069	0.3234151011583599
KNIEST-LIKE DYSPLASIA, LETHAL	0.00862069	0.3234151011583599
CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK	0.00862069	0.3234151011583599
%610158 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 2; FECD2;;FCD1 LOCUS;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	0.00862069	0.3234151011583599
CONGENITAL ENTEROCYTE HEPARAN SULFATE DEFICIENCY	0.00862069	0.3234151011583599
GLAUCOMA 3, PRIMARY CONGENITAL, E; GLC3E	0.00862069	0.3234151011583599
DISSECTING CELLULITIS OF THE SCALP	0.00862069	0.3234151011583599
THYMIC EPITHELIAL NEOPLASM	0.00862069	0.3234151011583599
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00862069	0.3234151011583599
NK-CELL ENTEROPATHY	0.00862069	0.3234151011583599
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00862069	0.3234151011583599
PIERSON SYNDROME	0.00862069	0.3234151011583599
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00862069	0.3234151011583599
DERMATITIS HERPETIFORMIS	0.00862069	0.3234151011583599
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.00862069	0.3234151011583599
ANEURYSM OF SINUS OF VALSALVA	0.00862069	0.3234151011583599
WHITE SPONGE NEVUS 2; WSN2	0.00862069	0.3234151011583599
EOSINOPHILIC GASTROENTERITIS	0.00862069	0.3234151011583599
CHILBLAIN LUPUS 2; CHBL2	0.00862069	0.3234151011583599
SAPHO SYNDROME	0.00862069	0.3234151011583599
NEPHROTIC SYNDROME, TYPE 9; NPHS9	0.00862069	0.3234151011583599
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00862069	0.3234151011583599
WELLS SYNDROME	0.00862069	0.3234151011583599
MELAS	0.00851935	0.31961321449367436
SALLA DISEASE	0.008256713	0.3097600853447399
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.008189222999999999	0.3072281203654658
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.007965333	0.29882862948963745
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.007963624	0.29876451438888807
PITT-HOPKINS-LIKE SYNDROME	0.007959489	0.29860938510767154
ASPARTYLGLUCOSAMINURIA; AGU	0.007937639	0.2977896572250647
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.007862163	0.2949580882700242
CHOREOACANTHOCYTOSIS	0.0076436690000000005	0.28676103454085694
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.0076436690000000005	0.28676103454085694
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.28466519480804997
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007587804	0.28466519480804997
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.28466519480804997
W SYNDROME	0.007587804	0.28466519480804997
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.28466519480804997
X SMALL RINGS	0.007587804	0.28466519480804997
OROFACIODIGITAL SYNDROME TYPE 2	0.007587804	0.28466519480804997
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2845100655268335
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2845100655268335
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.0075463430000000005	0.2831097377032096
GALACTOSE EPIMERASE DEFICIENCY	0.007512294	0.28183235030390147
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.007508159	0.281677221022685
HEREDITARY FRUCTOSE INTOLERANCE	0.007508159	0.281677221022685
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.007508159	0.281677221022685
ZELLWEGER SYNDROME	0.007508159	0.281677221022685
21Q22.11Q22.12 MICRODELETION SYNDROME	0.007316609	0.27449100244541524
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.007316609	0.27449100244541524
TOXIC EPIDERMAL NECROLYSIS	0.00720026	0.27012603588187173
NEUROLEPTIC MALIGNANT SYNDROME	0.00720026	0.27012603588187173
STEVENS-JOHNSON SYNDROME	0.00720026	0.27012603588187173
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00716792	0.26891276358331306
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26419810898344104
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26419810898344104
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26419810898344104
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26419810898344104
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26419810898344104
HALLERMANN-STREIFF SYNDROME; HSS	0.00704225	0.26419810898344104
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26419810898344104
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26419810898344104
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.26419810898344104
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00704225	0.26419810898344104
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.26419810898344104
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26419810898344104
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00704225	0.26419810898344104
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.26419810898344104
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.26419810898344104
HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB	0.00696674	0.26136526447929254
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.00696674	0.26136526447929254
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.00696674	0.26136526447929254
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	0.00696674	0.26136526447929254
EMANUEL SYNDROME	0.006779613	0.25434497983450655
CHROMOSOME 10Q26 DELETION SYNDROME	0.006779613	0.25434497983450655
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.006779613	0.25434497983450655
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.006779613	0.25434497983450655
CLASSIC GALACTOSEMIA	0.00674026	0.2528686067743588
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.006712123	0.25181301485523255
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.006712123	0.25181301485523255
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.0066605499999999995	0.24987819443922865
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.006578433	0.24679748073048596
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.006578433	0.24679748073048596
PIERPONT SYNDROME	0.006488233	0.2434135239794041
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.006488233	0.2434135239794041
CHROMOSOME 16P13.2 DELETION SYNDROME	0.006488233	0.2434135239794041
SRD5A3-CDG	0.006485643	0.24331635715029876
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.006485643	0.24331635715029876
ALG11-CDG	0.006485643	0.24331635715029876
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0063519530000000005	0.23830082302555225
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.0063519530000000005	0.23830082302555225
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.006166569	0.2313459290306236
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.006166569	0.2313459290306236
CLASSIC HOMOCYSTINURIA	0.006166569	0.2313459290306236
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.006166569	0.2313459290306236
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.006166569	0.2313459290306236
METHYLMALONIC ACIDURIA, CBLA TYPE	0.006069243	0.2276946321929762
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.006069243	0.2276946321929762
PROPIONIC ACIDEMIA	0.006069243	0.2276946321929762
GAUCHER DISEASE, TYPE II	0.006069243	0.2276946321929762
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.0060605730000000005	0.22736936717044984
CHROMOSOME 1P35 DELETION SYNDROME	0.0060605730000000005	0.22736936717044984
MENTAL RETARDATION, X-LINKED 104; MRX104	0.0060605730000000005	0.22736936717044984
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.0060605730000000005	0.22736936717044984
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.0060605730000000005	0.22736936717044984
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.0060605730000000005	0.22736936717044984
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0060605730000000005	0.22736936717044984
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0060605730000000005	0.22736936717044984
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.006060573	0.22736936717044978
GAPO SYNDROME; GAPOS	0.006032879	0.22633039490587703
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.005946814000000001	0.22310156743601167
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.005942679	0.22294643815479517
COG8-CDG	0.005940089	0.22284927132568982
OROFACIODIGITAL SYNDROME TYPE 1	0.005940089	0.22284927132568982
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.005940089	0.22284927132568982
ATAXIA-TELANGIECTASIA	0.005940089	0.22284927132568982
FOLATE MALABSORPTION, HEREDITARY	0.005842763	0.21919797448804243
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.005842763	0.21919797448804243
BARDET-BIEDL SYNDROME 21; BBS21	0.00582633	0.21858147159125166
REVESZ SYNDROME	0.005810534	0.21798886648215976
PRIMARY CONGENITAL HYPOTHYROIDISM	0.005808714	0.2179205870887344
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.005808714	0.2179205870887344
PERMANENT CONGENITAL HYPOTHYROIDISM	0.005808714	0.2179205870887344
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.005808714	0.2179205870887344
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.005808714	0.2179205870887344
FAMILIAL THYROID DYSHORMONOGENESIS	0.005808714	0.2179205870887344
THYROID ECTOPIA	0.005808714	0.2179205870887344
THYROID HEMIAGENESIS	0.005808714	0.2179205870887344
PERIPHERAL HYPOTHYROIDISM	0.005808714	0.2179205870887344
THYROID HYPOPLASIA	0.005808714	0.2179205870887344
NEURONAL CEROID LIPOFUSCINOSIS	0.005806399	0.21783373720094332
CRIGLER-NAJJAR SYNDROME	0.005804579000000001	0.21776545780751796
ACTH DEFICIENCY, ISOLATED; IAD	0.005804579000000001	0.21776545780751796
RIFT VALLEY FEVER	0.005804579000000001	0.21776545780751796
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.005804579000000001	0.21776545780751796
224250 DYSMYELINATION WITH JAUNDICE	0.005804579000000001	0.21776545780751796
TRANSKETOLASE DEFICIENCY	0.005745634	0.21555406833199112
FORSYTHE-WAKELING SYNDROME; FWS	0.005729004	0.21493017475360426
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.005729004	0.21493017475360426
LIG4 SYNDROME	0.005729004	0.21493017475360426
16Q24.3 MICRODELETION SYNDROME	0.005724869	0.2147750454723878
CORNELIA DE LANGE SYNDROME 1	0.005724869	0.2147750454723878
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.005626859	0.21109808758798054
NEUROENDOCRINE TUMOR OF STOMACH	0.00562515	0.21103397248723113
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00562515	0.21103397248723113
NEUROENDOCRINE TUMOR OF THE COLON	0.00562515	0.21103397248723113
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00562515	0.21103397248723113
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00562515	0.21103397248723113
GLYCINE N-METHYLTRANSFERASE DEFICIENCY	0.00562515	0.21103397248723113
GLYCOGEN STORAGE DISEASE IXA	0.00562515	0.21103397248723113
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00562515	0.21103397248723113
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00562515	0.21103397248723113
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.005527824	0.20738267564958368
METHYLMALONIC ACIDURIA, CBLB TYPE	0.005527824	0.20738267564958368
SHWACHMAN-DIAMOND SYNDROME	0.005527824	0.20738267564958368
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.005527824	0.20738267564958368
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.005527824	0.20738267564958368
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.005527824	0.20738267564958368
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.005527824	0.20738267564958368
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.005527824	0.20738267564958368
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.005523689	0.20722754636836727
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.005519154	0.20705741062705735
YOU-HOOVER-FONG SYNDROME; YHFS	0.005519154	0.20705741062705735
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.005519154	0.20705741062705735
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.005519154	0.20705741062705735
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.005515019	0.2069022813458409
ANGELMAN SYNDROME	0.0055150189999999995	0.20690228134584085
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.0055150189999999995	0.20690228134584085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.0055150189999999995	0.20690228134584085
HOYERAAL-HREIDARSSON SYNDROME	0.0053013439999999995	0.19888601794464997
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.005297208999999999	0.19873088866343347
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00526498	0.19752178065755083
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00526498	0.19752178065755083
CEREBELLOPARENCHYMAL DISORDER V	0.00526498	0.19752178065755083
REFSUM DISEASE	0.00526498	0.19752178065755083
46,XX GONADAL DYSGENESIS	0.00526498	0.19752178065755083
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00526498	0.19752178065755083
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00526316	0.19745350126412547
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00526316	0.19745350126412547
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00526316	0.19745350126412547
ELLIPTOCYTOSIS 1; EL1	0.00526316	0.19745350126412547
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRINMETABOLISM	0.00526316	0.19745350126412547
DOMINANT BETA-THALASSEMIA	0.00526316	0.19745350126412547
SPECTRIN, BETA, ERYTHROCYTIC	0.00526316	0.19745350126412547
HYPERBILIRUBINEMIA, ROTOR TYPE	0.00526316	0.19745350126412547
CONGENITAL PANCREATIC CYST	0.00526316	0.19745350126412547
CRIGLER-NAJJAR SYNDROME, TYPE II	0.00526316	0.19745350126412547
EVANS SYNDROME	0.00526316	0.19745350126412547
NEUROFIBROMATOSIS-PHEOCHROMOCYTOMA-DUODENAL CARCINOID SYNDROME	0.00526316	0.19745350126412547
GILBERT SYNDROME	0.00526316	0.19745350126412547
PANCREATOBLASTOMA	0.00526316	0.19745350126412547
YELLOW FEVER	0.00526316	0.19745350126412547
ROTOR SYNDROME	0.00526316	0.19745350126412547
SPHEROCYTOSIS, TYPE 2	0.00526316	0.19745350126412547
ACETAMINOPHEN METABOLISM	0.00526316	0.19745350126412547
HEREDITARY CHRONIC PANCREATITIS	0.00526316	0.19745350126412547
HEMOLYTIC ANEMIA, CONGENITAL, X-LINKED	0.00526316	0.19745350126412547
RH-NULL, REGULATOR TYPE; RHNR	0.00526316	0.19745350126412547
JAUNDICE, FAMILIAL OBSTRUCTIVE, OF INFANCY	0.00526316	0.19745350126412547
EDINBURGH MALFORMATION SYNDROME	0.00526316	0.19745350126412547
SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1	0.00526316	0.19745350126412547
HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATALBREASTFEEDING JAUNDICE, INCLUDED	0.00526316	0.19745350126412547
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE III	0.00526316	0.19745350126412547
HYPERBILIRUBINEMIA, CONJUGATED, TYPE III	0.00526316	0.19745350126412547
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00526316	0.19745350126412547
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.005008543000000001	0.18790125164006544
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.005008543000000001	0.18790125164006544
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.005008543000000001	0.18790125164006544
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.005008543000000001	0.18790125164006544
17Q12 MICRODELETION SYNDROME	0.005008543000000001	0.18790125164006544
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.005008543000000001	0.18790125164006544
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.005008543000000001	0.18790125164006544
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.005008543000000001	0.18790125164006544
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.00498227	0.18691558982497478
ACQUIRED IDIOPATHIC SIDEROBLASTIC ANEMIA	0.00498227	0.18691558982497478
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.00498227	0.18691558982497478
DENGUE FEVER	0.00498227	0.18691558982497478
FELTY SYNDROME	0.00498227	0.18691558982497478
GAUCHER DISEASE, TYPE I	0.00498227	0.18691558982497478
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00498227	0.18691558982497478
ALLAN-HERNDON-DUDLEY SYNDROME	0.0049736	0.18659032480244842
MUCOLIPIDOSIS TYPE IV	0.0049736	0.18659032480244842
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.0049736	0.18659032480244842
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.004874853	0.1828857175153189
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.004874853	0.1828857175153189
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004874853	0.1828857175153189
BARAITSER-WINTER SYNDROME 1; BRWS1	0.004874853	0.1828857175153189
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.004874853	0.1828857175153189
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.0046953130000000004	0.17615006790235613
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.004583473000000001	0.17195426166021652
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.004583473000000001	0.17195426166021652
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.004583473000000001	0.17195426166021652
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.004583473000000001	0.17195426166021652
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.004583473000000001	0.17195426166021652
LISSENCEPHALY 8; LIS8	0.004583473000000001	0.17195426166021652
ANGELMAN SYNDROME	0.004583473000000001	0.17195426166021652
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.004583473000000001	0.17195426166021652
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.004583473000000001	0.17195426166021652
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.004583473000000001	0.17195426166021652
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.004583473000000001	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, X-LINKED 103	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.004583473000000001	0.17195426166021652
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.004583473000000001	0.17195426166021652
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.004583473000000001	0.17195426166021652
XQ28 (MECP2) DUPLICATION	0.004583473000000001	0.17195426166021652
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, X-LINKED 101; MRX101	0.004583473000000001	0.17195426166021652
FOIX-CHAVANY-MARIE SYNDROME	0.004583473000000001	0.17195426166021652
IMMUNODEFICIENCY 49; IMD49	0.004583473000000001	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.004583473000000001	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.004583473000000001	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.004583473000000001	0.17195426166021652
RAYNAUD-CLAES SYNDROME; MRXSRC	0.004583473000000001	0.17195426166021652
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.004583473000000001	0.17195426166021652
COFFIN-SIRIS SYNDROME 5	0.004583473000000001	0.17195426166021652
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.004583473000000001	0.17195426166021652
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.004583473000000001	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.004583473000000001	0.17195426166021652
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.004583473000000001	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.004583473000000001	0.17195426166021652
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.004583473000000001	0.17195426166021652
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.004583473000000001	0.17195426166021652
PITT-HOPKINS SYNDROME	0.004583473000000001	0.17195426166021652
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.004583473000000001	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.004583473000000001	0.17195426166021652
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, X-LINKED 91; MRX91	0.004583473000000001	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.004583473000000001	0.17195426166021652
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.004583473000000001	0.17195426166021652
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.004583473000000001	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.004583473000000001	0.17195426166021652
16P13.2 MICRODELETION SYNDROME	0.004583473000000001	0.17195426166021652
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.004583473000000001	0.17195426166021652
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.004583473000000001	0.17195426166021652
SCHAAF-YANG SYNDROME; SHFYNG	0.004583473000000001	0.17195426166021652
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.004583473000000001	0.17195426166021652
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.004583473000000001	0.17195426166021652
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.004583473000000001	0.17195426166021652
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.004583473000000001	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.004583473000000001	0.17195426166021652
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.004583473000000001	0.17195426166021652
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.004583473000000001	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.004583473000000001	0.17195426166021652
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.004583473000000001	0.17195426166021652
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.004583473000000001	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.004583473000000001	0.17195426166021652
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.004583473000000001	0.17195426166021652
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.004583473000000001	0.17195426166021652
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.004583473000000001	0.17195426166021652
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.004583473000000001	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.004583473000000001	0.17195426166021652
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.004583473000000001	0.17195426166021652
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.004583473000000001	0.17195426166021652
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.004583473000000001	0.17195426166021652
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.004583473000000001	0.17195426166021652
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.004583473000000001	0.17195426166021652
PONTINE TEGMENTAL CAP DYSPLASIA	0.004583473000000001	0.17195426166021652
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.004583473000000001	0.17195426166021652
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.004583473000000001	0.17195426166021652
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.004583473	0.1719542616602165
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.004583473	0.1719542616602165
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.004583473	0.1719542616602165
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004583473	0.1719542616602165
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.004583473	0.1719542616602165
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.004583473	0.1719542616602165
DISTAL MONOSOMY 10Q	0.004468833	0.1676534101974224
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.004468833	0.1676534101974224
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.004468833	0.1676534101974224
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.004468833	0.1676534101974224
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.004468833	0.1676534101974224
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.004468833	0.1676534101974224
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.004468833	0.1676534101974224
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.004468833	0.1676534101974224
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.004468833	0.1676534101974224
HSD10 DISEASE	0.004468833	0.1676534101974224
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.004468833	0.1676534101974224
PELIZAEUS-MERZBACHER DISEASE	0.004468833	0.1676534101974224
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.004468833	0.1676534101974224
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.004468833	0.1676534101974224
15Q11Q13 MICRODUPLICATION SYNDROME	0.004468832999999999	0.16765341019742236
MEDULLOBLASTOMA	0.004467124	0.16758929509667295
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.0043656630000000005	0.1637828689778091
JACOBSEN SYNDROME	0.004365663	0.16378286897780908
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.004365663	0.16378286897780908
HEREDITARY FOLATE MALABSORPTION	0.004365663	0.16378286897780908
MIRAGE SYNDROME; MIRAGE	0.004365663	0.16378286897780908
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.004365663	0.16378286897780908
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.004365663	0.16378286897780908
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.004365663	0.16378286897780908
STT3B-CDG	0.004365663	0.16378286897780908
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.004365663	0.16378286897780908
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.004333434	0.16257376097192638
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004333434	0.16257376097192638
CUTIS LAXA	0.004333434	0.16257376097192638
LARSEN-LIKE SYNDROME	0.004333434	0.16257376097192638
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.004329299	0.16241863169070997
EPILEPSY-TELANGIECTASIA	0.004329299	0.16241863169070997
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.004329299	0.16241863169070997
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.004329299	0.16241863169070997
HYPERLEUCINE-ISOLEUCINEMIA	0.004329299	0.16241863169070997
ICHTHYOSIS AND MALE HYPOGONADISM	0.004329299	0.16241863169070997
XYLOSIDASE DEFICIENCY	0.004329299	0.16241863169070997
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.004329299	0.16241863169070997
TAY-SACHS DISEASE	0.004267653	0.16010591109340183
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.004267653	0.16010591109340183
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.004267653	0.16010591109340183
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.004267653	0.16010591109340183
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.004267653	0.16010591109340183
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.004267653	0.16010591109340183
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.004267653	0.16010591109340183
RFT1-CDG	0.004267653	0.16010591109340183
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.004267653	0.16010591109340183
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.004267653	0.16010591109340183
INFANTILE REFSUM DISEASE	0.004267653	0.16010591109340183
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.004267653	0.16010591109340183
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.004267653	0.16010591109340183
ASPARTYLGLUCOSAMINURIA	0.004149759	0.1556829820777472
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.004042054000000001	0.15164230511682403
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.004042054000000001	0.15164230511682403
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.004042054000000001	0.15164230511682403
AL-RAQAD SYNDROME; ARS	0.004042054000000001	0.15164230511682403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.004042054000000001	0.15164230511682403
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.004042054000000001	0.15164230511682403
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.004042054000000001	0.15164230511682403
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.004042054000000001	0.15164230511682403
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.004042054000000001	0.15164230511682403
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.004042054000000001	0.15164230511682403
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.004042054000000001	0.15164230511682403
HADZISELIMOVIC SYNDROME	0.004042054000000001	0.15164230511682403
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.004042054000000001	0.15164230511682403
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.004042054000000001	0.15164230511682403
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.004042054000000001	0.15164230511682403
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.004042054000000001	0.15164230511682403
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.004042054000000001	0.15164230511682403
JOUBERT SYNDROME 24	0.004042054000000001	0.15164230511682403
OROFACIODIGITAL SYNDROME XIV; OFD14	0.004042054000000001	0.15164230511682403
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.004042054000000001	0.15164230511682403
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.004042054000000001	0.15164230511682403
INFANTILE DYSTONIA-PARKINSONISM	0.004042054000000001	0.15164230511682403
HOLMES-GANG SYNDROME	0.004042054000000001	0.15164230511682403
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.004037919000000001	0.15148717583560758
TEMPLE-BARAITSER SYNDROME	0.004037919000000001	0.15148717583560758
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.004037919000000001	0.15148717583560758
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.004037919000000001	0.15148717583560758
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.004037919000000001	0.15148717583560758
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.004037919000000001	0.15148717583560758
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.004037919000000001	0.15148717583560758
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.004037919000000001	0.15148717583560758
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.004037919000000001	0.15148717583560758
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.004037919000000001	0.15148717583560758
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.004037919000000001	0.15148717583560758
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.004037919000000001	0.15148717583560758
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.004037919000000001	0.15148717583560758
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.004037919000000001	0.15148717583560758
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.004037919000000001	0.15148717583560758
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.004037919000000001	0.15148717583560758
PITT-HOPKINS SYNDROME	0.004037919000000001	0.15148717583560758
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.004037919000000001	0.15148717583560758
HALL-RIGGS SYNDROME	0.004037919000000001	0.15148717583560758
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.004037919000000001	0.15148717583560758
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.004037919000000001	0.15148717583560758
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.004037919000000001	0.15148717583560758
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.004037919000000001	0.15148717583560758
ADENYLOSUCCINATE LYASE DEFICIENCY	0.004037919000000001	0.15148717583560758
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.004037919000000001	0.15148717583560758
CHILDHOOD DISINTEGRATIVE DISORDER	0.004037919000000001	0.15148717583560758
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.004037919000000001	0.15148717583560758
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004037919000000001	0.15148717583560758
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.004037919000000001	0.15148717583560758
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.004037919000000001	0.15148717583560758
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.003927414	0.1473414536540299
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.003927414	0.1473414536540299
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.003927414	0.1473414536540299
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.003927414	0.1473414536540299
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.003927414	0.1473414536540299
2Q23.1 MICRODELETION SYNDROME	0.003923279	0.14718632437281345
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.003923279	0.14718632437281345
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.003923279	0.14718632437281345
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.003923279	0.14718632437281345
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00392157	0.14712220927206404
COMMON VARIABLE IMMUNODEFICIENCY	0.00392157	0.14712220927206404
BECKER MUSCULAR DYSTROPHY	0.00392157	0.14712220927206404
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.00392157	0.14712220927206404
XFE PROGEROID SYNDROME; XFEPS	0.00392157	0.14712220927206404
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.00392157	0.14712220927206404
PRIMARY HYPEROXALURIA	0.00392157	0.14712220927206404
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.00392157	0.14712220927206404
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.00392157	0.14712220927206404
DPM3-CDG	0.00392157	0.14712220927206404
MCCUNE-ALBRIGHT SYNDROME	0.00392157	0.14712220927206404
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.00392157	0.14712220927206404
INTERSTITIAL NEPHRITIS, KARYOMEGALIC	0.00392157	0.14712220927206404
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.00392157	0.14712220927206404
X-LINKED SIDEROBLASTIC ANEMIA	0.00392157	0.14712220927206404
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00392157	0.14712220927206404
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.003824244	0.14347091243441662
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.003824244	0.14347091243441662
ROBERTS SYNDROME	0.003824244	0.14347091243441662
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.003824244	0.14347091243441662
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.003824244	0.14347091243441662
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.003824244	0.14347091243441662
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.003824244	0.14347091243441662
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.003820109	0.14331578315320018
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.003820109	0.14331578315320018
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.003820109	0.14331578315320018
DUBOWITZ SYNDROME	0.003820109	0.14331578315320018
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.003820109	0.14331578315320018
SMITH-KINGSMORE SYNDROME; SKS	0.003820109	0.14331578315320018
EBOLA HEMORRHAGIC FEVER	0.003820109	0.14331578315320018
VIRAL HEMORRHAGIC FEVER	0.003820109	0.14331578315320018
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.003820109	0.14331578315320018
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.003820109	0.14331578315320018
BERNARD-SOULIER SYNDROME	0.003820109	0.14331578315320018
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.14210667514731748
ETHANOLAMINOSIS	0.00378788	0.14210667514731748
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.14210667514731748
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.14210667514731748
HYPOASCORBEMIA	0.00378788	0.14210667514731748
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.14210667514731748
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.14210667514731748
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.14210667514731748
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.14210667514731748
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.14210667514731748
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00378788	0.14210667514731748
ZINC, ELEVATED PLASMA	0.00378788	0.14210667514731748
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.14210667514731748
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.14210667514731748
CITRULLINE TRANSPORT DEFECT	0.00378788	0.14210667514731748
NEPHROSIALIDOSIS	0.00378788	0.14210667514731748
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.14210667514731748
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.14210667514731748
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	0.14210667514731748
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.14210667514731748
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.14210667514731748
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.14210667514731748
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.14210667514731748
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.14210667514731748
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.14210667514731748
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.14210667514731748
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.14210667514731748
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.14210667514731748
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.14210667514731748
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.14210667514731748
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.14210667514731748
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.14210667514731748
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.14210667514731748
GLUTATHIONURIA	0.00378788	0.14210667514731748
BARTTER SYNDROME	0.00378788	0.14210667514731748
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.14210667514731748
HOOFT DISEASE	0.00378788	0.14210667514731748
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.14210667514731748
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	0.14210667514731748
AREDYLD	0.00378788	0.14210667514731748
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00378788	0.14210667514731748
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.14210667514731748
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.14210667514731748
DERMATITIS, ATOPIC	0.00378788	0.14210667514731748
LYMPHOKINE DEFICIENCY	0.00378788	0.14210667514731748
LIPASE DEFICIENCY, COMBINED	0.00378788	0.14210667514731748
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.14210667514731748
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.14210667514731748
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.14210667514731748
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.14210667514731748
%608572 BURN-MCKEOWN SYNDROME	0.00378788	0.14210667514731748
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00378788	0.14210667514731748
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.14210667514731748
DERMATOLEUKODYSTROPHY	0.00378788	0.14210667514731748
EHLERS-DANLOS SYNDROME, TYPE VI	0.00378788	0.14210667514731748
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.14210667514731748
X-LINKED ADRENOLEUKODYSTROPHY	0.00378788	0.14210667514731748
CARDIAC LIPIDOSIS, FAMILIAL	0.00378788	0.14210667514731748
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00378788	0.14210667514731748
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.14210667514731748
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.14210667514731748
ACETYLATION, SLOW	0.00378788	0.14210667514731748
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00378788	0.14210667514731748
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.14210667514731748
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.14210667514731748
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.14210667514731748
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.14210667514731748
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.14210667514731748
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	0.14210667514731748
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.14210667514731748
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.14210667514731748
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.14210667514731748
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.14210667514731748
FLOOD FACTOR DEFICIENCY	0.00378788	0.14210667514731748
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00378788	0.14210667514731748
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.14210667514731748
GLOMUVENOUS MALFORMATIONS	0.00378788	0.14210667514731748
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.14210667514731748
GLUTATHIONE REDUCTASE	0.00378788	0.14210667514731748
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.14210667514731748
HEINZ BODY ANEMIAS	0.00378788	0.14210667514731748
HYPERPROGLUCAGONEMIA	0.00378788	0.14210667514731748
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.14210667514731748
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00378788	0.14210667514731748
XM SYSTEM	0.00378788	0.14210667514731748
DELETED IN AZOOSPERMIA	0.00378788	0.14210667514731748
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.14210667514731748
GONADOBLASTOMA	0.00378788	0.14210667514731748
ONCOCYTOMA	0.00378788	0.14210667514731748
KERATOSIS, FAMILIAL ACTINIC	0.00378788	0.14210667514731748
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.14210667514731748
APOLIPOPROTEIN(A)	0.00378788	0.14210667514731748
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.14210667514731748
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.14210667514731748
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.14210667514731748
MACROCYTOSIS, FAMILIAL	0.00378788	0.14210667514731748
OVARIAN CANCER	0.00378788	0.14210667514731748
PYGMY	0.00378788	0.14210667514731748
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.14210667514731748
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00378788	0.14210667514731748
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.14210667514731748
PACMAN DYSPLASIA	0.00378788	0.14210667514731748
PENDRED SYNDROME	0.00378788	0.14210667514731748
FINGERPRINT BODY MYOPATHY	0.00378788	0.14210667514731748
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.14210667514731748
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.14210667514731748
OSTEOMESOPYKNOSIS	0.00378788	0.14210667514731748
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.14210667514731748
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.14210667514731748
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.14210667514731748
BEETURIA	0.00378788	0.14210667514731748
CARBOXYLESTERASE 1	0.00378788	0.14210667514731748
ICHTHYOSIS, X-LINKED	0.00378788	0.14210667514731748
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.14210667514731748
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.14210667514731748
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.14210667514731748
MACULAR CORNEAL DYSTROPHY	0.00378788	0.14210667514731748
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.14210667514731748
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.14210667514731748
COUMARIN RESISTANCE	0.00378788	0.14210667514731748
ALAND ISLAND EYE DISEASE	0.00378788	0.14210667514731748
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.14210667514731748
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.14210667514731748
CALVARIAL HYPEROSTOSIS	0.00378788	0.14210667514731748
PREMATURE OVARIAN FAILURE 1	0.00378788	0.14210667514731748
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.14210667514731748
T-SUBSTANCE ANOMALY	0.00378788	0.14210667514731748
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	0.14210667514731748
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.14210667514731748
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.14210667514731748
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00378788	0.14210667514731748
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.14210667514731748
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.14210667514731748
PERRY SYNDROME	0.00378788	0.14210667514731748
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00378788	0.14210667514731748
PARAOXONASE 1	0.00378788	0.14210667514731748
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.14210667514731748
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.14210667514731748
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.14210667514731748
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.14210667514731748
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.14210667514731748
PITUITARY DWARFISM IV	0.00378788	0.14210667514731748
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.14210667514731748
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.14210667514731748
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.14210667514731748
SPINAL ARACHNOIDITIS	0.00378788	0.14210667514731748
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.14210667514731748
MYOPATHY, SPHEROID BODY	0.00378788	0.14210667514731748
LARON SYNDROME	0.00378788	0.14210667514731748
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.14210667514731748
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.14210667514731748
OSTEOGENIC SARCOMA	0.00378788	0.14210667514731748
SCHIZOPHRENIA 4	0.00378788	0.14210667514731748
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.14210667514731748
CONGENITAL ADRENAL HYPERPLASIA	0.00378788	0.14210667514731748
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.14210667514731748
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.14210667514731748
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	0.14210667514731748
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.14210667514731748
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.14210667514731748
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.14210667514731748
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.14210667514731748
PROGESTERONE RESISTANCE	0.00378788	0.14210667514731748
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.14210667514731748
TRISOMY 18-LIKE SYNDROME	0.00378788	0.14210667514731748
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00378788	0.14210667514731748
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.14210667514731748
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.14210667514731748
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.14210667514731748
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.14210667514731748
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.14210667514731748
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.003726234	0.13979395455000937
SANDHOFF DISEASE	0.003722099	0.1396388252687929
MUCOPOLYSACCHARIDOSIS TYPE 3	0.003722099	0.1396388252687929
COCKAYNE SYNDROME A; CSA	0.003722099	0.1396388252687929
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.003722099	0.1396388252687929
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.003722099	0.1396388252687929
RETT SYNDROME	0.003722099	0.1396388252687929
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0034965000000000005	0.1311752192922151
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.0034965000000000005	0.1311752192922151
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0034965000000000005	0.1311752192922151
OPTICOCOCHLEODENTATE DEGENERATION	0.0034965000000000005	0.1311752192922151
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.0034965000000000005	0.1311752192922151
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0034965000000000005	0.1311752192922151
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.0034965000000000005	0.1311752192922151
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.0034965000000000005	0.1311752192922151
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.0034965000000000005	0.1311752192922151
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.0034965000000000005	0.1311752192922151
WARBURG MICRO SYNDROME 2; WARBM2	0.0034965000000000005	0.1311752192922151
MENTAL RETARDATION, X-LINKED 105; MRX105	0.0034965000000000005	0.1311752192922151
GABRIELE-DE VRIES SYNDROME	0.0034965000000000005	0.1311752192922151
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.0034965000000000005	0.1311752192922151
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.0034965000000000005	0.1311752192922151
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.0034965000000000005	0.1311752192922151
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.0033818599999999996	0.12687436782942096
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0033818599999999996	0.12687436782942096
GOOD SYNDROME	0.00327869	0.12300382660980769
DIAMOND-BLACKFAN ANEMIA 1	0.00327869	0.12300382660980769
REFRACTORY ANEMIA	0.00327869	0.12300382660980769
THROMBOCYTOPENIA 2	0.00327869	0.12300382660980769
THROMBOCYTOPENIA, CYCLIC	0.00327869	0.12300382660980769
%614200 BLEEDING DISORDER, PLATELET-TYPE, 9; BDPLT9;;GLYCOPROTEIN IA DEFICIENCY;;GP IA DEFICIENCY;;COLLAGEN PLATELET RECEPTOR DEFICIENCY	0.00327869	0.12300382660980769
BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17	0.00327869	0.12300382660980769
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00327869	0.12300382660980769
BEEMER-ERTBRUGGEN SYNDROME	0.00327869	0.12300382660980769
FANCONI ANEMIA	0.00327869	0.12300382660980769
188030 THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP;;IMMUNE THROMBOCYTOPENIC PURPURA; ITP;;IDIOPATHIC THROMBOCYTOPENIC PURPURA	0.00327869	0.12300382660980769
167850 PANCYTOPENIA AND OCCLUSIVE VASCULAR DISEASE	0.00327869	0.12300382660980769
CERNUNNOS-XLF DEFICIENCY	0.00327869	0.12300382660980769
ISOLATED AGAMMAGLOBULINEMIA	0.00327869	0.12300382660980769
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.00327869	0.12300382660980769
VON WILLEBRAND DISEASE, TYPE 2; VWD2	0.00327869	0.12300382660980769
AREGENERATIVE ANEMIA	0.00327869	0.12300382660980769
IVIC SYNDROME	0.00327869	0.12300382660980769
STORMORKEN SYNDROME; STRMK	0.00327869	0.12300382660980769
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00327869	0.12300382660980769
HERMANSKY-PUDLAK SYNDROME 9	0.00327869	0.12300382660980769
WISKOTT-ALDRICH SYNDROME	0.00327869	0.12300382660980769
MALARIA	0.00327869	0.12300382660980769
PLATELET SIGNAL PROCESSING DEFECT	0.00327869	0.12300382660980769
PLATELET DISORDER, UNDEFINED	0.00327869	0.12300382660980769
MOYAMOYA DISEASE WITH EARLY-ONSET ACHALASIA	0.00327869	0.12300382660980769
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.00327869	0.12300382660980769
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.00327869	0.12300382660980769
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00327869	0.12300382660980769
EOSINOPHILIA, FAMILIAL	0.00327869	0.12300382660980769
TUFTED ANGIOMA	0.00327869	0.12300382660980769
IVIC SYNDROME	0.00327869	0.12300382660980769
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00327869	0.12300382660980769
SENGERS SYNDROME	0.00327869	0.12300382660980769
DEAFNESS, AUTOSOMAL DOMINANT 1	0.00327869	0.12300382660980769
JACOBSEN SYNDROME	0.00327869	0.12300382660980769
BEEMER LETHAL MALFORMATION SYNDROME	0.00327869	0.12300382660980769
ATYPICAL HEMOLYTIC UREMIC SYNDROME	0.00327869	0.12300382660980769
WT LIMB-BLOOD SYNDROME	0.00327869	0.12300382660980769
FIBULAR HEMIMELIA	0.00327869	0.12300382660980769
GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA	0.00327869	0.12300382660980769
IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	0.00327869	0.12300382660980769
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00327869	0.12300382660980769
ACQUIRED PURPURA FULMINANS	0.00327869	0.12300382660980769
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00327869	0.12300382660980769
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.00327869	0.12300382660980769
THROMBOCYTOPENIA 5; THC5	0.00327869	0.12300382660980769
IMMUNE THROMBOCYTOPENIC PURPURA	0.00327869	0.12300382660980769
NIJMEGEN BREAKAGE SYNDROME	0.00327869	0.12300382660980769
TRANSCOBALAMIN DEFICIENCY	0.00327869	0.12300382660980769
CYCLIC NEUTROPENIA	0.00327869	0.12300382660980769
THROMBOCYTOPENIA 3	0.00327869	0.12300382660980769
SLC35A1-CDG	0.00327869	0.12300382660980769
GRAY PLATELET SYNDROME	0.00327869	0.12300382660980769
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00327869	0.12300382660980769
SEBASTIAN SYNDROME	0.00327869	0.12300382660980769
THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY	0.00327869	0.12300382660980769
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.00327869	0.12300382660980769
IMMUNODEFICIENCY 52; IMD52	0.00327869	0.12300382660980769
BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15	0.00327869	0.12300382660980769
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.00327869	0.12300382660980769
ROCH-LERI MESOSOMATOUS LIPOMATOSIS	0.00327869	0.12300382660980769
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.00327869	0.12300382660980769
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.00327869	0.12300382660980769
OSTEOGENESIS IMPERFECTA	0.00327869	0.12300382660980769
AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	0.00327869	0.12300382660980769
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.00327869	0.12300382660980769
MONOSOMY 7 OF BONE MARROW	0.00327869	0.12300382660980769
CHRONIC MYELOID LEUKEMIA	0.00327869	0.12300382660980769
NIJMEGEN BREAKAGE SYNDROME	0.00327869	0.12300382660980769
ACUTE PROMYELOCYTIC LEUKEMIA	0.00327869	0.12300382660980769
ACUTE MYELOMONOCYTIC LEUKEMIA	0.00327869	0.12300382660980769
VON WILLEBRAND DISEASE, TYPE 3; VWD3	0.00327869	0.12300382660980769
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00327869	0.12300382660980769
IDIOPATHIC APLASTIC ANEMIA	0.00327869	0.12300382660980769
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00327869	0.12300382660980769
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.00327869	0.12300382660980769
OSTEOPETROSIS AND RELATED DISORDERS	0.00327869	0.12300382660980769
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.00327869	0.12300382660980769
BETA-THALASSEMIA-X-LINKED THROMBOCYTOPENIA SYNDROME	0.00327869	0.12300382660980769
DRUG-INDUCED LUPUS ERYTHEMATOSUS	0.00327869	0.12300382660980769
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00327869	0.12300382660980769
THROMBOCYTOPENIA 6	0.00327869	0.12300382660980769
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.00327869	0.12300382660980769
BLEEDING DISORDER, PLATELET-TYPE, 20	0.00327869	0.12300382660980769
CLASSIC HODGKIN LYMPHOMA	0.00318068	0.11932686872540042
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00318068	0.11932686872540042
HODGKIN LYMPHOMA	0.00318068	0.11932686872540042
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00318068	0.11932686872540042
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00318068	0.11932686872540042
CAMURATI-ENGELMANN DISEASE	0.00318068	0.11932686872540042
TYPHOID	0.00318068	0.11932686872540042
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.002991733	0.11223830468718902
JOUBERT SYNDROME 30; JBTS30	0.002991733	0.11223830468718902
AL KAISSI SYNDROME; ALKAS	0.002991733	0.11223830468718902
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.002991733	0.11223830468718902
GLASS SYNDROME	0.002991733	0.11223830468718902
PRADER-WILLI SYNDROME; PWS	0.002991733	0.11223830468718902
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.002991733	0.11223830468718902
15Q14 MICRODELETION SYNDROME	0.002991733	0.11223830468718902
WEAVER SYNDROME	0.002991733	0.11223830468718902
KLEEFSTRA SYNDROME 2; KLEFS2	0.002991733	0.11223830468718902
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.002991733	0.11223830468718902
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.002991733	0.11223830468718902
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.002991733	0.11223830468718902
ADENYLOSUCCINASE DEFICIENCY	0.002991733	0.11223830468718902
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.002991733	0.11223830468718902
FG SYNDROME TYPE 1	0.002991733	0.11223830468718902
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.002991733	0.11223830468718902
SMITH-MAGENIS SYNDROME	0.002991733	0.11223830468718902
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.002991733	0.11223830468718902
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.002991733	0.11223830468718902
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.002991733	0.11223830468718902
CHROMOSOME 5Q12 DELETION SYNDROME	0.002991733	0.11223830468718902
CK SYNDROME	0.002991733	0.11223830468718902
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.002991733	0.11223830468718902
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.002991733	0.11223830468718902
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.002991733	0.11223830468718902
WITTEVEEN-KOLK SYNDROME	0.002991733	0.11223830468718902
MENTAL RETARDATION, X-LINKED 9	0.002991733	0.11223830468718902
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.002991733	0.11223830468718902
11P15.4 MICRODUPLICATION SYNDROME	0.002991733	0.11223830468718902
XQ25 DUPLICATION SYNDROME	0.002991733	0.11223830468718902
DISTAL MONOSOMY 15Q	0.002991733	0.11223830468718902
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.002991733	0.11223830468718902
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.002991733	0.11223830468718902
SHASHI-PENA SYNDROME; SHAPNS	0.002991733	0.11223830468718902
MEHMO SYNDROME; MEHMO	0.002991733	0.11223830468718902
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.002991733	0.11223830468718902
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.002991733	0.11223830468718902
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.002991733	0.11223830468718902
CHROMOSOME 19P13.13 DELETION SYNDROME	0.002991733	0.11223830468718902
WIEACKER-WOLFF SYNDROME	0.002991733	0.11223830468718902
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.002991733	0.11223830468718902
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.002991733	0.11223830468718902
6Q TERMINAL DELETION SYNDROME	0.002991733	0.11223830468718902
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.002991733	0.11223830468718902
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.002991733	0.11223830468718902
LUSCAN-LUMISH SYNDROME; LLS	0.002991733	0.11223830468718902
48,XXXY SYNDROME	0.002991733	0.11223830468718902
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.002991733	0.11223830468718902
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.002991733	0.11223830468718902
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.002991733	0.11223830468718902
17Q11.2 MICRODUPLICATION SYNDROME	0.002991733	0.11223830468718902
EMANUEL SYNDROME	0.002991733	0.11223830468718902
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.002991733	0.11223830468718902
KLEEFSTRA SYNDROME	0.002991733	0.11223830468718902
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.002991733	0.11223830468718902
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.002991733	0.11223830468718902
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.002991733	0.11223830468718902
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.002991733	0.11223830468718902
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.002991733	0.11223830468718902
WIEDEMANN-STEINER SYNDROME; WDSTS	0.002991733	0.11223830468718902
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.002991733	0.11223830468718902
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.002991733	0.11223830468718902
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.002991733	0.11223830468718902
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.002991733	0.11223830468718902
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.002991733	0.11223830468718902
MENTAL RETARDATION, X-LINKED 90	0.002991733	0.11223830468718902
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.002991733	0.11223830468718902
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.002991733	0.11223830468718902
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.002991733	0.11223830468718902
SHUKLA-VERNON SYNDROME; SHUVER	0.002991733	0.11223830468718902
11Q22.2Q22.3 MICRODELETION SYNDROME	0.002991733	0.11223830468718902
DESANTO-SHINAWI SYNDROME	0.002991733	0.11223830468718902
COFFIN-SIRIS SYNDROME 2; CSS2	0.002991733	0.11223830468718902
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.002991733	0.11223830468718902
LANDAU-KLEFFNER SYNDROME	0.002991733	0.11223830468718902
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.002991733	0.11223830468718902
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.002991733	0.11223830468718902
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.002991733	0.11223830468718902
GENITOPATELLAR SYNDROME	0.002991733	0.11223830468718902
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.002991733	0.11223830468718902
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.0027905530000000003	0.1046908055831685
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.0027905530000000003	0.1046908055831685
MULTIPLE SULFATASE DEFICIENCY	0.0027905530000000003	0.1046908055831685
PYRUVATE CARBOXYLASE DEFICIENCY	0.0027905530000000003	0.1046908055831685
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.0027905530000000003	0.1046908055831685
MUCOPOLYSACCHARIDOSIS TYPE 2	0.0027905530000000003	0.1046908055831685
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.0027905530000000003	0.1046908055831685
C SYNDROME	0.0027905530000000003	0.1046908055831685
KAGAMI-OGATA SYNDROME	0.0027905530000000003	0.1046908055831685
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.0027905530000000003	0.1046908055831685
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.0027905530000000003	0.1046908055831685
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.002790553	0.10469080558316848
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.002564073	0.09619414787823474
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.002564073	0.09619414787823474
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.002564073	0.09619414787823474
HARTNUP DISEASE	0.002564073	0.09619414787823474
CENTRAL BILATERAL MACROGYRIA	0.002564073	0.09619414787823474
JOUBERT SYNDROME WITH RENAL DEFECT	0.002564073	0.09619414787823474
48,XXYY SYNDROME	0.002564073	0.09619414787823474
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.002564073	0.09619414787823474
JOUBERT SYNDROME WITH OCULAR DEFECT	0.002564073	0.09619414787823474
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.002564073	0.09619414787823474
MEVALONIC ACIDURIA	0.002564073	0.09619414787823474
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.002564073	0.09619414787823474
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.002564073	0.09619414787823474
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.002564073	0.09619414787823474
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.002564073	0.09619414787823474
PYRUVATE DEHYDROGENASE DEFICIENCY	0.002564073	0.09619414787823474
OROFACIODIGITAL SYNDROME TYPE 6	0.002564073	0.09619414787823474
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.002564073	0.09619414787823474
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.002564073	0.09619414787823474
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.002564073	0.09619414787823474
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.002564073	0.09619414787823474
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.002564073	0.09619414787823474
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.002564073	0.09619414787823474
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.002564073	0.09619414787823474
SULFOCYSTEINURIA	0.002564073	0.09619414787823474
MYHRE SYNDROME	0.002564073	0.09619414787823474
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.002564073	0.09619414787823474
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.002564073	0.09619414787823474
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.002564073	0.09619414787823474
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.002564073	0.09619414787823474
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.002564073	0.09619414787823474
JOUBERT SYNDROME	0.002564073	0.09619414787823474
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.002564073	0.09619414787823474
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.002564073	0.09619414787823474
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.002564073	0.09619414787823474
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.002564073	0.09619414787823474
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.002564073	0.09619414787823474
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.002564073	0.09619414787823474
EAST SYNDROME	0.002564073	0.09619414787823474
COWDEN SYNDROME	0.002564073	0.09619414787823474
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.002564073	0.09619414787823474
CEDNIK SYNDROME	0.002564073	0.09619414787823474
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.002564073	0.09619414787823474
MAPLE SYRUP URINE DISEASE	0.002564073	0.09619414787823474
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.002564073	0.09619414787823474
ELEJALDE DISEASE	0.002564073	0.09619414787823474
GRISCELLI SYNDROME TYPE 1	0.002564073	0.09619414787823474
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.002564073	0.09619414787823474
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.0025640729999999996	0.09619414787823473
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.0025640729999999996	0.09619414787823473
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.0025640729999999996	0.09619414787823473
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.002450314	0.09192634814379656
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.002450314	0.09192634814379656
DUCHENNE MUSCULAR DYSTROPHY	0.002450314	0.09192634814379656
OKAMOTO SYNDROME	0.002450314	0.09192634814379656
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.002450314	0.09192634814379656
DESBUQUOIS DYSPLASIA 2; DBQD2	0.002450314	0.09192634814379656
SPINOCEREBELLAR ATAXIA TYPE 29	0.002450314	0.09192634814379656
6Q16 MICRODELETION SYNDROME	0.002450314	0.09192634814379656
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.002450314	0.09192634814379656
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.002450314	0.09192634814379656
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.002450314	0.09192634814379656
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.002450314	0.09192634814379656
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.002450314	0.09192634814379656
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.002450314	0.09192634814379656
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.002450314	0.09192634814379656
BARATELA-SCOTT SYNDROME	0.002450314	0.09192634814379656
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.002450314	0.09192634814379656
COFFIN-SIRIS SYNDROME 6; CSS6	0.002450314	0.09192634814379656
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.002450314	0.09192634814379656
DE BARSY SYNDROME	0.002450314	0.09192634814379656
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.002450314	0.09192634814379656
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.002450314	0.09192634814379656
3Q29 MICRODELETION SYNDROME	0.002450314	0.09192634814379656
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.002450314	0.09192634814379656
8P23.1 DUPLICATION SYNDROME	0.002450314	0.09192634814379656
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.002450314	0.09192634814379656
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.002450314	0.09192634814379656
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.002450314	0.09192634814379656
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.002450314	0.09192634814379656
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.002450314	0.09192634814379656
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.002450314	0.09192634814379656
1P21.3 MICRODELETION SYNDROME	0.002450314	0.09192634814379656
2Q32Q33 MICRODELETION SYNDROME	0.002450314	0.09192634814379656
COFFIN-SIRIS SYNDROME 7; CSS7	0.002450314	0.09192634814379656
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.002450314	0.09192634814379656
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.002450314	0.09192634814379656
ABLEPHARON MACROSTOMIA SYNDROME	0.002450314	0.09192634814379656
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.002450314	0.09192634814379656
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.002450314	0.09192634814379656
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.002450314	0.09192634814379656
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.002450314	0.09192634814379656
48,XYYY SYNDROME	0.002450314	0.09192634814379656
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.002450314	0.09192634814379656
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.002450314	0.09192634814379656
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.002450314	0.09192634814379656
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.002450314	0.09192634814379656
EPIDERMAL NEVUS SYNDROME	0.002450314	0.09192634814379656
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.002450314	0.09192634814379656
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.002450314	0.09192634814379656
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.002450314	0.09192634814379656
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.002450314	0.09192634814379656
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.002450314	0.09192634814379656
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.002450314	0.09192634814379656
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.002450314	0.09192634814379656
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.002450314	0.09192634814379656
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.002450314	0.09192634814379656
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.002450314	0.09192634814379656
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.002450314	0.09192634814379656
SAY-BARBER-MILLER SYNDROME	0.002450314	0.09192634814379656
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.002450314	0.09192634814379656
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.002450314	0.09192634814379656
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.002450314	0.09192634814379656
SAUL-WILSON SYNDROME; SWILS	0.002450314	0.09192634814379656
2P15P16.1 MICRODELETION SYNDROME	0.002450314	0.09192634814379656
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.002450314	0.09192634814379656
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.002450314	0.09192634814379656
DISTAL MONOSOMY 6P	0.002450314	0.09192634814379656
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.002450314	0.09192634814379656
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.002450314	0.09192634814379656
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.002450314	0.09192634814379656
COHEN-GIBSON SYNDROME; COGIS	0.002450314	0.09192634814379656
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.002450314	0.09192634814379656
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.002450314	0.09192634814379656
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.002450314	0.09192634814379656
16P11.2P12.2 MICRODELETION SYNDROME	0.002450314	0.09192634814379656
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.002450314	0.09192634814379656
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.002450314	0.09192634814379656
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.002450314	0.09192634814379656
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.002450314	0.09192634814379656
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.002450314	0.09192634814379656
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.002450314	0.09192634814379656
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.002450314	0.09192634814379656
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.002450314	0.09192634814379656
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.002450314	0.09192634814379656
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.002450314	0.09192634814379656
LAMB-SHAFFER SYNDROME	0.002450314	0.09192634814379656
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.002450314	0.09192634814379656
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.002450314	0.09192634814379656
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.002450314	0.09192634814379656
TONNE-KALSCHEUER SYNDROME; TOKAS	0.002450314	0.09192634814379656
CHROMOSOME 9P DELETION SYNDROME	0.002450314	0.09192634814379656
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.002450314	0.09192634814379656
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.0024461789999999997	0.0917712188625801
20Q13.33 MICRODELETION SYNDROME	0.0024461789999999997	0.0917712188625801
7Q11.23 MICRODUPLICATION SYNDROME	0.0024461789999999997	0.0917712188625801
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.0024461789999999997	0.0917712188625801
17Q24.2 MICRODELETION SYNDROME	0.0024461789999999997	0.0917712188625801
17Q12 MICRODUPLICATION SYNDROME	0.0024461789999999997	0.0917712188625801
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.0024461789999999997	0.0917712188625801
47,XYY SYNDROME	0.0024461789999999997	0.0917712188625801
PARTINGTON SYNDROME	0.0024461789999999997	0.0917712188625801
ADNP SYNDROME	0.0024461789999999997	0.0917712188625801
20P13 MICRODELETION SYNDROME	0.0024461789999999997	0.0917712188625801
4Q21 MICRODELETION SYNDROME	0.0024461789999999997	0.0917712188625801
SMITH-FINEMAN-MYERS SYNDROME	0.0024461789999999997	0.0917712188625801
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.0024461789999999997	0.0917712188625801
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.0024461789999999997	0.0917712188625801
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.0024461789999999997	0.0917712188625801
5Q14.3 MICRODELETION SYNDROME	0.0024461789999999997	0.0917712188625801
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.0024461789999999997	0.0917712188625801
FAMILIAL MULTIPLE LIPOMATOSIS	0.0024461789999999997	0.0917712188625801
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.0024461789999999997	0.0917712188625801
WIEDEMANN-STEINER SYNDROME	0.0024461789999999997	0.0917712188625801
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.0024461789999999997	0.0917712188625801
9Q21.13 MICRODELETION SYNDROME	0.0024461789999999997	0.0917712188625801
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.0024461789999999997	0.0917712188625801
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.0024461789999999997	0.0917712188625801
HUNTINGTON DISEASE-LIKE 1	0.0024461789999999997	0.0917712188625801
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.0024461789999999997	0.0917712188625801
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.0024461789999999997	0.0917712188625801
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.0024461789999999997	0.0917712188625801
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.0024461789999999997	0.0917712188625801
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.0024461789999999997	0.0917712188625801
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.0024461789999999997	0.0917712188625801
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.0024461789999999997	0.0917712188625801
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.0024461789999999997	0.0917712188625801
AUTISM	0.0024461789999999997	0.0917712188625801
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.0024461789999999997	0.0917712188625801
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0024461789999999997	0.0917712188625801
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.0024461789999999997	0.0917712188625801
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.0024461789999999997	0.0917712188625801
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.0024461789999999997	0.0917712188625801
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.0024461789999999997	0.0917712188625801
TENORIO SYNDROME; TNORS	0.0024461789999999997	0.0917712188625801
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.0024461789999999997	0.0917712188625801
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.0024461789999999997	0.0917712188625801
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.0024461789999999997	0.0917712188625801
SPINOCEREBELLAR ATAXIA 47; SCA47	0.0024461789999999997	0.0917712188625801
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.0024461789999999997	0.0917712188625801
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.0024461789999999997	0.0917712188625801
KLEEFSTRA SYNDROME	0.0024461789999999997	0.0917712188625801
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0024461789999999997	0.0917712188625801
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.0024461789999999997	0.0917712188625801
COFFIN-SIRIS SYNDROME 8; CSS8	0.0024461789999999997	0.0917712188625801
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.0024461789999999997	0.0917712188625801
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.0024461789999999997	0.0917712188625801
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.002249134	0.08437884903977601
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.002249134	0.08437884903977601
LIG4 SYNDROME	0.002249134	0.08437884903977601
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.002249134	0.08437884903977601
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.002249134	0.08437884903977601
PEROXISOME BIOGENESIS DISORDER 3B	0.002249134	0.08437884903977601
MACROCEPHALY/AUTISM SYNDROME	0.002249134	0.08437884903977601
HURLER SYNDROME	0.002249134	0.08437884903977601
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.002249134	0.08437884903977601
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.002249134	0.08437884903977601
ROIFMAN SYNDROME; RFMN	0.002249134	0.08437884903977601
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.002249134	0.08437884903977601
WOLMAN DISEASE	0.002249134	0.08437884903977601
ALPHA-MANNOSIDOSIS	0.002249134	0.08437884903977601
OCULOSKELETODENTAL SYNDROME; OCSKD	0.002249134	0.08437884903977601
GLUTARIC ACIDEMIA I; GA1	0.002244999	0.08422371975855956
MUCOPOLYSACCHARIDOSIS, TYPE II	0.002244999	0.08422371975855956
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.002244999	0.08422371975855956
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.002244999	0.08422371975855956
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.002244999	0.08422371975855956
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.002244999	0.08422371975855956
GAUCHER DISEASE, TYPE IIIC	0.002244999	0.08422371975855956
ZIMMERMANN-LABAND SYNDROME 1	0.002244999	0.08422371975855956
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.002244999	0.08422371975855956
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.002244999	0.08422371975855956
ZIMMERMANN-LABAND SYNDROME	0.002244999	0.08422371975855956
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.002244999	0.08422371975855956
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.002244999	0.08422371975855956
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.002244999	0.08422371975855956
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.002244999	0.08422371975855956
JOUBERT SYNDROME 28	0.0020226539999999996	0.07588219133484225
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0020226539999999996	0.07588219133484225
WAARDENBURG-SHAH SYNDROME	0.0020226539999999996	0.07588219133484225
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 21	0.0020226539999999996	0.07588219133484225
USHER SYNDROME TYPE 1	0.0020226539999999996	0.07588219133484225
MECKEL SYNDROME 13; MKS13	0.0020226539999999996	0.07588219133484225
MARINESCO-SJÖGREN SYNDROME	0.0020226539999999996	0.07588219133484225
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.0020226539999999996	0.07588219133484225
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.0020226539999999996	0.07588219133484225
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.0020226539999999996	0.07588219133484225
BAKER-GORDON SYNDROME; BAGOS	0.0020226539999999996	0.07588219133484225
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0020226539999999996	0.07588219133484225
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0020226539999999996	0.07588219133484225
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.0020226539999999996	0.07588219133484225
BRAIN-LUNG-THYROID SYNDROME	0.0020226539999999996	0.07588219133484225
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.0020226539999999996	0.07588219133484225
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.0020226539999999996	0.07588219133484225
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.0020226539999999996	0.07588219133484225
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.0020226539999999996	0.07588219133484225
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.0020226539999999996	0.07588219133484225
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0020226539999999996	0.07588219133484225
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.0020226539999999996	0.07588219133484225
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0020226539999999996	0.07588219133484225
MARINESCO-SJOGREN SYNDROME; MSS	0.0020226539999999996	0.07588219133484225
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 35; JBTS35	0.0020226539999999996	0.07588219133484225
PELLAGRA-LIKE SYNDROME	0.0020226539999999996	0.07588219133484225
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0020226539999999996	0.07588219133484225
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 27	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 25	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 32; JBTS32	0.0020226539999999996	0.07588219133484225
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 17; JBTS17	0.0020226539999999996	0.07588219133484225
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.0020226539999999996	0.07588219133484225
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 15	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 14	0.0020226539999999996	0.07588219133484225
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.0020226539999999996	0.07588219133484225
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.0020226539999999996	0.07588219133484225
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.0020226539999999996	0.07588219133484225
OXOGLUTARIC ACIDURIA	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 33; JBTS33	0.0020226539999999996	0.07588219133484225
RICHARDS-RUNDLE SYNDROME; RRNS	0.0020226539999999996	0.07588219133484225
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.0020226539999999996	0.07588219133484225
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.0020226539999999996	0.07588219133484225
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 8	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 7	0.0020226539999999996	0.07588219133484225
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0020226539999999996	0.07588219133484225
ALEXANDER DISEASE	0.002018519	0.07572706205362581
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.002018519	0.07572706205362581
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.002018519	0.07572706205362581
KALLMANN SYNDROME	0.002018519	0.07572706205362581
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.002018519	0.07572706205362581
KEARNS-SAYRE SYNDROME; KSS	0.002018519	0.07572706205362581
CAMOS SYNDROME	0.002018519	0.07572706205362581
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.002018519	0.07572706205362581
TYROSINEMIA TYPE 2	0.002018519	0.07572706205362581
TRIPLE A SYNDROME	0.002018519	0.07572706205362581
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.002018519	0.07572706205362581
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.002018519	0.07572706205362581
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.002018519	0.07572706205362581
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.002018519	0.07572706205362581
CONGENITAL MYASTHENIC SYNDROME	0.002018519	0.07572706205362581
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002018519	0.07572706205362581
CYCLIC VOMITING SYNDROME	0.002018519	0.07572706205362581
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.002018519	0.07572706205362581
OCULODENTODIGITAL DYSPLASIA	0.002018519	0.07572706205362581
LHERMITTE-DUCLOS DISEASE	0.002018519	0.07572706205362581
FLYNN-AIRD SYNDROME	0.002018519	0.07572706205362581
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.002018519	0.07572706205362581
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.002018519	0.07572706205362581
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.002018519	0.07572706205362581
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.002018519	0.07572706205362581
ALEXANDER DISEASE	0.002018519	0.07572706205362581
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.002018519	0.07572706205362581
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.002018519	0.07572706205362581
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.002018519	0.07572706205362581
LISSENCEPHALY 3; LIS3	0.002018519	0.07572706205362581
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.002018519	0.07572706205362581
EPISODIC ATAXIA TYPE 6	0.002018519	0.07572706205362581
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.002018519	0.07572706205362581
DYSEQUILIBRIUM SYNDROME	0.002018519	0.07572706205362581
BANGSTAD SYNDROME	0.002018519	0.07572706205362581
WOLFRAM SYNDROME	0.002018519	0.07572706205362581
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.002018519	0.07572706205362581
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.002018519	0.07572706205362581
GM1 GANGLIOSIDOSIS	0.002018519	0.07572706205362581
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.002018519	0.07572706205362581
KUFOR-RAKEB SYNDROME	0.002018519	0.07572706205362581
COCKAYNE SYNDROME	0.002018519	0.07572706205362581
METACHROMATIC LEUKODYSTROPHY	0.002018519	0.07572706205362581
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.002018519	0.07572706205362581
ISOLATED CEREBELLAR AGENESIS	0.002018519	0.07572706205362581
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.002018519	0.07572706205362581
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.002018519	0.07572706205362581
FAMILIAL DYSAUTONOMIA	0.002018519	0.07572706205362581
NEUROFIBROMATOSIS, TYPE II	0.002018519	0.07572706205362581
HEREDITARY HYPEREKPLEXIA	0.002018519	0.07572706205362581
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.002018519	0.07572706205362581
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.002018519	0.07572706205362581
KNOBLOCH SYNDROME 1; KNO1	0.002018519	0.07572706205362581
CEREBELLOPARENCHYMAL DISORDER II	0.002018519	0.07572706205362581
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.002018519	0.07572706205362581
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.002018519	0.07572706205362581
LEIGH SYNDROME	0.002018519	0.07572706205362581
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.002018519	0.07572706205362581
XERODERMA PIGMENTOSUM	0.002018519	0.07572706205362581
GLUTATHIONE SYNTHETASE DEFICIENCY	0.002018519	0.07572706205362581
GITELMAN SYNDROME	0.002018519	0.07572706205362581
ATYPICAL TERATOID RHABDOID TUMOR	0.002018519	0.07572706205362581
EARLY-ONSET LAFORA BODY DISEASE	0.002018519	0.07572706205362581
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.002018519	0.07572706205362581
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.002018519	0.07572706205362581
LISSENCEPHALY, X-LINKED, 1; LISX1	0.002018519	0.07572706205362581
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.002018519	0.07572706205362581
SYMMETRICAL THALAMIC CALCIFICATIONS	0.002018519	0.07572706205362581
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.002018519	0.07572706205362581
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.002018519	0.07572706205362581
FLYNN-AIRD SYNDROME	0.002018519	0.07572706205362581
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.002018519	0.07572706205362581
SPONTANEOUS PERIODIC HYPOTHERMIA	0.002018519	0.07572706205362581
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.002018519	0.07572706205362581
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.002018519	0.07572706205362581
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.002018519	0.07572706205362581
DIAMINOPENTANURIA	0.002018519	0.07572706205362581
CITRULLINEMIA TYPE I	0.002018519	0.07572706205362581
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.002018519	0.07572706205362581
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.002018519	0.07572706205362581
PERRAULT SYNDROME 5; PRLTS5	0.002018519	0.07572706205362581
SIALIDOSIS TYPE 1	0.002018519	0.07572706205362581
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00190476	0.07145926231918763
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00190476	0.07145926231918763
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00190476	0.07145926231918763
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00190476	0.07145926231918763
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00190476	0.07145926231918763
NAGER SYNDROME	0.00190476	0.07145926231918763
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.00190476	0.07145926231918763
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00190476	0.07145926231918763
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.00190476	0.07145926231918763
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00190476	0.07145926231918763
PRIMARY CILIARY DYSKINESIA	0.00190476	0.07145926231918763
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00190476	0.07145926231918763
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00190476	0.07145926231918763
MAXILLOFACIAL DYSOSTOSIS	0.00190476	0.07145926231918763
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00190476	0.07145926231918763
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.00190476	0.07145926231918763
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00190476	0.07145926231918763
VERVERI-BRADY SYNDROME; VERBRAS	0.00190476	0.07145926231918763
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00190476	0.07145926231918763
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00190476	0.07145926231918763
CRANIOSYNOSTOSIS 7	0.00190476	0.07145926231918763
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00190476	0.07145926231918763
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00190476	0.07145926231918763
MOEBIUS SYNDROME; MBS	0.00190476	0.07145926231918763
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00190476	0.07145926231918763
SPEECH-LANGUAGE DISORDER 1	0.00190476	0.07145926231918763
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00190476	0.07145926231918763
CHITAYAT SYNDROME	0.00190476	0.07145926231918763
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00190476	0.07145926231918763
TEMPLE SYNDROME	0.00190476	0.07145926231918763
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00190476	0.07145926231918763
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00190476	0.07145926231918763
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00190476	0.07145926231918763
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00190476	0.07145926231918763
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00190476	0.07145926231918763
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00190476	0.07145926231918763
22Q11 DELETION SYNDROME (VELOCARDIOFACIAL / DIGEORGE SYNDROME)	0.00190476	0.07145926231918763
MASA SYNDROME	0.00190476	0.07145926231918763
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00190476	0.07145926231918763
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00190476	0.07145926231918763
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00190476	0.07145926231918763
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00190476	0.07145926231918763
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00190476	0.07145926231918763
CHROMOSOME 13Q14 DELETION SYNDROME	0.00190476	0.07145926231918763
MEIER-GORLIN SYNDROME 3; MGORS3	0.00190476	0.07145926231918763
CLEFT LIP/PALATE	0.00190476	0.07145926231918763
TEMPLE SYNDROME	0.00190476	0.07145926231918763
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.00190476	0.07145926231918763
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00190476	0.07145926231918763
EPISODIC ATAXIA TYPE 1	0.00190476	0.07145926231918763
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00190476	0.07145926231918763
SPINOCEREBELLAR ATAXIA TYPE 3	0.00190476	0.07145926231918763
DUBOWITZ SYNDROME	0.00190476	0.07145926231918763
224550 DYSTONIA WITH RINGBINDEN	0.00190476	0.07145926231918763
3Q27.3 MICRODELETION SYNDROME	0.00190476	0.07145926231918763
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00190476	0.07145926231918763
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00190476	0.07145926231918763
MENTAL RETARDATION, X-LINKED 93	0.00190476	0.07145926231918763
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.00190476	0.07145926231918763
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00190476	0.07145926231918763
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.00190476	0.07145926231918763
FG SYNDROME 2; FGS2	0.00190476	0.07145926231918763
LARYNGOTRACHEAL ANGIOMA	0.00190476	0.07145926231918763
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00190476	0.07145926231918763
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.00190476	0.07145926231918763
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00190476	0.07145926231918763
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.00190476	0.07145926231918763
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00190476	0.07145926231918763
7Q11.23 DUPLICATION SYNDROME	0.00190476	0.07145926231918763
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00190476	0.07145926231918763
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00190476	0.07145926231918763
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00190476	0.07145926231918763
SOTOS SYNDROME 2	0.00190476	0.07145926231918763
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00190476	0.07145926231918763
MILD CANAVAN DISEASE	0.00190476	0.07145926231918763
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00190476	0.07145926231918763
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00190476	0.07145926231918763
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00190476	0.07145926231918763
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00190476	0.07145926231918763
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.00190476	0.07145926231918763
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00190476	0.07145926231918763
MICROTRIPLICATION 11Q24.1	0.00190476	0.07145926231918763
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00190476	0.07145926231918763
HYPOGLOSSIA WITH SITUS INVERSUS	0.00190476	0.07145926231918763
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00190476	0.07145926231918763
BRACHYDACTYLY, TYPE A1, D	0.00190476	0.07145926231918763
MENTAL RETARDATION, X-LINKED 95	0.00190476	0.07145926231918763
POSTORGASMIC ILLNESS SYNDROME	0.00190476	0.07145926231918763
DYSTONIA 16; DYT16	0.00190476	0.07145926231918763
MICROTIA	0.00190476	0.07145926231918763
ABLEPHARON-MACROSTOMIA SYNDROME	0.00190476	0.07145926231918763
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00190476	0.07145926231918763
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00190476	0.07145926231918763
GERODERMA OSTEODYSPLASTICUM; GO	0.00190476	0.07145926231918763
MACHADO-JOSEPH DISEASE TYPE 3	0.00190476	0.07145926231918763
MACHADO-JOSEPH DISEASE TYPE 2	0.00190476	0.07145926231918763
MACHADO-JOSEPH DISEASE TYPE 1	0.00190476	0.07145926231918763
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00190476	0.07145926231918763
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00190476	0.07145926231918763
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00190476	0.07145926231918763
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00190476	0.07145926231918763
MEIER-GORLIN SYNDROME 6; MGORS6	0.00190476	0.07145926231918763
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00190476	0.07145926231918763
OROFACIODIGITAL SYNDROME XVII	0.00190476	0.07145926231918763
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00190476	0.07145926231918763
PROGRESSIVE SUPRANUCLEAR PALSY	0.00190476	0.07145926231918763
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00190476	0.07145926231918763
MENTAL RETARDATION, X-LINKED 19	0.00190476	0.07145926231918763
19Q13.11 MICRODELETION SYNDROME	0.00190476	0.07145926231918763
FRAXE INTELLECTUAL DISABILITY	0.00190476	0.07145926231918763
NAKAJO-NISHIMURA SYNDROME	0.00170358	0.06391176321516709
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00170358	0.06391176321516709
HYPERLIPOPROTEINEMIA, TYPE ID	0.00170358	0.06391176321516709
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00170358	0.06391176321516709
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.00170358	0.06391176321516709
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.00170358	0.06391176321516709
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00170358	0.06391176321516709
NIEMANN-PICK DISEASE, TYPE B	0.00170358	0.06391176321516709
PFAPA SYNDROME	0.00170358	0.06391176321516709
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00170358	0.06391176321516709
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00170358	0.06391176321516709
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.00170358	0.06391176321516709
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00170358	0.06391176321516709
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00170358	0.06391176321516709
OPSISMODYSPLASIA	0.00170358	0.06391176321516709
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.00170358	0.06391176321516709
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00170358	0.06391176321516709
SCHEIE SYNDROME	0.00170358	0.06391176321516709
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00170358	0.06391176321516709
HURLER-SCHEIE SYNDROME	0.00170358	0.06391176321516709
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00170358	0.06391176321516709
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00170358	0.06391176321516709
GLYCOGEN STORAGE DISEASE II	0.00170358	0.06391176321516709
XYLT1-CDG	0.00170358	0.06391176321516709
HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN-BETA-THALASSEMIA SYNDROME	0.00170358	0.06391176321516709
HURLER-SCHEIE SYNDROME	0.00170358	0.06391176321516709
ACROOSTEOLYSIS DOMINANT TYPE	0.00170358	0.06391176321516709
FETAL CYTOMEGALOVIRUS SYNDROME	0.00170358	0.06391176321516709
MULIBREY NANISM	0.00170358	0.06391176321516709
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00170358	0.06391176321516709
SCHNITZLER SYNDROME	0.00170358	0.06391176321516709
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.00170358	0.06391176321516709
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00170358	0.06391176321516709
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00170358	0.06391176321516709
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.00170358	0.06391176321516709
APOLIPOPROTEIN C-II DEFICIENCY	0.00170358	0.06391176321516709
TANGIER DISEASE; TGD	0.00170358	0.06391176321516709
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.00170358	0.06391176321516709
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00170358	0.06391176321516709
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00170358	0.06391176321516709
MU-HEAVY CHAIN DISEASE	0.00170358	0.06391176321516709
CUTANEOUS MASTOCYTOSIS	0.00170358	0.06391176321516709
MAST CELL SARCOMA	0.00170358	0.06391176321516709
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00170358	0.06391176321516709
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00170358	0.06391176321516709
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00170358	0.06391176321516709
X-LINKED LYMPHOPROLIFERATIVE DISEASE	0.00170358	0.06391176321516709
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.00170358	0.06391176321516709
FAMILIAL MEDITERRANEAN FEVER; FMF	0.00170358	0.06391176321516709
FAMILIAL TUMORAL CALCINOSIS	0.00170358	0.06391176321516709
PACHYONYCHIA CONGENITA	0.00170358	0.06391176321516709
ALPHA-HEAVY CHAIN DISEASE	0.00170358	0.06391176321516709
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00170358	0.06391176321516709
AREDYLD SYNDROME	0.00170358	0.06391176321516709
PYCNODYSOSTOSIS	0.00170358	0.06391176321516709
MULTIPLE SYMMETRIC LIPOMATOSIS	0.00170358	0.06391176321516709
GAMMA-HEAVY CHAIN DISEASE	0.00170358	0.06391176321516709
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.00170358	0.06391176321516709
BRONCHIAL NEUROENDOCRINE TUMOR	0.00170358	0.06391176321516709
DIFFUSE CUTANEOUS MASTOCYTOSIS	0.00170358	0.06391176321516709
COLD AGGLUTININ DISEASE	0.00170358	0.06391176321516709
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.00170358	0.06391176321516709
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00170358	0.06391176321516709
LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3	0.00170358	0.06391176321516709
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00170358	0.06391176321516709
MUCKLE-WELLS SYNDROME	0.00170358	0.06391176321516709
THORACO-ABDOMINAL ENTERIC DUPLICATION	0.00170358	0.06391176321516709
MUCOLIPIDOSIS TYPE II	0.00170358	0.06391176321516709
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.00170358	0.06391176321516709
DISTAL MONOSOMY 17Q	0.00170358	0.06391176321516709
CARTILAGE-HAIR HYPOPLASIA	0.00170358	0.06391176321516709
MORQUIO SYNDROME A	0.00170358	0.06391176321516709
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.00170358	0.06391176321516709
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00170358	0.06391176321516709
LCAT DEFICIENCY	0.00170358	0.06391176321516709
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00170358	0.06391176321516709
SEVERE COMBINED IMMUNODEFICIENCY	0.00170358	0.06391176321516709
HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION	0.00170358	0.06391176321516709
THROMBOCYTOSIS, FAMILIAL X-LINKED	0.00170358	0.06391176321516709
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.00170358	0.06391176321516709
PROLIDASE DEFICIENCY	0.00170358	0.06391176321516709
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00170358	0.06391176321516709
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.00170358	0.06391176321516709
FISH-EYE DISEASE	0.00170358	0.06391176321516709
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.00170358	0.06391176321516709
POLYMYOSITIS	0.00170358	0.06391176321516709
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.00170358	0.06391176321516709
USHER SYNDROME	0.0014770999999999999	0.05541510551023333
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.0014770999999999999	0.05541510551023333
NEUROPATHY, HEREDITARY SENSORY, ATYPICAL	0.0014770999999999999	0.05541510551023333
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0014770999999999999	0.05541510551023333
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.0014770999999999999	0.05541510551023333
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.0014770999999999999	0.05541510551023333
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.0014770999999999999	0.05541510551023333
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0014770999999999999	0.05541510551023333
PENDRED SYNDROME	0.0014770999999999999	0.05541510551023333
MACHADO-JOSEPH DISEASE; MJD	0.0014770999999999999	0.05541510551023333
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0014770999999999999	0.05541510551023333
HEREDITARY SPASTIC PARAPLEGIA	0.0014770999999999999	0.05541510551023333
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.0014770999999999999	0.05541510551023333
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.0014770999999999999	0.05541510551023333
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.0014770999999999999	0.05541510551023333
ABETALIPOPROTEINEMIA	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.0014770999999999999	0.05541510551023333
DE SANCTIS-CACCHIONE SYNDROME	0.0014770999999999999	0.05541510551023333
RICHARDS-RUNDLE SYNDROME	0.0014770999999999999	0.05541510551023333
CHAND SYNDROME	0.0014770999999999999	0.05541510551023333
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA, X-LINKED 2	0.0014770999999999999	0.05541510551023333
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.0014770999999999999	0.05541510551023333
EPISODIC ATAXIA, TYPE 8	0.0014770999999999999	0.05541510551023333
ABETALIPOPROTEINEMIA	0.0014770999999999999	0.05541510551023333
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.0014770999999999999	0.05541510551023333
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.0014770999999999999	0.05541510551023333
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.0014770999999999999	0.05541510551023333
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.0014770999999999999	0.05541510551023333
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0014770999999999999	0.05541510551023333
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.0014770999999999999	0.05541510551023333
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.0014770999999999999	0.05541510551023333
WERNICKE-KORSAKOFF SYNDROME	0.0014770999999999999	0.05541510551023333
PIEBALDISM	0.0014770999999999999	0.05541510551023333
ACERULOPLASMINEMIA	0.0014770999999999999	0.05541510551023333
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.0014770999999999999	0.05541510551023333
ALLAN-HERNDON-DUDLEY SYNDROME	0.0014770999999999999	0.05541510551023333
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA 41; SCA41	0.0014770999999999999	0.05541510551023333
GEMIGNANI SYNDROME	0.0014770999999999999	0.05541510551023333
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.0014770999999999999	0.05541510551023333
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.0014770999999999999	0.05541510551023333
ADULT POLYGLUCOSAN BODY DISEASE	0.0014770999999999999	0.05541510551023333
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.0014770999999999999	0.05541510551023333
ATAXIA-HYPOGONADISM-CHOROIDAL DYSTROPHY SYNDROME	0.0014770999999999999	0.05541510551023333
CENTRAL NEUROCYTOMA	0.0014770999999999999	0.05541510551023333
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.0014770999999999999	0.05541510551023333
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.0014770999999999999	0.05541510551023333
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.0014770999999999999	0.05541510551023333
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA 32; SCA32	0.0014770999999999999	0.05541510551023333
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.0014770999999999999	0.05541510551023333
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.0014770999999999999	0.05541510551023333
GILLESPIE SYNDROME; GLSP	0.0014770999999999999	0.05541510551023333
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.0014770999999999999	0.05541510551023333
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA 31	0.0014770999999999999	0.05541510551023333
PITUITARY CARCINOMA	0.0014770999999999999	0.05541510551023333
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0014770999999999999	0.05541510551023333
GIANT CELL ARTERITIS	0.0014770999999999999	0.05541510551023333
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.0014770999999999999	0.05541510551023333
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.0014770999999999999	0.05541510551023333
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0014770999999999999	0.05541510551023333
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 30	0.0014770999999999999	0.05541510551023333
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.0014770999999999999	0.05541510551023333
CHIARI MALFORMATION TYPE II	0.0014770999999999999	0.05541510551023333
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.0014770999999999999	0.05541510551023333
HYPOMYELINATION-HYPOGONADOTROPIC HYPOGONADISM-HYPODONTIA SYNDROME	0.0014770999999999999	0.05541510551023333
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.0014770999999999999	0.05541510551023333
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0014770999999999999	0.05541510551023333
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.0014770999999999999	0.05541510551023333
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA TYPE 17	0.0014770999999999999	0.05541510551023333
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0014770999999999999	0.05541510551023333
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0014770999999999999	0.05541510551023333
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0014770999999999999	0.05541510551023333
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.0014770999999999999	0.05541510551023333
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA TYPE 4	0.0014770999999999999	0.05541510551023333
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.0014770999999999999	0.05541510551023333
LEBER HEREDITARY OPTIC NEUROPATHY	0.0014770999999999999	0.05541510551023333
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA 30; SCA30	0.0014770999999999999	0.05541510551023333
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0014770999999999999	0.05541510551023333
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.0014770999999999999	0.05541510551023333
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.0014770999999999999	0.05541510551023333
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.0014770999999999999	0.05541510551023333
DEMENTIA, FAMILIAL DANISH	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.0014770999999999999	0.05541510551023333
POSTERIOR CORTICAL ATROPHY	0.0014770999999999999	0.05541510551023333
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.0014770999999999999	0.05541510551023333
RAVINE SYNDROME	0.0014770999999999999	0.05541510551023333
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.0014770999999999999	0.05541510551023333
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.0014770999999999999	0.05541510551023333
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0014770999999999999	0.05541510551023333
STIMMLER SYNDROME	0.0014770999999999999	0.05541510551023333
NEUROFERRITINOPATHY	0.0014770999999999999	0.05541510551023333
MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	0.0014770999999999999	0.05541510551023333
JOUBERT SYNDROME 3; JBTS3	0.0014770999999999999	0.05541510551023333
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.0014770999999999999	0.05541510551023333
JOUBERT SYNDROME 4	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.0014770999999999999	0.05541510551023333
245800 LAURENCE-MOON SYNDROME	0.0014770999999999999	0.05541510551023333
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA 37; SCA37	0.0014770999999999999	0.05541510551023333
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0014770999999999999	0.05541510551023333
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0014770999999999999	0.05541510551023333
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.0014770999999999999	0.05541510551023333
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.0014770999999999999	0.05541510551023333
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.0014770999999999999	0.05541510551023333
FAMILIAL PAROXYSMAL ATAXIA	0.0014770999999999999	0.05541510551023333
KEARNS-SAYRE SYNDROME	0.0014770999999999999	0.05541510551023333
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0014770999999999999	0.05541510551023333
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0014770999999999999	0.05541510551023333
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.0014770999999999999	0.05541510551023333
OPTIC ATROPHY 1; OPA1	0.0014770999999999999	0.05541510551023333
165200 OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS	0.0014770999999999999	0.05541510551023333
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.0014770999999999999	0.05541510551023333
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.05541510551023333
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.0014770999999999999	0.05541510551023333
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.0014770999999999999	0.05541510551023333
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0014770999999999999	0.05541510551023333
POSTERIOR COLUMN ATAXIA	0.0014770999999999999	0.05541510551023333
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.0014770999999999999	0.05541510551023333
POLYMYOCLONUS, INFANTILE	0.0014770999999999999	0.05541510551023333
212835 CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA	0.0014770999999999999	0.05541510551023333
NYSTAGMUS, HEREDITARY VERTICAL	0.0014770999999999999	0.05541510551023333
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.0014770999999999999	0.05541510551023333
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.0014770999999999999	0.05541510551023333
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.0014770999999999999	0.05541510551023333
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	0.0014770999999999999	0.05541510551023333
MUSCULAR ATROPHY-ATAXIA-RETINITIS PIGMENTOSA-DIABETES MELLITUS SYNDROME	0.0014770999999999999	0.05541510551023333
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0014770999999999999	0.05541510551023333
KURU, SUSCEPTIBILITY TO	0.0014770999999999999	0.05541510551023333
CEREBELLAR HYPOPLASIA	0.0014770999999999999	0.05541510551023333
NON-DISTAL MONOSOMY 10Q	0.0014770999999999999	0.05541510551023333
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.0014770999999999999	0.05541510551023333
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.05541510551023333
272600 TAPETORETINAL DEGENERATION WITH ATAXIA	0.0014770999999999999	0.05541510551023333
EPISODIC ATAXIA TYPE 4	0.0014770999999999999	0.05541510551023333
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.0014770999999999999	0.05541510551023333
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.0014770999999999999	0.05541510551023333
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0014770999999999999	0.05541510551023333
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.0014770999999999999	0.05541510551023333
ARGININOSUCCINIC ACIDURIA	0.0014770999999999999	0.05541510551023333
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.0014770999999999999	0.05541510551023333
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.0014770999999999999	0.05541510551023333
JOUBERT SYNDROME 5	0.0014770999999999999	0.05541510551023333
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.0014770999999999999	0.05541510551023333
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0014770999999999999	0.05541510551023333
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.0014770999999999999	0.05541510551023333
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.0014770999999999999	0.05541510551023333
TRYPTOPHANURIA WITH DWARFISM	0.0014770999999999999	0.05541510551023333
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.0014770999999999999	0.05541510551023333
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.0014770999999999999	0.05541510551023333
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.0014770999999999999	0.05541510551023333
USHER SYNDROME TYPE 2	0.0014770999999999999	0.05541510551023333
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.0014770999999999999	0.05541510551023333
ATAXIA WITH FASCICULATIONS	0.0014770999999999999	0.05541510551023333
NEUROFIBROMATOSIS TYPE 2	0.0014770999999999999	0.05541510551023333
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.0014770999999999999	0.05541510551023333
SPASTIC PARAPLEGIA TYPE 2	0.0014770999999999999	0.05541510551023333
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.0014770999999999999	0.05541510551023333
BOUCHER-NEUHAUSER SYNDROME	0.0014770999999999999	0.05541510551023333
USHER SYNDROME TYPE 3	0.0014770999999999999	0.05541510551023333
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.0014770999999999999	0.05541510551023333
COFFIN-SIRIS SYNDROME 4; CSS4	0.001086973	0.040779042368001395
ADAMS-OLIVER SYNDROME 2; AOS2	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001086973	0.040779042368001395
COFFIN-SIRIS SYNDROME 3; CSS3	0.001086973	0.040779042368001395
ISOVALERIC ACIDEMIA	0.001086973	0.040779042368001395
RUBINSTEIN-TAYBI SYNDROME	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.040779042368001395
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.040779042368001395
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.040779042368001395
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.040779042368001395
ARGININEMIA	0.001086973	0.040779042368001395
MONOSOMY 9Q22.3	0.001086973	0.040779042368001395
ALG3-CDG	0.001086973	0.040779042368001395
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001086973	0.040779042368001395
TEMTAMY SYNDROME; TEMTYS	0.001086973	0.040779042368001395
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.001086973	0.040779042368001395
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.001086973	0.040779042368001395
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.040779042368001395
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001086973	0.040779042368001395
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.040779042368001395
DISTAL TRISOMY 17Q	0.001086973	0.040779042368001395
SCHIZENCEPHALY	0.001086973	0.040779042368001395
WILSON-TURNER SYNDROME	0.001086973	0.040779042368001395
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.040779042368001395
LISSENCEPHALY 4	0.001086973	0.040779042368001395
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001086973	0.040779042368001395
DISTAL MONOSOMY 1Q	0.001086973	0.040779042368001395
TRISOMY X	0.001086973	0.040779042368001395
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001086973	0.040779042368001395
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.040779042368001395
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.040779042368001395
CLASSIC PHENYLKETONURIA	0.001086973	0.040779042368001395
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.040779042368001395
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.040779042368001395
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001086973	0.040779042368001395
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.040779042368001395
TETRASOMY 5P	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.040779042368001395
STT3A-CDG	0.001086973	0.040779042368001395
CRANIOPHARYNGIOMA	0.001086973	0.040779042368001395
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001086973	0.040779042368001395
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.040779042368001395
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.001086973	0.040779042368001395
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.040779042368001395
KEUTEL SYNDROME	0.001086973	0.040779042368001395
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001086973	0.040779042368001395
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001086973	0.040779042368001395
WAISMAN SYNDROME; WSMN	0.001086973	0.040779042368001395
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.040779042368001395
SCHINDLER DISEASE, TYPE I	0.001086973	0.040779042368001395
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.040779042368001395
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001086973	0.040779042368001395
INCONTINENTIA PIGMENTI	0.001086973	0.040779042368001395
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.001086973	0.040779042368001395
MACDERMOT-WINTER SYNDROME	0.001086973	0.040779042368001395
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001086973	0.040779042368001395
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001086973	0.040779042368001395
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001086973	0.040779042368001395
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001086973	0.040779042368001395
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.001086973	0.040779042368001395
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.040779042368001395
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001086973	0.040779042368001395
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.001086973	0.040779042368001395
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.040779042368001395
PHACE ASSOCIATION	0.001086973	0.040779042368001395
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.001086973	0.040779042368001395
MUENKE SYNDROME	0.001086973	0.040779042368001395
VICI SYNDROME; VICIS	0.001086973	0.040779042368001395
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.001086973	0.040779042368001395
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001086973	0.040779042368001395
BOHRING-OPITZ SYNDROME	0.001086973	0.040779042368001395
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.040779042368001395
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.040779042368001395
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.040779042368001395
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.001086973	0.040779042368001395
XQ25 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.001086973	0.040779042368001395
BAND HETEROTOPIA; BH	0.001086973	0.040779042368001395
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.040779042368001395
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.001086973	0.040779042368001395
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.040779042368001395
TIMOTHY SYNDROME; TS	0.001086973	0.040779042368001395
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.040779042368001395
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.040779042368001395
WYBURN-MASON SYNDROME	0.001086973	0.040779042368001395
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.040779042368001395
CODAS SYNDROME	0.001086973	0.040779042368001395
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.040779042368001395
NETHERTON SYNDROME	0.001086973	0.040779042368001395
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001086973	0.040779042368001395
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001086973	0.040779042368001395
DYSTONIA-APHONIA SYNDROME	0.001086973	0.040779042368001395
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.001086973	0.040779042368001395
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001086973	0.040779042368001395
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.001086973	0.040779042368001395
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001086973	0.040779042368001395
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.040779042368001395
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.040779042368001395
MEND SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
MEND SYNDROME; MEND	0.001086973	0.040779042368001395
PRADER-WILLI-LIKE SYNDROME	0.001086973	0.040779042368001395
MAN1B1-CDG	0.001086973	0.040779042368001395
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.040779042368001395
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001086973	0.040779042368001395
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.001086973	0.040779042368001395
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.001086973	0.040779042368001395
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.040779042368001395
WALKER-WARBURG SYNDROME	0.001086973	0.040779042368001395
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.040779042368001395
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.040779042368001395
SSR4-CDG	0.001086973	0.040779042368001395
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.040779042368001395
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001086973	0.040779042368001395
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001086973	0.040779042368001395
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.040779042368001395
DPAGT1-CDG	0.001086973	0.040779042368001395
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001086973	0.040779042368001395
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.040779042368001395
CORNELIA DE LANGE SYNDROME 3	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 7	0.001086973	0.040779042368001395
NARP SYNDROME	0.001086973	0.040779042368001395
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.040779042368001395
PETTIGREW SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.040779042368001395
LEBER CONGENITAL AMAUROSIS	0.001086973	0.040779042368001395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001086973	0.040779042368001395
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.040779042368001395
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001086973	0.040779042368001395
HARTNUP DISORDER	0.001086973	0.040779042368001395
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001086973	0.040779042368001395
PHACE SYNDROME	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001086973	0.040779042368001395
611961 STEVENSON-CAREY SYNDROME	0.001086973	0.040779042368001395
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001086973	0.040779042368001395
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001086973	0.040779042368001395
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.040779042368001395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001086973	0.040779042368001395
MONOSOMY 9P	0.001086973	0.040779042368001395
DUANE RETRACTION SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001086973	0.040779042368001395
TARP SYNDROME	0.001086973	0.040779042368001395
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.040779042368001395
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.001086973	0.040779042368001395
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 2; HPE2	0.001086973	0.040779042368001395
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.040779042368001395
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.001086973	0.040779042368001395
KBG SYNDROME	0.001086973	0.040779042368001395
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001086973	0.040779042368001395
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.040779042368001395
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.001086973	0.040779042368001395
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.001086973	0.040779042368001395
15Q24 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001086973	0.040779042368001395
PFEIFFER SYNDROME TYPE 2	0.001086973	0.040779042368001395
PALLISTER-HALL SYNDROME	0.001086973	0.040779042368001395
KABUKI SYNDROME 1	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001086973	0.040779042368001395
HYDRANENCEPHALY	0.001086973	0.040779042368001395
2Q37 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.040779042368001395
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.001086973	0.040779042368001395
KBG SYNDROME	0.001086973	0.040779042368001395
MATERNAL PHENYLKETONURIA	0.001086973	0.040779042368001395
CATEL-MANZKE SYNDROME; CATMANS	0.001086973	0.040779042368001395
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001086973	0.040779042368001395
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001086973	0.040779042368001395
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.040779042368001395
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.040779042368001395
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.040779042368001395
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.040779042368001395
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001086973	0.040779042368001395
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.001086973	0.040779042368001395
49,XXXXY SYNDROME	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.040779042368001395
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001086973	0.040779042368001395
8P11.2 DELETION SYNDROME	0.001086973	0.040779042368001395
8P23.1 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.001086973	0.040779042368001395
DISTAL MONOSOMY 19P13.3	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001086973	0.040779042368001395
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.040779042368001395
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.001086973	0.040779042368001395
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.040779042368001395
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.001086973	0.040779042368001395
6Q25 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
XP21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.040779042368001395
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
20P12.3 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
RECOMBINANT CHROMOSOME 8 SYNDROME	0.001086973	0.040779042368001395
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.040779042368001395
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.040779042368001395
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.001086973	0.040779042368001395
ZTTK SYNDROME; ZTTKS	0.001086973	0.040779042368001395
3Q29 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001086973	0.040779042368001395
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.040779042368001395
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.040779042368001395
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001086973	0.040779042368001395
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.040779042368001395
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.040779042368001395
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.001086973	0.040779042368001395
HEART AND BRAIN MALFORMATION SYNDROME	0.001086973	0.040779042368001395
10Q22.3Q23.3 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.001086973	0.040779042368001395
L1 SYNDROME	0.001086973	0.040779042368001395
2Q31.1 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.001086973	0.040779042368001395
HYPEREKPLEXIA 4; HKPX4	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.001086973	0.040779042368001395
JABERI-ELAHI SYNDROME; JABELS	0.001086973	0.040779042368001395
KOOLEN-DE VRIES SYNDROME	0.001086973	0.040779042368001395
1Q21.1 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.040779042368001395
1Q21.1 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
MICRO SYNDROME	0.001086973	0.040779042368001395
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.040779042368001395
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001086973	0.040779042368001395
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.040779042368001395
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.001086973	0.040779042368001395
15Q13.3 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.001086973	0.040779042368001395
XQ21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001086973	0.040779042368001395
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.040779042368001395
2P21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
CANAVAN DISEASE	0.001086973	0.040779042368001395
HELSMOORTEL-VAN DER AA SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.040779042368001395
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.040779042368001395
RUVALCABA SYNDROME	0.001086973	0.040779042368001395
POTOCKI-SHAFFER SYNDROME	0.001086973	0.040779042368001395
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.001086973	0.040779042368001395
MONOSOMY 18Q	0.001086973	0.040779042368001395
MOSAIC TRISOMY 14	0.001086973	0.040779042368001395
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.040779042368001395
WEBB-DATTANI SYNDROME; WEDAS	0.001086973	0.040779042368001395
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001086973	0.040779042368001395
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.001086973	0.040779042368001395
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001086973	0.040779042368001395
SEVERE CANAVAN DISEASE	0.001086973	0.040779042368001395
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.040779042368001395
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.040779042368001395
FILIPPI SYNDROME	0.001086973	0.040779042368001395
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
VICI SYNDROME	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.040779042368001395
OPTIC PATHWAY GLIOMA	0.001086973	0.040779042368001395
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001086973	0.040779042368001395
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.040779042368001395
COFFIN-SIRIS SYNDROME	0.001086973	0.040779042368001395
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.040779042368001395
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA TYPE 13	0.001086973	0.040779042368001395
DONNAI-BARROW SYNDROME	0.001086973	0.040779042368001395
COHEN SYNDROME	0.001086973	0.040779042368001395
ADAMS-OLIVER SYNDROME 1; AOS1	0.001086973	0.040779042368001395
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
OROTIC ACIDURIA	0.000545554	0.020467085824608922
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.020467085824608922
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.020467085824608922
CDAGS SYNDROME	0.000545554	0.020467085824608922
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.020467085824608922
HYDROXYKYNURENINURIA	0.000545554	0.020467085824608922
TEMTAMY SYNDROME	0.000545554	0.020467085824608922
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.020467085824608922
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.000545554	0.020467085824608922
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.020467085824608922
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME VI	0.000545554	0.020467085824608922
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.020467085824608922
MARDEN-WALKER SYNDROME	0.000545554	0.020467085824608922
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.020467085824608922
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.020467085824608922
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.020467085824608922
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.020467085824608922
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.020467085824608922
BRESEK SYNDROME	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000545554	0.020467085824608922
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.020467085824608922
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.020467085824608922
TRISOMY 8Q	0.000545554	0.020467085824608922
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000545554	0.020467085824608922
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.020467085824608922
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.020467085824608922
CURRY-JONES SYNDROME	0.000545554	0.020467085824608922
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000545554	0.020467085824608922
DISTAL TRISOMY 6P	0.000545554	0.020467085824608922
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.000545554	0.020467085824608922
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.020467085824608922
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.020467085824608922
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.020467085824608922
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.020467085824608922
GENITOPATELLAR SYNDROME; GTPTS	0.000545554	0.020467085824608922
EAR-PATELLA-SHORT STATURE SYNDROME	0.000545554	0.020467085824608922
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.020467085824608922
MIETENS SYNDROME	0.000545554	0.020467085824608922
3MC SYNDROME 2	0.000545554	0.020467085824608922
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.000545554	0.020467085824608922
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.020467085824608922
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.020467085824608922
DISTAL MONOSOMY 9P	0.000545554	0.020467085824608922
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.020467085824608922
SEPTOOPTIC DYSPLASIA	0.000545554	0.020467085824608922
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.020467085824608922
ALG6-CDG	0.000545554	0.020467085824608922
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.020467085824608922
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.020467085824608922
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.020467085824608922
N SYNDROME	0.000545554	0.020467085824608922
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.020467085824608922
CURRARINO SYNDROME	0.000545554	0.020467085824608922
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.000545554	0.020467085824608922
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.020467085824608922
FRONTOOCULAR SYNDROME	0.000545554	0.020467085824608922
RAINE SYNDROME	0.000545554	0.020467085824608922
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.020467085824608922
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.020467085824608922
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.020467085824608922
DISTAL TRISOMY 18Q	0.000545554	0.020467085824608922
CHAR SYNDROME	0.000545554	0.020467085824608922
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.020467085824608922
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.020467085824608922
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.020467085824608922
ROTHMUND-THOMSON SYNDROME	0.000545554	0.020467085824608922
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.020467085824608922
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.020467085824608922
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.020467085824608922
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.020467085824608922
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.020467085824608922
NOONAN SYNDROME 2; NS2	0.000545554	0.020467085824608922
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.020467085824608922
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.020467085824608922
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.020467085824608922
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.020467085824608922
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.020467085824608922
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.020467085824608922
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020467085824608922
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.020467085824608922
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
HYPERTRICHOSIS CUBITI	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.020467085824608922
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.020467085824608922
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.020467085824608922
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.020467085824608922
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.020467085824608922
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.020467085824608922
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.000545554	0.020467085824608922
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.020467085824608922
NOONAN SYNDROME 11; NS11	0.000545554	0.020467085824608922
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.020467085824608922
CRANIOFRONTONASAL SYNDROME; CFNS	0.000545554	0.020467085824608922
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.020467085824608922
AARSKOG-SCOTT SYNDROME	0.000545554	0.020467085824608922
POPOV-CHANG SYNDROME; POPCHAS	0.000545554	0.020467085824608922
ICF SYNDROME	0.000545554	0.020467085824608922
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.020467085824608922
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.020467085824608922
COLE-CARPENTER SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.020467085824608922
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.020467085824608922
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.020467085824608922
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.020467085824608922
OGDEN SYNDROME; OGDNS	0.000545554	0.020467085824608922
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.020467085824608922
3C SYNDROME	0.000545554	0.020467085824608922
ZECHI-CEIDE SYNDROME	0.000545554	0.020467085824608922
17Q21.31 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.020467085824608922
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.020467085824608922
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.020467085824608922
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.020467085824608922
JOUBERT SYNDROME 10	0.000545554	0.020467085824608922
JAWAD SYNDROME	0.000545554	0.020467085824608922
PETERS PLUS SYNDROME	0.000545554	0.020467085824608922
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.020467085824608922
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.020467085824608922
GERODERMA OSTEODYSPLASTICA	0.000545554	0.020467085824608922
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000545554	0.020467085824608922
PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.020467085824608922
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.020467085824608922
TURNPENNY-FRY SYNDROME; TPFS	0.000545554	0.020467085824608922
8Q12 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
TRISOMY 9P	0.000545554	0.020467085824608922
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.020467085824608922
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.020467085824608922
FETAL TRIMETHADIONE SYNDROME	0.000545554	0.020467085824608922
ATELOSTEOGENESIS TYPE III	0.000545554	0.020467085824608922
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.020467085824608922
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000545554	0.020467085824608922
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.020467085824608922
RING CHROMOSOME 12 SYNDROME	0.000545554	0.020467085824608922
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.020467085824608922
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
LOWRY-MACLEAN SYNDROME	0.000545554	0.020467085824608922
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.020467085824608922
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.020467085824608922
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.020467085824608922
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.020467085824608922
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.020467085824608922
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.020467085824608922
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.020467085824608922
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.020467085824608922
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.020467085824608922
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.020467085824608922
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.020467085824608922
ZEBRA BODY MYOPATHY	0.000545554	0.020467085824608922
AURICULOCONDYLAR SYNDROME	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.000545554	0.020467085824608922
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.020467085824608922
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.020467085824608922
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.020467085824608922
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.020467085824608922
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.020467085824608922
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.020467085824608922
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.020467085824608922
RABSON-MENDENHALL SYNDROME	0.000545554	0.020467085824608922
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.020467085824608922
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.020467085824608922
TOLUENE EMBRYOPATHY	0.000545554	0.020467085824608922
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.020467085824608922
TARP SYNDROME; TARPS	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.020467085824608922
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.020467085824608922
RIGID SPINE SYNDROME	0.000545554	0.020467085824608922
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.020467085824608922
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.020467085824608922
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.020467085824608922
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.020467085824608922
AU-KLINE SYNDROME; AUKS	0.000545554	0.020467085824608922
NOONAN SYNDROME 9; NS9	0.000545554	0.020467085824608922
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.020467085824608922
CONGENITAL VARICELLA SYNDROME	0.000545554	0.020467085824608922
WARSAW BREAKAGE SYNDROME; WABS	0.000545554	0.020467085824608922
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.020467085824608922
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.020467085824608922
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.000545554	0.020467085824608922
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.020467085824608922
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.020467085824608922
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.020467085824608922
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.020467085824608922
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.020467085824608922
CHOPS SYNDROME; CHOPS	0.000545554	0.020467085824608922
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.020467085824608922
TRISOMY 18	0.000545554	0.020467085824608922
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.020467085824608922
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.020467085824608922
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.020467085824608922
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.000545554	0.020467085824608922
CRANIOSYNOSTOSIS 6; CRS6	0.000545554	0.020467085824608922
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.000545554	0.020467085824608922
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.020467085824608922
VASCULAR EHLERS-DANLOS SYNDROME	0.000545554	0.020467085824608922
SECKEL SYNDROME 9; SCKL9	0.000545554	0.020467085824608922
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.020467085824608922
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.020467085824608922
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.000545554	0.020467085824608922
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.020467085824608922
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000545554	0.020467085824608922
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.020467085824608922
STEEL SYNDROME; STLS	0.000545554	0.020467085824608922
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000545554	0.020467085824608922
TYSHCHENKO SYNDROME	0.000545554	0.020467085824608922
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.020467085824608922
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.020467085824608922
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.020467085824608922
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.020467085824608922
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.020467085824608922
ALAZAMI SYNDROME; ALAZS	0.000545554	0.020467085824608922
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.020467085824608922
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.020467085824608922
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.020467085824608922
HEREDITARY OROTIC ACIDURIA	0.000545554	0.020467085824608922
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.020467085824608922
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000545554	0.020467085824608922
HOLOPROSENCEPHALY 11	0.000545554	0.020467085824608922
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.020467085824608922
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.020467085824608922
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020467085824608922
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.020467085824608922
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.020467085824608922
XIA-GIBBS SYNDROME	0.000545554	0.020467085824608922
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.020467085824608922
ISOLATED PLAGIOCEPHALY	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 2	0.000545554	0.020467085824608922
2Q23.1 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.020467085824608922
CULLER-JONES SYNDROME; CJS	0.000545554	0.020467085824608922
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.020467085824608922
COSTELLO SYNDROME; CSTLO	0.000545554	0.020467085824608922
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.020467085824608922
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.020467085824608922
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.020467085824608922
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000545554	0.020467085824608922
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.000545554	0.020467085824608922
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.020467085824608922
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.020467085824608922
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.020467085824608922
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.020467085824608922
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.020467085824608922
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.020467085824608922
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.020467085824608922
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.020467085824608922
ELSAHY-WATERS SYNDROME; ESWS	0.000545554	0.020467085824608922
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.020467085824608922
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.020467085824608922
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.020467085824608922
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.020467085824608922
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.020467085824608922
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.020467085824608922
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.020467085824608922
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.020467085824608922
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.020467085824608922
AUSTRALIA ANTIGEN	0.000545554	0.020467085824608922
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.020467085824608922
WEAVER SYNDROME	0.000545554	0.020467085824608922
SECKEL SYNDROME 8; SCKL8	0.000545554	0.020467085824608922
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.020467085824608922
JOUBERT SYNDROME 26	0.000545554	0.020467085824608922
ALAZAMI-YUAN SYNDROME	0.000545554	0.020467085824608922
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.000545554	0.020467085824608922
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.020467085824608922
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000545554	0.020467085824608922
ABETAL34V AMYLOIDOSIS	0.000545554	0.020467085824608922
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.020467085824608922
FRIAS SYNDROME	0.000545554	0.020467085824608922
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.020467085824608922
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.020467085824608922
NOONAN SYNDROME 3; NS3	0.000545554	0.020467085824608922
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000545554	0.020467085824608922
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.020467085824608922
MEIER-GORLIN SYNDROME 7	0.000545554	0.020467085824608922
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.020467085824608922
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.020467085824608922
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.020467085824608922
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.020467085824608922
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000545554	0.020467085824608922
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.020467085824608922
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.000545554	0.020467085824608922
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.020467085824608922
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.020467085824608922
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.020467085824608922
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.020467085824608922
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.020467085824608922
HARTSFIELD SYNDROME; HRTFDS	0.000545554	0.020467085824608922
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.000545554	0.020467085824608922
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.020467085824608922
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.020467085824608922
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.020467085824608922
FRIED SYNDROME	0.000545554	0.020467085824608922
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.020467085824608922
TRISOMY 17P	0.000545554	0.020467085824608922
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.020467085824608922
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.020467085824608922
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.020467085824608922
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.020467085824608922
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000545554	0.020467085824608922
RAHMAN SYNDROME	0.000545554	0.020467085824608922
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.020467085824608922
ATHYREOSIS	0.000545554	0.020467085824608922
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.020467085824608922
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.020467085824608922
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.020467085824608922
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.020467085824608922
CHAR SYNDROME	0.000545554	0.020467085824608922
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.020467085824608922
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.020467085824608922
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.020467085824608922
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.020467085824608922
HYDROXYKYNURENINURIA	0.000545554	0.020467085824608922
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.020467085824608922
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.020467085824608922
NOONAN SYNDROME 5; NS5	0.000545554	0.020467085824608922
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
OGDEN SYNDROME	0.000545554	0.020467085824608922
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.020467085824608922
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.020467085824608922
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.020467085824608922
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.020467085824608922
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000545554	0.020467085824608922
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.020467085824608922
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.020467085824608922
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.020467085824608922
LATERAL MENINGOCELE SYNDROME	0.000545554	0.020467085824608922
OTOFACIOCERVICAL SYNDROME	0.000545554	0.020467085824608922
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.020467085824608922
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.020467085824608922
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.020467085824608922
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.020467085824608922
EVEN-PLUS SYNDROME	0.000545554	0.020467085824608922
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.020467085824608922
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.020467085824608922
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.020467085824608922
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.020467085824608922
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.020467085824608922
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.000545554	0.020467085824608922
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.000545554	0.020467085824608922
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME TYPE 4	0.000545554	0.020467085824608922
OPITZ G/BBB SYNDROME	0.000545554	0.020467085824608922
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.020467085824608922
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.020467085824608922
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.020467085824608922
TREACHER-COLLINS SYNDROME	0.000545554	0.020467085824608922
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.020467085824608922
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.020467085824608922
PHENYLKETONURIA	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.020311956543392476
NIPAH VIRUS DISEASE	0.000541419	0.020311956543392476
2Q33.1 DELETION SYNDROME	0.000541419	0.020311956543392476
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000541419	0.020311956543392476
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020311956543392476
COHEN SYNDROME	0.000541419	0.020311956543392476
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.020311956543392476
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.020311956543392476
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.020311956543392476
SECONDARY SYRINGOMYELIA	0.000541419	0.020311956543392476
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.000541419	0.020311956543392476
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.020311956543392476
MOGS-CDG	0.000541419	0.020311956543392476
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.020311956543392476
1P36 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
FRAGILE X SYNDROME	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020311956543392476
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.020311956543392476
ALG2-CDG	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.020311956543392476
SAETHRE-CHOTZEN SYNDROME	0.000541419	0.020311956543392476
HADDAD SYNDROME	0.000541419	0.020311956543392476
ALG9-CDG	0.000541419	0.020311956543392476
DERMOTRICHIC SYNDROME	0.000541419	0.020311956543392476
PORPHYRIA VARIEGATA	0.000541419	0.020311956543392476
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020311956543392476
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.020311956543392476
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020311956543392476
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.020311956543392476
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.020311956543392476
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.000541419	0.020311956543392476
MARDEN-WALKER SYNDROME	0.000541419	0.020311956543392476
KEUTEL SYNDROME; KTLS	0.000541419	0.020311956543392476
KIFAFA SEIZURE DISORDER	0.000541419	0.020311956543392476
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.020311956543392476
MEHMO SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
KRABBE DISEASE	0.000541419	0.020311956543392476
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000541419	0.020311956543392476
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.020311956543392476
ACROCALLOSAL SYNDROME; ACLS	0.000541419	0.020311956543392476
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.020311956543392476
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392476
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.020311956543392476
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.020311956543392476
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
HYPER-BETA-ALANINEMIA	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.020311956543392476
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020311956543392476
SNEDDON SYNDROME	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020311956543392476
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392476
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392476
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392476
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.020311956543392476
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.020311956543392476
HYPERPROLINEMIA, TYPE II	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020311956543392476
PARIETAL FORAMINA	0.000541419	0.020311956543392476
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020311956543392476
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.020311956543392476
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392476
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392476
ADDISON DISEASE	0.000541419	0.020311956543392476
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020311956543392476
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.020311956543392476
ISOLATED SPINA BIFIDA	0.000541419	0.020311956543392476
CROME SYNDROME	0.000541419	0.020311956543392476
SNEDDON SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020311956543392476
EPILEPSY, READING	0.000541419	0.020311956543392476
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392476
SJÖGREN-LARSSON SYNDROME	0.000541419	0.020311956543392476
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.020311956543392476
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.020311956543392476
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.020311956543392476
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.020311956543392476
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.020311956543392476
DARIER-WHITE DISEASE; DAR	0.000541419	0.020311956543392476
CROUZON SYNDROME	0.000541419	0.020311956543392476
SECKEL SYNDROME 1; SCKL1	0.000541419	0.020311956543392476
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.020311956543392476
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.020311956543392476
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.020311956543392476
HUNTINGTON DISEASE; HD	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392476
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020311956543392476
OHDO SYNDROME	0.000541419	0.020311956543392476
ENCEPHALITIS LETHARGICA	0.000541419	0.020311956543392476
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
DYSOSTEOSCLEROSIS	0.000541419	0.020311956543392476
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.020311956543392476
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020311956543392476
INSULINOMA	0.000541419	0.020311956543392476
SCRUB TYPHUS	0.000541419	0.020311956543392476
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.020311956543392476
PFEIFFER SYNDROME TYPE 3	0.000541419	0.020311956543392476
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000541419	0.020311956543392476
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.020311956543392476
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020311956543392476
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.020311956543392476
MPDU1-CDG	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.020311956543392476
MOYAMOYA DISEASE	0.000541419	0.020311956543392476
MOYNAHAN SYNDROME	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.000541419	0.020311956543392476
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020311956543392476
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392476
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000541419	0.020311956543392476
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020311956543392476
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.020311956543392476
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.020311956543392476
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020311956543392476
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392476
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020311956543392476
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.020311956543392476
MOMO SYNDROME	0.000541419	0.020311956543392476
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020311956543392476
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.020311956543392476
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.020311956543392476
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.000541419	0.020311956543392476
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.020311956543392476
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020311956543392476
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020311956543392476
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.020311956543392476
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
AICA-RIBOSIDURIA	0.000541419	0.020311956543392476
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020311956543392476
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.000541419	0.020311956543392476
PINEOBLASTOMA	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392476
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020311956543392476
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.020311956543392476
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020311956543392476
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.020311956543392476
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.020311956543392476
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000541419	0.020311956543392476
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392476
RAMON SYNDROME	0.000541419	0.020311956543392476
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.020311956543392476
ATYPICAL RETT SYNDROME	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.020311956543392476
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.020311956543392476
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000541419	0.020311956543392476
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.020311956543392476
15Q OVERGROWTH SYNDROME	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.000541419	0.020311956543392476
QAZI-MARKOUIZOS SYNDROME	0.000541419	0.020311956543392476
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.020311956543392476
XP22.13P22.2 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
NASU-HAKOLA DISEASE	0.000541419	0.020311956543392476
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.020311956543392476
MICROFORM HOLOPROSENCEPHALY	0.000541419	0.020311956543392476
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020311956543392476
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.020311956543392476
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
PROLACTINOMA	0.000541419	0.020311956543392476
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392476
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020311956543392476
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020311956543392476
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
PORENCEPHALY	0.000541419	0.020311956543392476
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.020311956543392476
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.020311956543392476
RING CHROMOSOME 10 SYNDROME	0.000541419	0.020311956543392476
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.020311956543392476
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.020311956543392476
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.020311956543392476
COFFIN-LOWRY SYNDROME	0.000541419	0.020311956543392476
FRONTAL ENCEPHALOCELE	0.000541419	0.020311956543392476
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020311956543392476
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.020311956543392476
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.020311956543392476
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392476
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020311956543392476
CADASIL	0.000541419	0.020311956543392476
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000541419	0.020311956543392476
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020311956543392476
BOWEN-CONRADI SYNDROME	0.000541419	0.020311956543392476
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.020311956543392476
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.000541419	0.020311956543392476
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020311956543392476
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.020311956543392476
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392476
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020311956543392476
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.020311956543392476
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.000541419	0.020311956543392476
DISTAL MONOSOMY 3P	0.000541419	0.020311956543392476
2Q24 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
ROSAÏ-DORFMAN DISEASE	0.000541419	0.020311956543392476
DISTAL TRISOMY 15Q	0.000541419	0.020311956543392476
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.020311956543392476
KNOBLOCH SYNDROME	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.020311956543392476
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.020311956543392476
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020311956543392476
CRISPONI SYNDROME	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.020311956543392476
CENTRAL DIABETES INSIPIDUS	0.000541419	0.020311956543392476
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.020311956543392476
ACROCARDIOFACIAL SYNDROME	0.000541419	0.020311956543392476
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.020311956543392476
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020311956543392476
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.000541419	0.020311956543392476
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020311956543392476
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.020311956543392476
CONGENITAL HYDROCEPHALUS	0.000541419	0.020311956543392476
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020311956543392476
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020311956543392476
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.000541419	0.020311956543392476
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020311956543392476
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.020311956543392476
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.020311956543392476
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020311956543392476
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020311956543392476
KABUKI SYNDROME	0.000541419	0.020311956543392476
SANJAD-SAKATI SYNDROME	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.020311956543392476
MOWAT-WILSON SYNDROME	0.000541419	0.020311956543392476
FRYNS SYNDROME	0.000541419	0.020311956543392476
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020311956543392476
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.020311956543392476
BETA-MANNOSIDOSIS	0.000541419	0.020311956543392476
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392476
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.020311956543392476
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.020311956543392476
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020311956543392476
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.020311956543392476
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020311956543392476
HARROD SYNDROME	0.000541419	0.020311956543392476
CYSTATHIONINURIA	0.000541419	0.020311956543392476
HENNEKAM-BEEMER SYNDROME	0.000541419	0.020311956543392476
ROMANO-WARD SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020311956543392476
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.020311956543392476
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392476
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.020311956543392476
LUJO HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
DPM1-CDG	0.000541419	0.020311956543392476
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000541419	0.020311956543392476
MUSCLE-EYE-BRAIN DISEASE	0.000541419	0.020311956543392476
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.020311956543392476
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.020311956543392476
CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392476
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392476
RENPENNING SYNDROME 1; RENS1	0.000541419	0.020311956543392476
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020311956543392476
MENKES DISEASE	0.000541419	0.020311956543392476
LOWE OCULOCEREBRORENAL SYNDROME	0.000541419	0.020311956543392476
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.020311956543392476
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020311956543392476
INCONTINENTIA PIGMENTI; IP	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020311956543392476
HHHH SYNDROME	0.000541419	0.020311956543392476
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.020311956543392476
NEVUS COMEDONICUS SYNDROME	0.000541419	0.020311956543392476
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.020311956543392476
COFFIN-LOWRY SYNDROME; CLS	0.000541419	0.020311956543392476
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.020311956543392476
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.020311956543392476
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.020311956543392476
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020311956543392476
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.020311956543392476
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392476
WHIM SYNDROME	0.000541419	0.020311956543392476
PALLISTER-KILLIAN SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.020311956543392476
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.020311956543392476
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020311956543392476
GURRIERI SYNDROME	0.000541419	0.020311956543392476
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020311956543392476
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.020311956543392476
RETT SYNDROME; RTT	0.000541419	0.020311956543392476
MICROPHTHALMIA, LENZ TYPE	0.000541419	0.020311956543392476
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000541419	0.020311956543392476
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020311956543392476
ONDINE SYNDROME	0.000541419	0.020311956543392476
TAY-SACHS DISEASE; TSD	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020311956543392476
ZUNICH NEUROECTODERMAL SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.020311956543392476
THREONINEMIA	0.000541419	0.020311956543392476
DEND SYNDROME	0.000541419	0.020311956543392476
EPISODIC ATAXIA TYPE 3	0.000541419	0.020311956543392476
FILIPPI SYNDROME; FLPIS	0.000541419	0.020311956543392476
LISSENCEPHALY, X-LINKED, 2	0.000541419	0.020311956543392476
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.020311956543392476
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020311956543392476
HEREDITARY COPROPORPHYRIA	0.000541419	0.020311956543392476
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392476
RAMON SYNDROME	0.000541419	0.020311956543392476
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.020311956543392476
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020311956543392476
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000541419	0.020311956543392476
RABIES	0.000541419	0.020311956543392476
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.000541419	0.020311956543392476
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.020311956543392476
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.020311956543392476
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020311956543392476
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020311956543392476
FAMILIAL THROMBOCYTOSIS	0.000541419	0.020311956543392476
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392476
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.020311956543392476
CLARK-BARAITSER SYNDROME	0.000541419	0.020311956543392476
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020311956543392476
PORPHYRIA	0.000541419	0.020311956543392476
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.020311956543392476
ATKIN-FLAITZ SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020311956543392476
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.020311956543392476
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS 2	0.000541419	0.020311956543392476
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392476
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.020311956543392476
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.000541419	0.020311956543392476
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392476
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000541419	0.020311956543392476
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020311956543392476
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.020311956543392476
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392476
PERRAULT SYNDROME 3	0.000541419	0.020311956543392476
ADIPOSIS DOLOROSA	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.020311956543392476
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020311956543392476
NOONAN SYNDROME 7; NS7	0.000541419	0.020311956543392476
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392476
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.020311956543392476
RETT SYNDROME, CONGENITAL VARIANT	0.000541419	0.020311956543392476
GALACTOSIALIDOSIS	0.000541419	0.020311956543392476
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.020311956543392476
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.020311956543392476
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392476
RENPENNING SYNDROME	0.000541419	0.020311956543392476
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000541419	0.020311956543392476
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020311956543392476
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020311956543392476
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.020311956543392476
TAKAYASU ARTERITIS	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.000541419	0.020311956543392476
CHIME SYNDROME	0.000541419	0.020311956543392476
TETRASOMY 18P	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.020311956543392476
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.020311956543392476
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.020311956543392476
SECKEL SYNDROME 7; SCKL7	0.000541419	0.020311956543392476
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.000541419	0.020311956543392476
WORSTER-DROUGHT SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.020311956543392476
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.020311956543392476
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020311956543392476
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020311956543392476
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020311956543392476
GLUTAMINE DEFICIENCY, CONGENITAL	0.000541419	0.020311956543392476
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.020311956543392476
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020311956543392476
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.020311956543392476
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.000541419	0.020311956543392476
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.020311956543392476
ALZHEIMER DISEASE 3; AD	0.000541419	0.020311956543392476
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.020311956543392476
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.020311956543392476
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392476
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.020311956543392476
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020311956543392476
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020311956543392476
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392476
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020311956543392476
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.000541419	0.020311956543392476
EPISODIC ATAXIA, TYPE 6	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.020311956543392476
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
MALAN OVERGROWTH SYNDROME	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.020311956543392476
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.020311956543392476
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392476
KEPPEN-LUBINSKY SYNDROME	0.000541419	0.020311956543392476
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000541419	0.020311956543392476
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA	0.000541419	0.020311956543392476
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020311956543392476
